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ABSTRACT
This study characterized the oxidative biotransformation capacity of the hepatic 
cytochrome P-450 system o f selected avian species representing the Galliformes 
(chicken, turkey and Japanese quail) and Anseriformes (goose, Pekin duck, Khaki 
Campbell duck, and Muscovy duck) orders. Two objectives were addressed; first, 
important biotransformation pathways were evaluated in economically major and 
minor food-producing avian species to provide a framework on which to base drug 
approval decisions in these species. Second, the potential use of the selected species 
as sentinel organisms utilizing cytochrome P-450 induction as a biomarker of 
environmental chemical exposure was evaluated. The male rat was utilized for the 
mammalian model and as a point of reference. Two groups of animals for each 
species were evaluated, a control group, which received no treatment, and a treatment 
group which was administered /3-naphthoflavone (/3NF). Investigations included the 
quantitation of microsomal protein, cytochrome P-450, NADH- and NADPH- 
cytochrome c reductase activity, ethoxyresorufin O-deethylase activity and 
benzo[<z]pyrene hydroxylase activity with the development of profiles for four major 
metabolites.
\
This study found that constitutive microsomal protein levels, cytochrome P-450 
content, NADPH-cytochrome c reductase activities and ethoxyresorufin 0-deethylase 
activities were similar among the species studied while NADH-cytochrome c reductase 
activities differed. In response to /3NF, microsomal protein levels, cytochrome P-450
content, and ethoxyresorufin 0-deethylase activities were increased but no change was 
observed in NADPH- or NADH-cytochrome c reductase activities. Interspecies 
differences were observed in the response of the hepatic microsomal system to /3NF 
treatment.
Interspecies differences were also observed in the capacity of the avian hepatic 
microsomal system to hydroxylate benzo[a]pyrene and in the effect of (3NF treatment 
upon metabolite production. 3-Hydroxybenzo[a]pyrene was the primary metabolite 
produced by all the species studied; interspecies and interorder differences in product 
distributions were observed for the 9-hydroxybenzo[a]pyrene, benzo[a]pyrene 7,8- 
dihydrodiol and benzo[a]pyrene 9,10-dihydrodiol metabolites.
1.0. INTRODUCTION
The hepatic cytochrome P-450 enzyme system functions in the metabolism of 
exogenous as well as endogenous compounds and, therefore, plays a critical role in 
controlling the biological activities of drugs, toxins and other xenobiotics. Extensive 
research in the biotransformation of xenobiotics has led to recognition of the biological 
importance of this system. The majority of cytochrome P-450 studies have been 
directed at the characterization of the mammalian hepatic microsomal system. 
Consequently, relatively little is known about the hepatic cytochrome P-450 system 
o f avian species. Hence, further studies on the processes of xenobiotic metabolismin 
avian species were deemed necessary to evaluate potential risks in the use of drugs, 
pesticides and other chemicals in the poultry industry and for interpreting responses 
o f domestic and wildlife avian species to environmental toxicological challenges.
The present study was conducted to characterize the oxidative capacity of the hepatic 
microsomal systems of Anseriformes and Galliformes birds' utilizing a model 
substrate, benzo[a]pyrene (B[a]P). The oxidative metabolic pathways of B[a]P have 
been well described in laboratory rodents and to a lesser extent in birds. Cytochrome 
P-450 activities in control and /3-naphthoflavone (/JNF) treated groups of avian species 
were measured and comparison of these activities were made between avian species, 
between avian orders and between avian species and a mammalian model, the rat.
'The avian species considered were the White Leghorn chicken (G allus gallus), Japanese quail (Coturnix  
coturnix), turkey (M elegris ga llopavo), Khaki Campbell duck (Anscr p latyrhynchos), Pekin duck (Anser 
platyrhynchos), M uscovy duck ( Cairina m oschata) and goose (A nser anser).
1
2The resulting database provided the tools to evaluate two distinct areas of scientific 
interest and public concern which may be profoundly affected by the activities of the 
cytochrome P-450 system. These areas include drug approval processes in minor 
food-producing avian species; and the use of domestic avian species as environmental 
sentinels for ecotoxicological studies. Two objectives were addressed by this study. 
First, an important biotransformation pathway was evaluated in economically major 
and minor food-producing avian species to provide a framework on which to base 
drug approval decisions in these species. Second, the potential use o f the selected 
species as sentinel organisms utilizing cytochrome P-450 induction as a biomarker of 
environmental chemical exposure was evaluated. The research described herein has 
served to initiate a database for addressing these areas for selected avian species.
1.1 Approval of Minor Use New Animal Drugs
The Food and Drug Administration (FDA) has the responsibility of ensuring that 
animal drugs are effective and safe for their intended use and that food products 
derived from medicated animals are safe for human consumption. This responsibility 
stems from the 1968 amendment to the Federal Food, Drug and Cosmetic Act which 
set forth regulations governing the use of animal drugs (21 CFR 500-599). These 
amendments specifically address the safe and effective use of animal drugs and the 
prevention of unsafe drug residues in products intended for human consumption (Food 
and Drug Administration, 1992). Minor use new animal drugs are defined by the 
FDA as drugs "(1) used in minor species of animals or (2) used in animal species for
the control of a disease that occurs infrequently and in limited geographic areas." 
(Food and Drug Administration, 1979; Food and Drug Administration, 1983; 21 CFR 
514.1). For purposes of drug approval, the FDA defines minor species as "animals 
other than cattle, horses, swine, chickens, turkeys, dogs, and cats" (Food and Drug 
Administration, 1979; Food and Drug Administration, 1983; 21 CFR 514.1). Due 
to the economic limitations o f the minor species industry, no drugs have received 
approval for use in control of disease in minor avian species. Lack of treatment in 
diseased flocks may result in injury or death of affected individuals and may 
potentially result in a significant loss in production, and may eventually present health 
hazards to other species or to humans whether by direct or indirect contact, or by 
serving as a source of unwholesome food products for human consumers (Food and 
Drug Administration, 1983). Of equal concern to regulatory agencies is that use of 
non-approved drugs in minor species may result in unexpected or unusual drug 
metabolism with bioaccumulation of drug or metabolites and possible development of 
organisms resistant to the compound and its marketed analogs (Food and Drug 
Administration, 1983).
In recognition of these issues and in an attempt to encourage the submission of 
applications for needed minor use drugs, the FDA proposed, in July 1979, to amend 
the animal drug regulations (21 CRF 514.1) to provide for the use of supporting safety 
and effectiveness data in the approval of new animal drug applications. Concurrent 
to the issuance of this proposal, guidelines specifying the types of data needed to meet
4the requirements of animal safety and effectiveness, as set forth in the Animal Drug 
Act, were issued by the FDA. These guidelines included specific requirements for 
studies of drug applications in domestic ducks and game birds (Food and Drug 
Administration, 1979; Food and Drug Administration, 1986; Food and Drug 
Administration, 1986a). In January 1983, the final ruling on new animal drug 
applications was issued allowing sponsors, where appropriate, "to use data supporting 
an approved major use of a drug to support a new animal drug application for a minor 
use of the same drug" (Food and Drug Administration, 1983). In general, these 
regulations require prior approval of the drug in a major species in conjunction with 
supporting metabolic and residue data in the minor species (Juskevich, 1987). To 
further promote drug approval in minor species, the Food and Drug Administration 
Center for Veterinary Medicine (FDA/CVM) is exploring the use of alternative studies 
to satisfy the data requirements set forth by the animal drug regulations (Juskevich,
1987).
In support of this objective, the FDA/CVM sponsored an extramural drug research 
program for minor species (Dalvi, 1988; Juskevich, 1987; Teske, 1987; Short et al.,
1988). The objectives of this program were to "investigate the comparative 
physiology, metabolism, pharmacology, and toxicology of major and minor animal 
species and to study the applications and limitations of pharmacokinetic parameters 
as a basis for the extrapolation of data from approved major use drugs to minor use 
drugs for fish, game birds, goats, rabbits, and similar food animals" (Teske, 1987).
A portion of the FDA/CVM program was implemented as a consortium between 
Louisiana State University. Auburn University, University of Illinois, and Mississippi 
State University (Teske, 1987).
As part o f the program, a study was conducted on the comparative metabolism and 
disposition of fenbendazole in minor species (Short, et al., 1988). One phase of this 
project included a comparative study of the metabolism of fenbendazole by the hepatic 
microsomal enzyme system of the chicken, turkey, and duck. In summary, dramatic 
differences in the rate of p-hydroxylation of fenbendazole were observed among these 
avian species. Furthermore, the results showed that for the avian subset studied, the 
differences in oxidative metabolism were often greater between major species within 
an order (chicken and turkey) than between a minor species (duck) and a member of 
the major species group of another order. Studies utilizing model substrates were 
conducted to compare a variety of other microsomal activities in these avian species 
and it was found that for the various microsomal activities evaluated, the metabolic 
capacity of the duck was frequently different from that of the chicken and turkey. 
Taken together, these observations necessitated further studies in which certain 
metabolic activities of the avian Galliformes and Anseriformes orders were compared 
(Short et al., 1988 and Short, et al., 1988a).
In order to address the need for further information on comparative oxidative 
metabolism in minor and major avian species, the research project described in this
dissertation was undertaken. A major objective of this study was to characterize the 
aryl hydrocarbon hydroxylase (AHH) activity in Galliformes and Anseriformes birds 
utilizing the classical substrate model, benzo[a]pyrene. Characterization of a specific 
mixed function monooxygenase (MFO) activity, e.g. aryl hydrocarbon hydroxylation, 
has provided data for the estimation of the activity of this system and for the relative 
rate of oxidation of structurally similar, untested compounds in the represented avian 
species (Walker, 1978). Therefore, a major objective of this research was to provide 
information on the cytochrome P-450-dependent metabolic capacity of seven avian 
species for a given class of xenobiotics and to characterize the differences in 
metabolism of model compounds between the species. This objective was intended 
to develop tools to support interpretation of data submitted for the purpose of 
obtaining approval of minor use avian drugs.
1.2 Avian Species as Sentinels in Ecotoxicological Studies
1.2.1 Biological Markers
Chemical contamination of the environment has become a major public concern 
throughout the last half century (Basscietto, et al., 1990; Carson, 1962; De Witt, 
1955; Harris, et al., 1990; Keith, 1966; Mendelssohn, 1962; Ratcliff, 1967; Peakall, 
1967; Stickel, 1946). In recognition of this concern, the identification, 
characterization, and remediation of hazardous waste sites has become a top priority 
of the U.S. Environmental Protection Agency (EPA), which has a major objective of 
protecting human health and the environment. The regulations governing these
activities, the Comprehensive Environmental Response Compensation and Liability 
Act (CERCLA), as amended by the Superfund Amendment and Reauthorization Act 
(SARA), stipulate that the remedial actions implemented at a hazardous waste site 
achieve protection of terrestrial and aquatic organisms (Environmental Protection 
Agency, 1989). In an effort to comply with these regulations, considerable attention 
has been focused on the assessment of ecological risks (Bascietto, et al., 1990). This 
focus has lead to the realization in scientific and regulatory communities that cause 
and effect relationships associated with environmental chemical exposures are poorly 
understood and that research into environmental toxicology is of paramount 
importance for evaluating impacts to ecological systems and for achieving compliance 
with environmental regulations.
Utilization of biological markers in plants and animals (sentinel species) has been 
explored as an innovative approach for assessing environmental quality and chemical 
exposure (Ahokas, et al., 1976; Beardsley, et al., 1978; Bend, et al., 1977; 
Elangbam, et al., 1989; Fossi, et al., 1992; Khattab, et al., 1993; Knight and Walker, 
1982a; Kurelec, et al., 1977; Lubet, et al., 1992; McCarthy and Shugart 1990; 
Payne, 1976; Payne, 1977; Peakall, 1967; Peakall et al., 1987; Rattner et al., 1989; 
Sandhu and Lower, 1989; Talmage and Walton, 1991; Walker, 1992). A sentinel 
species could be any domestic or wild animal, plant or microorganism that can serve 
as an indicator of chemical exposure for the purpose of assessing the potential impacts 
of pollution on environmental and human health (EPA, 1991). A sentinel species may
be a organism indigenous to the area of concern or it may be a "control" organism 
confined at the site for the assessment of in-situ exposures (DiGiulio, 1989; Sandhu 
and Lower, 1989; Shugart, et al. 1992) . The use of sentinel species for this purpose 
is referred to as biological monitoring or biomonitoring (EPA 1991). The term 
biological marker, or biomarker, refers to the measurement of a physiological or 
biochemical parameter in individual organisms that serves as a sensitive indicator of 
environmental chemical exposure and sublethal stress (Baker, 1989). The use of 
biomarkers in the evaluation of environmental contamination presents a unique 
opportunity for environmental managers to obtain information concerning potential 
ecological impacts that is not available from the chemical analyses of affected 
environmental media and/or tissues of exposed organisms routinely conducted at 
hazardous waste sites. Biomarker data can provide a measure of environmental 
chemical exposure as well as a measure of the magnitude of the organism’s response 
to the exposure (McCarthy and Shugart 1990; Shugart, et al., 1992). Biornarkers can 
validate the biological significance of chemical exposure on a site-specific basis by 
providing evidence that the chemical(s) was absorbed by the organism, distributed 
within the tissues, and that a physiological or biochemical response was elicited at a 
critical target (McCarthy and Shugart 1990). This type of data, in conjunction with 
laboratory studies, can aid in the elucidation of dose-response relationships for 
environmental chemical exposure in wildlife species (Baker, 1989). Furthermore, 
biomarkers can provide a biologically relevant indication of the cumulative effect of 
toxicological and pharmacological interactions associated with exposure to chemical
9mixtures. Biomarkers used in conjunction with site-characterization data can provide 
an indication of bioavailability. These can also provide evidence of exposure to 
constituents that are readily metabolized and excreted, and therefore do not 
bioaccumulate, such as organophosphates and polycyclic aromatic hydrocarbons 
(PAHs) (Baker, 1989; Khattab, et al., 1993; McCarthy and Shugart 1990; Sandhu and 
Lower, 1989; Shugart, et al. 1992; Walker, 1992). Biomarker data can also serve as 
an indicator that basic physiological or biochemical responses have been disrupted at 
defined concentrations of environmental chemicals which in turn can provide valuable 
input to the assessment of potential human health hazards associated with a hazardous 
waste site (Baker, 1989; McCarthy and Shugart 1990; Sandhu and Lower, 1989). 
Based on these considerations, it is apparent that biological monitoring is an 
informative and logical complement to routine sampling of contaminated media for the 
assessment of ecological impacts resulting from chemical releases to the environment.
1.2.2 Mixed-Function Monooxygenases as Biological Markers
Many common and toxicologically significant contaminants, such as PAHs, 
polychlorinated biphenyls, polybrominated biphenyls, dioxins, petroleum 
hydrocarbons, organochlorine pesticides, and organophosphorus insecticides, are 
known inducers of the MFO system (refer to Section 2.1.3 for a discussion on 
induction of the MFO system). Based on this, induction of the MFO system has been 
examined for its potential use as a biomarker of environmental exposure to these types 
of constituents (Bend, et al., 1977; DiGiulio, 1989; Kleinow, et al., 1987; Knight and
Walker, 1982a; Jimenez, et al., 1990; Kurelec, et al., 1977; Payne, 1976; Payne, 
1977; Payne, J .F ., 1987; Rattner, et al., 1989; Shugart, et al., 1992; Walker and 
Ronis, 1989). In addition, there has been considerable interest in the critical role of 
the MFO system in xenobiotic detoxification and the toxicological implications 
associated with induction of this system (DiGiulio, 1989; Kleinow, et al., 1987; 
Hutson, et al., 1991; Rattner, et al., 1989; Payne, J .F ., 1987; Peakall, 1967; Sell, 
et al., 1971; Walker, 1991; Walker, et al., 1991; Varanasi, et al., 1987). One area 
of interest that has been identified is the potential for increased xenobiotic activation 
and the augmentation of toxicity in organisms subjected to chronic environmental 
chemical exposures. Other concerns include the induction of tumors and reproductive 
impairment due to imbalances in the synthesis and metabolism of endogenous steroids. 
There has also been considerable interest in the potential for exposed organisms to 
develop an increased capacity for xenobiotic detoxification with the subsequent 
development of tolerance.
The use of MFO induction as an indicator of environmental chemical exposure offers 
a number of advantages in biological monitoring programs (Baker, 1989). Induction 
of the MFO system is usually detectable in exposed organisms prior to the onset of 
more serious pathologies. Therefore this response can be used as an early warning 
signal that basic biological processes have been altered as a result of environmental 
chemical exposure. And, unlike other physiological or biochemical responses to 
chemical stress, MFO induction is indicative of a detoxification response (Payne, et
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al., 1987). Mixed-function oxidase studies can be conducted under both laboratory 
and field conditions, thus providing an important linkage between traditional toxicity 
testing and effects observed under field conditions (Baker, 1989). For example, dose- 
response relationships established for MFO induction under laboratory conditions 
provide important data for making decisions concerning the "acceptability" or "non­
acceptability" of chemical concentrations detected in the environment. Mixed-function 
oxidase measurements made in the field provide an important index o f bioavailability 
and biological response for actual exposure conditions (DiGiulio, 1989). And, since 
MFO induction is a biochemical response that crosses taxonomic lines, M FO data 
obtained in sentinel species can provide inferences for potential human health effects 
(Baker, 1989; DiGiulio, 1989).
Characterization of the mixed-function oxygenase system provides information on the 
constitutive and inducible properties of the xenobiotic-metabolizing enzymes of 
organisms that may be exposed to chemicals released to the environment. Studies of 
this nature can serve to identify species which may be more, or perhaps less, 
susceptible to environmental pollution due to the presence, or absence, o f certain 
constitutive MFO enzymes or due to the inducibility, or lack of inducibility, of 
specific MFO enzymes (Walker, 1978). For example, the increased susceptibility of 
certain avian species to environmental contamination has been linked to species- 
specific characteristics of the hepatic MFO system (Knight and Walker, 1982a; 
Peakall, 1967; Knight, e ta l. ,  1981; Walker, et al. 1987; Walker, et al., 1991). The
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detoxification of environmental contaminants, particularly pesticides, by food- 
producing avian species such as the chicken, turkey, goose and duck is also an 
important concern for the protection of human health (Walker and Ronis, 1989).
Because MFO induction responds rapidly to changes in environmental quality, it can 
serve as an early and sensitive warning system for the detection of potentially 
significant ecological effects due to environmental contamination. Biological 
monitoring of the MFO system of ecological species can serve as a practical and 
economical tool for environmental managers faced with real or perceived concerns 
regarding chemicals present at, or migrating from, a hazardous waste site (Payne, et 
al., 1987). Mixed-function oxidase biomarkers can also be used as short-term 
indicators of changes in exposure conditions associated with changes in environmental 
quality and thus can serve to delineate boundary limits for point sources of 
contamination and provide a practical method to assess improvements in 
environmental quality associated with remedial efforts (Payne, et a l. , 1987 and Flarris, 
et a l., 1990).
1.2.3 Historical Perspective on the Use of Mixed-Function Monooxygenases as 
Biological Markers
Induction of the MFO system has been validated as a biomarker of environmental 
chemical exposure in a number of wildlife species (Payne, et al., 1987; Lubet, et al., 
1990). The majority of work in the field of MFO biomarkers has focused on aquatic 
invertebrates and fish. Research efforts have successfully demonstrated that a variety
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of organic chemicals, when released into an aquatic system, result in MFO induction 
and that the response is of such sensitivity that it can be used to assess water quality 
overbroad geographic regions (Kleinow, et al., 1987; Payne, J .F ., 1987; Rattner, et 
al., 1989). However, data on the applicability of MFO induction to monitor exposure 
in other wildlife species, such as mammals, birds, reptiles, and amphibians is very 
limited (Rattner, et al., 1989). Interest in the MFO activity of these groups has 
increased in recent times due to the continuing concern over the environmental and 
biological fate of lipophilic contaminants released to the environment (Walker and 
Ronis, 1989). This interest has lead to the characterization of baseline MFO activity 
in a variety of avian species (Fossi, et a l., 1986; Peakall, et a l., 1987; Knight and 
Walker, 1982; Knight and Walker 1982a; Walker, et al., 1991). In addition, a 
number of environmentally important chemicals have been demonstrated to induce the 
hepatic mixed-function oxidase system of avian species (Pan and Fouts, 1978). This 
finding has lead researchers to recognize the applicability of induction o f the avian 
monooxygenase system as a biochemical indicator of environmental chemical exposure 
(Ronis and Walker, 1989). Available data on the effects of environmental 
contamination on avian species suggest that the measurement of MFO activity in 
embryos and hatchlings may be useful as a biomonitoring tool (Rattner, et a l., 1989; 
Hoffman, et a l., 1990). Data generated to date with adult birds indicate that there is 
high variability in MFO activity among individuals and therefore, the relationship 
between exposure and induction is much less predictable (Buckpitt and Boyd, 1982; 
Fossi, et al., 1990; Peakall, et al., 1987; Rattner, et al., 1989). Consequently,
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researchers have concluded that a more detailed characterization of the avian MFO 
system, and the factors that influence it, is needed before MFO responses can be 
applied as a routine biomarker of environmental contamination (Fossi, et a l., 1990; 
Jimenez, et al., 1990; Knight, et a l., 1981; Peakall, et a l., 1987; Rattner, et a l., 
1989; Ronis and Walker, 1985).
Substrates that have been used to characterize induction of the cytochrome P-450 
system associated with chemical exposure include cytochrome c (as a measure of 
NADPH cytochrome P-450 reductase activity), benzo[a]pyrene, ethoxyresorufin, 
pentoxyresorufin, benzyloxyresorufin, ethoxycoumarin, benzphetamine, aldrin, 
aniline, aminopyrine, ethylmorphine, and p-nitroanisole (Lubet, et a l., 1990; Payne, 
et a l., 1987; Peakall, et al., 1986; Rattner, et al., 1989; Simmons and McKee, 1992; 
Walker, et al., 1991). The efficacy of using AHH and 7-ethoxyresorufin-O- 
deethylase (EROD) activities as indicators of exposure to 3-methylchloanthrene 
(3MC)-type environmental chemical inducers has been established by a number of 
investigators for a variety of wildlife species including birds (Lubet, et al., 1990; 
Simmons and McKee, 1992; Payne, 1976; Rattner, et al., 1989; Mineau, et al., 
1984; Gilbertson and Fox, 1977; Ellenton, et a l., 1985; Jewell, et al., 1989; Kleinow, 
et a l., 1987; Knight and Walker, 1982; Lubet, 1992; Hoffman, et a l., 1987; Martin, 
et al., 1987; Walker, 1991). Due to the degree of variation in substrate specificity 
of phenobarbital (PB)-inducible forms of cytochrome P-450, pentoxyresorufin and 
benzoxyresorufin dealkylase activities have been recommended as sensitive biomarkers
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of P-450 induction for the detection of exposure to phenobarbital-type environmental 
inducers in mammals (Lubet, et al., 1990; Simmons and McKee, 1992). However, 
preliminary studies indicate that the chicken has very low basal levels of 
pentoxyresorufin depentylase and that this activity is not inducible by phenobarbital 
in this species (Lorr and Bloom, 1987). Therefore, the use of this activity for 
biomonitoring purposes in avian and other nonmammalian species requires further 
study. Hepatic MFO activities are most commonly utilized for biomonitoring 
purposes but some work has been done to characterize induction of MFO systems 
present in other tissues such as the skin, kidney, and duodenum (Lubet, et al., 1990; 
Knight and Walker, 1982).
The development and inteipretation of biomarker responses and the validation and 
application of biomarker-based monitoring is a relatively new field (Shugart, et a l., 
1992) and the association between MFO induction and environmental contamination 
has not yet been unequivocally demonstrated (Payne, J .F ., 1987; Rattner, et al., 
1989.) Nevertheless, based on the demonstrated success of using MFO induction as 
a biomarker in aquatic species and the encouraging data generated in other wildlife 
species, further study on the use of MFO activity as a biomonitoring tool is warranted 
(Rattner, et a l . , 1989). Numerous directions for future research in wildlife MFO have 
been proposed by investigators. Recommendations relevant to this study include: 
characterization of constitutive and inducible cytochrome P-450 isozymes in avian 
species (Rattner, e ta l., 1989); evaluation o f the inducibility of the hepatic cytochrome
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P-450 system in avian species (Rattner, et a l., 1989); and investigations of the 
metabolism of environmentally relevant substrates, such as benzo[a]pyrene including 
the quantitation of individual metabolites by HPLC analysis (Payne, et al., 1987).
The second specific objective of this study was, therefore, to characterize AHH and 
EROD activities in control and |3NF-treated Anseriformes and Galliformes birds to 
evaluate the use o f cytochrome P-450 induction as a biomarker of environmental 
chemical exposure in avian species.
2.0 LITERATURE REVIEW
2.1 Cytochrome P-450-Dependent Mixed Function Monooxygenase System
The cytochrome P-450 dependent mixed function monooxygenases were first identified 
in 1958 as a reduced pigment characterized by a maximum absorption of light (Soret 
band) at 450 nm when bound to carbon monoxide (Klingenberg, 1958; Garfinkle, 
1958). In 1961, Omura and Sato provided evidence that this pigment was a new P- 
450 cytochrome of liver microsomes and that the unique spectral properties of this 
hemoprotein were lost when dissociated from the microsomal membrane (Omura and 
Sato, 1962; Omura and Sato, 1964, Omura and Sato, 1964a). In 1965, researchers 
identified the P-450 hemoprotein as having a role in the microsomal mixed function 
monooxygenase system (Cooper, et al., 1965; Omura et al., 1965). Since that time, 
the cytochrome P-450 system has been studied intensely leading to the recognized 
importance of the physiological and detoxification roles this system plays within the 
biological system (Ioannides, et a l., 1984). In the physiological role, the MFO 
system functions in the biosynthesis and metabolism of endogenous substances such 
as steroid hormones, bile acids, cholesterol, fatty acids, and vitamin D (Coon et al., 
1992; Gonzalez, 1989; Kupfer, 1980; Parke, 1980; Waterman, et al., 1986). In the 
detoxification role, the cytochrome P-450 monooxygenases function in the metabolism 
of foreign chemicals, thus providing a protective mechanism against the accumulation 
and harmful effects of these chemicals (Ioannides, et al., 1984).
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In general, chemicals that are fat-soluble are readily absorbed through the 
gastrointestinal tract, lungs and skin, but are poorly excreted. These chemicals are 
metabolized to more water-soluble, polar metabolites. This process serves to enhance 
excretion of the xenobiotics. Biotransformation refers to the metabolic conversion to 
which a xenobiotic is subjected following uptake by an organism. The 
biotransformation of xenobiotics is catalyzed by a group of enzymes located primarily 
in the liver. The biotransformation reactions catalyzed by these enzymes have been 
defined by Williams (1959) to include oxidations, reductions, hydrolyses, and 
syntheses. These reactions occur sequentially and the extent to which a substrate 
undergoes metabolism is primarily dependent on chemical structure. Many 
xenobiotics are metabolized by a series of reactions which include oxidation, 
reduction, and/or hydrolysis followed by a synthetic reaction. However, there are 
some compounds that are metabolized via oxidation, reduction, or hydrolysis and do 
not undergo a subsequent synthetic reaction. Ethanol is an example of such a 
compound. Other compounds, such as phenol, do not undergo oxidation, reduction 
or hydrolysis but rather are metabolized solely via synthesis reactions. Some 
chemicals may be sufficiently polar to be excreted unchanged and thereby bypass 
metabolism altogether (Williams, 1967). Oxidation, reduction and hydrolysis 
reactions serve 2 functions: (1) to introduce a functional group into the molecule to 
enhance the water solubility, and thus, promote excretion, and (2) to transform the 
molecule to a suitable substrate for synthetic or conjugation reactions. The synthesis 
reactions function to conjugate xenobiotics directly or those metabolites produced by
19
the oxidation, reduction or hydrolysis reactions with endogenous moieties to further 
enhance water solubility and excretion. Representative compounds or groups involved 
in conjugation processes include glucuronic acid, glutathione, glycine, methionine as 
well as miscellaneous agents such as acetyl, sulfate and thio group functionalities 
(Williams, 1959; Williams 1967). The cytochrome P-450-dependent mixed function 
monooxygenases are the major enzyme system involved in oxidation and reduction 
biotransformations. Other enzymes which may function in the initial metabolism of 
xenobiotics include the flavin-containing monooxygenases; these were historically 
referred to as the mixed function amine oxidases (Kimura, et al., 1983; Sabourin, et 
al., 1984; Zeigler, 1988; Zeigler and Mitchell, 1972). The mixed function amine 
oxidases often compete with cytochrome P-450 monooxygenases in the oxidation of 
amine, hydrazine, and organic sulfur compounds.
2.1.1 Properties and Characteristics of the Cytochrome P-450 Monooxygenase 
System
The cytochrome P-450 monooxygenase system is a group of enzymes containing an 
iron-protopoiphyrin IX prosthetic group with molecular weights ranging from 
approximately 48,000 to 59,000 Daltons (Estabrook, 1984; Schlenk, et a l., 1993). 
The cytochrome P-450 system involved in the metabolism of xenobiotics consists of 
cytochrome P-450 and NADPH-cytochrome P-450 reductase at a molecular ratio of 
approximately 20 to 1, respectively (Guengerich, 1988). This system is in intimate 
association with the phospholipid matrix of the smooth endoplasmic reticulum (Fouts, 
1961; Holtzman, et al., 1968). The association of this system with the membrane
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structure of the endoplasmic reticulum serves to facilitate the interaction between the 
cytochrome P-450 molecule and the associated cytochrome reductase. It is 
hypothesized that the cytochrome P-450 enzymes are integral proteins of the 
membrane structure while the reductase is a peripheral protein anchored to the 
membrane surface via a hydrophobic peptide tail (Ito and Sato, 1969). Two 
hypotheses of membrane protein organization have been proposed to account for the 
transfer of electrons from one molecule of reductase to several molecules of 
cytochrome P-450. Yang and coworkers proposed that the fluid nature of the 
membrane allows the reductase molecule to transverse the membrane surface, allowing 
access to multiple P-450 molecules (Chapman, 1975; Lichtenberg, et a l., 1983; 
Strobel, et a l., 1970; Yang et a l., 1975). The second hypothesis proposed describes 
an organized protein complex within the membrane in which flavoprotein islands are 
surrounded peripherally by P-450 molecules (Estabrook, e ta l., 1971; Peterson, et al., 
1978). Other components of this system include cytochrome b5 and the associated 
reductase, NADH-cytochrome b5 reductase (Hildebrant and Estabrook, 1971). The 
cytochrome P-450 dependent monooxygenase system is concentrated predominantly 
in the liver. However, cytochrome P-450 enzymes are also present in all other 
tissues, with exception of erythrocytes and striated muscle (Guengerich, 1988).
In contrast, the cytochrome P-450 system involved in endogenous metabolism consists 
of cytochrome P-450 and may utilize ferredoxin (an iron-sulfur protein), adrenodoxin 
or cytochrome P-450 reductase as the electron donor system (Niramjan et al., 1984).
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These enzymes are located primarily in the mitochondria of steroidogenic tissues such 
as the adrenal cortex, testis, ovary, and placenta and in tissues involved in the 
metabolism of vitamin D such as the liver, kidney, and intestine (Waterman et al., 
1986). Some endogenous P-450 isozymes, like the detoxifying P-450s, are located 
in the endoplasmic reticulum of these tissues. The activities of endogenous P-450s 
are under the regulation of tissue-specific peptide hormones (Waterman, et a l . , 1986). 
Those located in the mitochondria, in general, have a high degree of catalytic 
specificity (Guengerich, 1988).
Cytochrome P-450 exists as a group of multiple isoforms rather than as a single 
enzyme form. These isoforms differ in their physicochemical properties, substrate 
specificity, enzyme kinetics, amino acid sequencing and immunological characteristics 
(Lu and West, 1980). A nomenclature system has been developed for the 
identification of P-450 isoforms, genes and transcripts based on evolution of the P-450 
superfamily (Nebert, et al., 1991). According to this system, the P-450 gene is 
indicated by the italicized root symbol CYP which denotes cytochrome P-450. This 
root symbol is followed by an Arabic number which designates the P-450 family. (By 
definition, P-450 isoforms within a family exhibit protein sequences which are >40%  
identical.) Following the family designation, the P-450 subfamily is indicated by a 
letter. [P-450 isoforms (mammalian) within the same subfamily demonstrate >55%  
homology]. Lastly, an Arabic number is used to denote the individual gene within the 
subfamily. The same nomenclature, but nonitalicized, is used for the mRNA and gene
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product (isozyme) (Nebert, et a l., 1991). Gene families designated 1 through 4 code 
for the cytochrome P-450 enzymes involved in primary xenobiotic metabolism. The 
cytochromes P-450 involved in steroid biosynthesis are coded for by gene families 11, 
17, 19, 21 and 22 (Gonzalez, 1989).
Individual cytochrome P-450 isoforms exhibit overlapping specificity with regard to 
substrate and the type of oxygenation reaction catalyzed. However, for certain 
substrates and reactions, varying degrees of selectivity may be demonstrated. This 
characteristic was first identified following the treatment of animals with the PAH 
3MC (Conney, 1967; Conney, et al., 1956; Conney et a l., 1957) and later with PB 
(Orrenius, 1965; Orrenius and Erickson, 1966; Orrenius, et a l., 1965). The isoforms 
induced following these treatments were noted to have different substrate specificities 
as well as different catalytic rates for similar substrates (Alvares et al., 1967; Sladek 
and Mannering, 1966; Sladek and Mannering, 1969; Sladek and Mannering, 1969a; 
Mannering, 1971; and Gnosspelius et a l., 1969). Following the isolation of these two 
hemoproteins and the correlation of specific catalytic activities with each, it was 
recognized that two distinct cytochrome P-450 enzymes, designated as cytochrome P- 
450 (induced by PB) and cytochrome P-448 (induced by 3MC), were present (Sladek 
and Mannering, 1966). The two most notable differences in these two families of 
cytochromes include differences in substrate binding sites and preference of substrate. 
The cytochrome P-450 isoforms, designated as CYP2B1 and CYP2B2, are inducible 
by PB and have a broad substrate specificity with an affinity for non-planar, bulky
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molecules. Specific substrates which interact with isozymes of the CYP2B subfamily, 
and are frequently used in the study of P-450 activity, include benzphetamine, 
ethylmorphine, aldrin, aminopyrine, and hexobarbital (Hodgson, et a l., 1980). In 
contrast, the isoforms inducible by 3MC and other PAHs, designated as CYP1A1 and 
CYP1A2, exhibit a narrow substrate specificity and react readily with rigid, planar 
molecules (Lewis, et al., 1986; Safe, et al., 1985). Substrates metabolized by this 
subfamily include benzo[a]pyrene, ethoxyresorufin, acetanilide, and p-nitrophenol 
(Hodgson, et al., 1980). However, differences in substrate specificity have been 
noted between the CYP1A1 and CYP1A2 isozymes. For example, both isozymes 
catalyze the metabolism of benzo[a]pyrene, but CYP1A1 has been demonstrated to be 
approximately 50 times more active than CYP1A2 (Ryan, et a l., 1980). Conversely, 
the CYP1A2 isozyme has been shown to be more active than CYP1A1 in the 
metabolism of aromatic amines (Hammons, et al., 1985). Another substrate, 
ethoxyresorufin, is metabolized almost exclusively by the CYP1A1 isozyme (Burke 
and Mayer, 1975; Guengerich, et a l., 1982; Goldstein, et a l., 1982). Substrates such 
as aniline, chlorpromazine and zoxazolamine are metabolized by both subfamilies of 
cytochromes (Lu and West, 1980).
Since the identification of these two important subfamilies of isozymes, researchers 
have identified over 150 cytochrome P-450 isoforms present in diverse phylogenetic 
groups which appear to be highly conserved through evolution (Coon, et a l., 1992).
24
The cytochromes P-450 that have been characterized in the rat are presented in Table 
1-1 (Nebert, et a l., 1991; Wrighton, 1990).
2 .1 .2  Functions of the Cytochrom e P-450 Monooxygenase System 
As previously noted, a major role of the microsomal cytochrome P-450 
monooxygenase system is to biotransform fat-soluble xenobiotics to hydrophilic 
metabolites that are more readily excreted. In this role, the microsomal 
monooxygenases function specifically to catalyze the oxidation of xenobiotics through 
the incorporation of one atom of molecular oxygen into the molecule with the 
reduction of the remaining oxygen atom to water (Brodie, et al., 1958; Estabrook and 
W erringloer, 1977; Gillette, 1971; Gillette, 1966; Hodgson and Dauterman, 1980). 
This oxidation process requires the following sequence of cytochrome P-450 reactions: 
(1) Cytochrome P-450, in its oxidized form (Fe+3), reacts with the substrate to form 
an enzyme/substrate complex; (2) NADPH, via NADPH-cytochrome P-450 reductase, 
transfers an electron to the complex resulting in the reduction of the heme moiety of 
cytochrome P-450 (Fe+2); (3) The reduced cytochrome P-450/substrate complex then 
combines with molecular oxygen; (4) NADPH, via NADPH-cytochrome P-450 
reductase, transfers a second electron to the complex and both accepted electrons, 
through an unknown mechanism, are transferred to the oxygen molecule creating an 
unstable, highly-reactive oxygen species. It is postulated that with some forms of 
cytochrome P-450, and with certain substrates, cytochrome b5 serves as a transferase
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Table 1-1
R at Cytochrom e P-450 Genes and  T heir P roducts
P-450 Gene1 Common N ame(s)1,2 Com m ents1,2,3,4’5
CYP1A1 c, 0NF-B PAH-inducible form; 
benzo[a]pyrene hydroxylase, 
ethoxy resorufin-O-deethylase
CYP1A2 P-448, d, HCB Isosafrole- and PAH-inducible form
CYP2A1 a l, a, 3, UT-F PAH-inducible form; 
testosterone 7a-hydroxylase
CYP2A2 a2, RLM2
CYP2A3 a3
CYP2B1 b, PB-4,PB-B PB-inducible form
CYP2B2 e, PB-5, PB-D PB-inducible form
CYP2B3 IIB3
CYP2B8 gene IV
CYP2C6 PB1, k, PB-C, pTF2, 
P45k
Constitutive and PB-inducible form
CYP2C6P (pseudogene)
CYP2C7 f, pTFl Constitutive
CYP2C11 h, M -l, 16a, 2c, 
UT-A, P450h
Constitutive
CYP2C12 i, 15(8, 2d, UT-1, P- 
450i
Constitutive
CYP2C13 + g , P450g Constitutive
CYP2C22 Md
CYP2C22 cll7
CYP2D1 d b l, UT-H Debrisoquine hydroxylase
CYP2D2 db2
CYP2D3 db3
CYP2D4 db4 .......................................
(table continued)
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Table 1-1
R at Cytochrom e P-450 Genes and T heir P roducts
CYP2D5 db5, C M Flb
CYP2E1 j ,  P450j Ethanol-, acetone-, isoniazid, 
pyrazole- inducible form; 
nitrosodimethylamine N-demethylase
CYP2G1 olfl
CYP3A1 pcnl, PCN-E, P-450p PB-, macrolide antibiotic-, steroid- 
inducible form; 
erythromycin N-demethylase
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CYP3A9 olf2
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'Nebert, et a l., 1991 
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3Ryan, et a l., 1980 
4Guengerich, et a l., 1982 
5Goldstein, et a l., 1982
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for the second electron equivalent. In this role, cytochrome bs is thought to accept 
an electron from NADH via NADH-cytochrome b5 reductase and to transfer the 
electron to the oxygenated substrate/P-450 complex. The function of the NADH- 
cytochrome b5 microsomal electron transport chain system in P-450 catalyzed 
reactions has not yet been fully established (Correia and Mannering, 1973; 
Guengerich, 1988; Hildebrant and Estabrook, 1971; Mannering, et a l., 1974; Oshina 
and Sato, 1972); (5) One atom of oxygen is then incorporated into the substrate 
molecule and the other is reduced to water; (6) The cytochrome P-450/oxygenated 
substrate complex dissociates releasing the oxidized substrate metabolite and 
regenerating the cytochrome P-450 molecule thus completing the cytochrome P-450 
catalytic cycle (Figure 2-1). The term mixed-function monooxygenase or oxidase is 
frequently used to refer to the cytochrome P-450 enzymes, due to the requirement of 
this system for both molecular oxygen and a reducing agent (Mason, 1957; Mason, 
1965).
The rate limiting step in the cytochrome P-450 catalytic cycle varies with the P-450 
isoform and the substrate. Electron transfer (Davies, et a l., 1969), hydrogen 
extraction and product release have all been identified as rate-limiting steps in various 
cytochrome P-450 reactions (Guengerich, 1991). The specific types of oxidative 
reactions catalyzed by the cytochrome P-450 enzymes include aliphatic and aromatic 
hydroxylation, epoxidation, N-, 0 - , 5-dealkylation, deamination, sulfoxidation, 
desulfuration, A-hydroxylation, and oxidative dehalogenation (Williams, 1959;
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Figure 2-1 Cytochrome P-450 catalytic cycle.
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Williams, 1967). To a lesser extent, the cytochrome P-450 monooxygenases also 
catalyze reduction reactions. These reactions include azo reduction, aromatic 
nitro reduction, and reductive dehalogenation (Williams, 1959). Depending on the 
physicochemical characteristics of the substrate, it has been postulated that all of these 
reactions could be catalyzed by a single P-450 isozyme (Guengerich, 1988). The 
biotransformation process, in general, yields products with decreased activity and, 
therefore, functions in the role of detoxification. However, with some compounds, 
biotransformation reactions result in the formation of intermediate or final products 
that exhibit greater reactivity than the parent compound, thereby serving as a 
bioactivation mechanism (Hodgson and Dauterman, 1980). For example, the 
oxygenation of PAHs in conformationally hindered positions, such as the bay region, 
results in the formation of reactive epoxide intermediates (Brookes and Lawley, 1964; 
Gelboin, 1969; Grover and Sims, 1968; Miller, 1951; Boyland, 1950; Comiey, et al., 
1957; Sims, 1975; Sims, et a l., 1974; Parke and Ioannides, 1984; Ioannides and 
Parke, 1987). These electrophilic metabolites react with critical nucleophiles, such 
as DNA, which may lead to various pathological processes. Another example is the 
conversion of parathion, a relatively nontoxic organophosphate pesticide, to paraoxon 
which is a potent inhibitor of cholinesterase activity (Davison, 1954; Davison, 1955). 
The bioactivation and/or detoxification of a xenobiotic is dependent on the catalytic 
selectivity of the individual cytochrome P-450 isoforms present. Therefore, the 
balance between the overall activation and detoxification of a xenobiotic is influenced 
by the P-450 isoforms present and the partitioning of the xenobiotic between the
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metabolic pathways catalyzed by the different isoforms (Guengerich and Liebler, 
1985). Other factors which influence this balance include genetics, age, nutrition, and 
the selective induction of cytochrome P-450 isozymes following chemical exposure 
(Parke and Ioannides, 1984). For example, an increase in the activity of the CYP2A 
isozyme family (as with induction following PB administration) will result in an 
increase in the activation of some compounds such as 2-naphthylamine and 
cyclophosphamide while an increase in detoxification will occur with other xenobiotics 
such as aflatoxin and A-2-fluorenylacetamide (Hodgson, et al., 1980).
2.1.3 Factors Affecting the Cytochrome P-450 Monooxygenase System and 
Biotransformation
One of the most profound factors influencing the biotransformation of xenobiotics is 
the enhancement of cytochrome P-450 activity following exposure to certain 
chemicals. This process is referred to as induction and results from an increase in the 
rate o f synthesis of cytochrome P-450 enzymes (Conney, 1967). Hundreds of 
chemicals have been demonstrated to induce the cytochrome P-450 system, but the 
most widely studied inducing agents are PAH and PB. The two major families of 
inducible cytochromes associated with these agents include CYP1A (PAH-inducible 
isoforms) and CYP2B (PB-inducible isoforms) (Nebert, et al, 1991). In addition to 
PAHs, the CTP1A1 family is induced by such compounds as 2,3 ,7 ,8- 
tetrachlorodibenzo-p-dioxin (TCDD) (Poland and Glover, 1973), /3NF (Lau and 
Strobel, 1982), planar polyhalogenated biphenyls (Parkinson, et al.. 1983), 
aminoazobenzenes (Degawa, et al., 1985), aromatic amines (Ioannides, et a l., 1984)
and amides (Astrom and DePierre, 1985). The CYP2B family is also induced by 
nonplanar polyhalogenated biphenyls and the pesticides l,l,l-trichloro-2 ,2-bis(p- 
chlorophenyl)-ethane (DDT) and gamma chlordane (Parkinson, et al., 1983). 
Constitutive levels of these isoforms comprise less that 5 percent of the total hepatic 
cytochrome P-450 population (Pickett, et al., 1981; Waxman and Walsh, 1982). 
Following induction, their levels may increase 70-fold (Thomas, et a l., 1979; 
Thomas, et a l., 1981) and thereby comprise nearly 80 percent of the total cytochrome 
P-450 content (Ioannides and Parke, 1987). In the absence of induction, the P-450 
gene subfamily CYP1A is not expressed in extrahepatic tissues while the CYP2B 
subfamily is, most notably in the lung and sebaceous glands (Freidberg, et a l., 1990). 
Other agents, such as Aroclors (polychlorinated biphenyl mixtures) (Parkinson, et al., 
1983), safrole and isosafrole, and certain drugs (phenothiazine and chlorpromazine) 
(Thomas, et a l., 1983), have been demonstrated to act as mixed-type inducers by 
producing a response characteristic of both PB and PAH induction (Ioannides and 
Parke, 1987). The onset, magnitude and duration of induction may vary with species, 
strain and sex of the organism, type and dose of chemical received or administered, 
the duration of the exposure and the tissue and substrate used to measure 
monooxygenase activity (Hodgson et al., 1980). Not all agents capable of inducing 
the cytochrome P-450 monooxygenases are readily metabolized by the system 
(Guengerich, 1988). In addition, the induction of one family of cytochromes P-450 
may result in the suppression of another family of P-450s (Vlasuk, et a l., 1982; 
Vlasuk, et al., 1982a, Serabjit-Singh, et al., 1983).
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The mechanism of cytochrome P-450 {CYP1 A) induction has been described for PAH- 
type inducing agents. Initiation of the induction process involves the binding of the 
inducing agent or its metabolite with a cytosolic receptor [referred to as the aromatic 
hydrocarbon (Ah) receptor], translocation of the receptor-1 igand complex to the 
nucleus, reaction of the complex with specific genomic recognition sites, 
transcriptional activation of the CYP1A1 and CYP 1A2 genes and a subsequent increase 
in cytoplasmic CYP1A1 and CYP1A2 mRNA and associated proteins (Poland and 
Glover, 1976; Poland and Knutson, 1982). This regulation process plays an important 
role in determining individual risk of environmentally-caused toxicities and cancer 
since the CYP1A1 gene product is thought to activate procarcinogens, such as 
benzo[a]pyrene (Heidelberger, 1975; Miller, 1970; Kapitulnik, et al., 1978; Nebert 
and Jones, 1989; Sims and Grover, 1974). Induction of the CYPA gene family by 
clofibrate, a hypolipidemic drug, has also been demonstrated to occur via a receptor 
(Lalwani, et al., 1987). For the other types of inducers, neither receptors nor 
molecular mechanisms governing the induction response have been identified. 
However, it has been demonstrated that the CYP2 and CYP3 gene families, induced 
by PB (Atchison and Adesnik, 1983; Hardwick et a l., 1983; Pike, et al., 1985) and 
dexamethasone (Gonzalez, et a l., 1986; Hardwick, et a l., 1983), respectively, are 
regulated via transcriptional activation which leads to an increase in mRNA and 
cytochrome P-450 in the endoplasmic reticulum.
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In contrast to the induction process, certain chemicals are able to inhibit cytochrome 
P-450 monooxygenase activity and, thus, decrease the ability of the system to 
metabolize xenobiotics (Conney, 1967). The inhibition of cytochrome P-450 activity 
is dependent on the substrate, type of reaction and type of isozymes present (Lu and 
West, 1980). For example, ellipticine inhibits B[a]P hydroxylation in constitutive, 
PAH-induced and PB-induced microsomes while 7,8-benzoflavone only inhibits this 
activity in PAH-induced microsomes (Weibel, et al., 1971). Inhibitory mechanisms 
and representative agents that have been described include, but are not limited to, 
decreased synthesis of P-450 enzymes (3-amino-l,2,3-triazole), generalized destruction 
o f P-450 (associated with lipid peroxidation), competitive inhibition due to two or 
more xenobiotics competing for P-450 active sites (benzene and toluene metabolism), 
suicide inhibition due to destruction of the heme moiety by a reactive metabolite (vinyl 
chloride, allylisopropylacetamide), coordination to the heme moiety (cyanide); 
destruction of the protein structure by a reactive metabolite (carbon disulfide, 
parathion, chloramphenicol), and reduction of P-450 content due to loss of tissue mass 
(DeMatteis, 1978; Halpert and Neal, 1980; Guengerich and Strickland, 1977; Oritz 
de Montellano and Correia, 1983; Oritz de Montellano and Mico, 1981; Sato and 
Nakajima, 1979).
Other important factors affecting biotransformation include species, strain, sex, age, 
and diet. Quantitative and qualitative differences in the cytochrome P-450 
monooxygenase system and associated activities have been described for different
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species and strains. These differences in the cytochrome P-450 system have been 
attributed, in part, to variations in isozymes, content, and response to inducers and 
the presence of enzyme defects or unique enzyme activities in certain species (Walker, 
1980; Williams, 1967). In addition, variation in genetic constitution among 
individuals within a given species or strain has been identified as a source of variation 
in monooxygenase activity. This source of variation is expected to be considerably 
greater in wild species than in laboratory species (Walker, 1980). Gender differences 
in cytochrome P-450 monooxygenase activity have been noted in several species of 
laboratory animals with the most dramatic difference demonstrated in the rat. The 
female rat has been shown to have a 10 to 30 percent lower hepatic microsomal P-450 
content than the male rat and also has been observed to have a slower rate of 
xenobiotic and drug metabolism. This profound sex-related difference is seen at 4 to 
51 weeks of age and is thought to be due to differences in the contribution of sex- 
specific P-450 isoforms to the total P-450 content (Chengelis, 1988; Kato and Onoda, 
1970; Waxman, et al., 1985). Other sex-related differences that have been observed 
in the MFO of the rat include a greater NADPH-cytochrome c reductase activity in 
the male at age 12 to 78 weeks, greater NADH-cytochrome c reductase activity in the 
female at age 12 to 51 weeks and inconsistent differences in cytochrome bs at various 
ages (Chengelis, 1988). Sex-related variations in MFO have been observed in some 
species of birds at certain stages of the reproductive cycle. A discussion of these 
findings is presented in Section 2.3.1. Gender differences in cytochrome P-450 
content and activity have also been demonstrated in certain fish species. For these
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species, the females have generally been shown to have lower P-450 content and 
activity than their male counterparts (Kleinow, et al., 1987). Differences in age have 
also been shown to affect xenobiotic biotransformation. The cytochrome P-450 
monooxygenase system of mammalian species has been shown to develop during the 
gestational period with the onset o f maturation beginning at birth (Short, et al., 1976). 
Postnatal patterns o f development have been observed to vary with the species and 
substrate studied. For the rat, MFO activity has been shown to peak at 3 weeks of 
age in the female and at 3 to 8 weeks of age in the male. Following the peak, activity 
levels plateau or decrease in the female and plateau in the male (Short, et a l., 1976). 
In contrast to mammals, avian species, in general, have been demonstrated to have 
significant MFO activity during the embryonic and neonatal periods. A discussion of 
the development of the avian MFO system is presented in Section 2.2.1. Age-related 
differences in the cytochrome P-450 content and activity have also been observed in 
certain fish species (Kleinow, et al., 1987). Another age-related difference is seen 
in older animals. Older animals have a decreased capacity for biotransformation due 
to decreased concentrations of cytochrome P-450 and its associated reductase. Other 
related factors may include decreased hepatic and renal blood flow, reduced hepatic 
mass and decreased efficiency of excretory systems (Sipes and Gandolfi, 1991). Diet 
can affect biotransformation in a number of ways. Nutritional deficiencies, such as 
vitamin, mineral, and protein deficiencies, or periods of starvation, can decrease 
cytochrome P-450 monooxygenase activity by reducing basal levels of cytochrome P- 
450. They can also reduce the availability of high-energy cofactors required in Phase
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II reactions. Furthermore, chemicals present in the diet can affect biotransformation 
through the induction or inhibition of certain P-450 activities (Walker, 1980; Yang, 
et al., 1992). For example, diallyl sulfide, a natural constituent o f garlic (Brady, et 
a l., 1991); phenethyl isothiocyanate, a component of cruceriferous vegetables 
(Ishizaki, et al., 1990); and psoralens, present in edible plants such as parsley, celery, 
and parsnip (Tinel, et al., 1987) have been demonstrated to inactivate certain 
cytochrome P-450 isozymes. Other dietary components such as ethanol (Koop, et a l., 
1982) and flavinoids (Conney, 1982) have been reported to enhance cytochrome P- 
450-dependent activities.
2.2 Avian Hepatic Cytochrome P-450 Monooxygenase System
The avian hepatic cytochrome P-450 monooxygenase system is similar in structure and 
function to the mammalian MFO system. However, there are some important 
differences between these classes in relation to cytochrome P-450 content, activity, 
and regulation. In addition, there are significant qualitative and quantitative 
differences in the MFO systems of species within the Aves class.
2.2.1 Cytochrome P-450 Content and Activity
Mixed function monooxygenase studies have been conducted on a variety of avian 
species which collectively represent 10 orders: Passeriformes, Striges, Accipitres, 
Anseriformes, Pelecaniformes, Tubinares, Pygopodes, Columbiformes and 
Galliformes (Ronis and Walker, 1989; Walker and Ronis, 1989). The majority of the
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work has focused on characterizing basal MFO activity of birds and lesser amounts 
of data are available on the induced system. The cytochrome P-450 content of avian 
hepatic microsomes has, on average, been shown to be approximately one-fourth that 
of mammalian microsomes (Walker and Ronis, 1989). It is currently speculated that 
this difference in P-450 content is due to differences in endogenous metabolism 
between the avian and mammalian classes. Within the Aves class, Passeriformes 
(house sparrow, black bird, African bulbul, starling) and Galliformes (domestic fowl, 
grey partridge, red partridge, Japanese quail) demonstrate relatively high levels of 
cytochrome P-450 (0.20 to 0.51 and 0.18 to 0.45 nmol P-450/mg protein, 
respectively) while the fish-eating Pelecaniformes (cormorant, shag) and 
Charadriformes (puffin, razorbill, guillemot) demonstrate relatively low P-450 levels 
(0.15 to 0.29 nmol P-450/mg protein) compared to other orders of birds (0.3 nmol/ 
mg protein on average) (Ronis and Walker, 1989; Walker and Ronis, 1989). In 
keeping with the relatively low levels of P-450 in birds, the monooxygenase activities 
reported in avian species are, in most cases, lower than those in mammalian species. 
Walker and Ronis (1989) reported that, in general, avian monooxygenase activities for 
aminopyrine, aldrin, and HCE (l,2 ,3 ,4 ,9 ,9-hexachloro-l,4 ,4a,5,6,7,8,8a-octahydro- 
exo-7,8-epoxy-1,4-methanonaphthalene) have been shown to be lower than those seen 
in mammals and in contrast, activity levels observed for aniline hydroxylation (ANH) 
are comparable to those observed in mammals while the activity levels for EROD are 
greater (Walker and Ronis, 1989).
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Most monooxygenase activity in the bird is present in the liver but other tissues have 
been demonstrated to have significant MFO activity in certain species. For example, 
the duodenum has been shown to have relatively high MFO activity compared to the 
liver in the grey partridge, domestic fowl and Japanese quail (Galliformes) for certain 
substrates (Bartlet and Kirinya, 1976; Riviere, 1980; Riviere, et a l., 1983). In 
contrast, duodenal activity in the cormorant was relatively low (Knight and Walker, 
1982). Avian species have also been shown to have significant MFO activity in the 
kidney (Pan and Fouts, 1978). This finding is postulated to be associated with the 
renal portal shunt present in birds (but not in mammals) which carries blood from the 
gastrointestinal tract directly to the kidneys. Renal activity in the razorbill and herring 
gull, in contrast to other birds, was found to be relatively low (Ronis and Walker, 
1989). Buckpitt and Boyd (1982) investigated the P-450 system in the lung and 
kidney of the Japanese quail and the chicken and found relatively low P-450 content 
and oxidative activity towards the substrate 4-ipomeanol. Although MFO activity has 
been shown to be high in some extrahepatic tissues, the overall contribution of these 
MFO sources to the total MFO activity is minor due to the relatively small mass of 
these tissues compared to that of the liver. Nevertheless, these extrahepatic activities 
may play a significant role in the detoxification and/or activation of certain xenobiotics 
in target tissues (Ronis and Walker, 1989).
An interesting feature o f the avian MFO system is the reported presence of significant 
activity in embryos and neonatal birds. Hepatic monooxygenase activities in the
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chicken embryo have been demonstrated to be comparable to or greater than those 
of an adult from day 3 of incubation through hatching (Drummond, et a l., 1972; 
Hamilton, et al., 1983; Powis, et al., 1976). Immediately following hatching, hepatic 
MFO activities have been observed to reach a peak and then gradually decrease to 
adult levels within one week (Ilaug, et al., 1980; Brunstrom, 1986). In addition, 
substantial hepatic MFO activity has been shown in the embryos of the Herring gull 
(Ellenton, et al., 1985; Boersma, et al., 1986; Peakall, et al., 1986) and black- 
crowned night heron (Hoffman, et a l., 1986). This characteristic of the avian MFO 
system is in sharp contrast to the development of the MFO system in mammals. 
Mixed function monooxygenase activity in mammals is absent or very low at birth and 
gradually develops during the postnatal period (Short, et al., 1976).
Data on temporal variations in activity in birds are very limited and are discussed in 
Section 2.3 .1 . Gender differences in MFO activity are seldom seen in avian species 
(Ronis and Walker, 1989). However, a few exceptions have been noted and these 
observations are discussed in Section 2.3.1.
2.2.2 Induction of the Avian Cytochrome P-450 System
In general, the response of the avian MFO system to inducers has been demonstrated 
to be similar to that of mammals. However, there are some important distinguishing 
characteristics between the Aves and Mammalia classes (Ronis and Walker, 1989). 
The avian monooxygenase system, represented by the chicken, Japanese quail, homing
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pigeon, robin and Forster’s tern, has been shown to be readily induced by 3MC, 
TCDD and other 3MC-type inducers such as /3NF, PAHs, and coplanar PCBs 
(Brunstrom, 1990; Brunstrom, 1992; Hoffman, et a l., 1987; Martin, et a l., 1987; 
Husain, et a l., 1982; Husain, et al., 1984; Ronis and Walker, 1989). The pattern of 
induction observed is similar to that seen in mammals, i.e ., increases in P-450 content 
and AHH and EROD activities. Distinct differences in the induction response to 
3MC-type inducers that have been seen in avian species, which are not seen in the 
mammalian species, include the induction of aminopyrine A-demethylase (APDM), 
ethylmorphine A-demethylase (EMDM), biphenyl 2-hydroxylase (Ronis and Walker, 
1989) and 4-dimethylaminoantipyrine A-demethylase activities (Sawyer, et al., 1986). 
In addition, 3MC-type inducers tend to produce a greater increase in microsomal 
protein and total P-450 content in birds than in mammals (Buynitzky, et al., 1978; 
Ronis and Walker, 1989) and there is some evidence that MFO activity in the 
Japanese quail is induced to a greater extent by 3MC than in mammals (Ronis and 
Walker, 1989). Also, 1,2,4-trichlorobenzene has been shown to induce EROD 
activity in the quail and the chicken but not in the rat (Riviere, et al., 1985; Miranda, 
et al., 1984). Another interesting difference in the inducibility of the avian MFO 
system is the reported ability o f the embryonic system to be induced by 3MC-type 
inducers. Mixed function monooxygenase activity of the chicken embryo has been 
demonstrated to be highly sensitive to induction by 3MC, /3NF, TCDD, and 3 ,3 ’,4 ,4 ’- 
tetrachlorobiphenyl (Althaus et al., 1972; Brunstrom, et al., 1976; Darbey, et al., 
1984; Darbey, et al., 1985; Darbey, et al., 1986; Dogra and Israels, 1987;
Hamilton, et al., 1983; Poland and Glover, 1977; Topp and van Bladeren, 1986). 
Aryl hydrocarbon hydrolase activity has been demonstrated to be inducible in the 
chicken at day 5 of incubation, with inducibility reaching adult levels by day 7 and 
peaking at day 1 post hatch (Hamilton, et al., 1983). Limited study has been 
conducted on the role of a high affinity cytosolic Ah receptor in the induction of the 
avian hepatic cytochrome P-450 system by 3MC type inducers. Sawyer and 
coworkers (1986) were unable to detect a receptor in embryo or 2-week-old chickens. 
In contrast, Denison et al. (1985) reported low levels of the receptor in the cytosol 
of chick hepatocytes and Brunstrom and Lund (1988) detected a TCDD receptor in 
the liver of 7-day-old chick embryos. However, in the same study, a receptor was 
not detected in the embryonic turkey liver (Brunstrom and Lund, 1988). Brunstrom 
(1992) demonstrated that coplanar PCBs and PAHs avidly bind to an Ah receptor in 
chicken embryos and that the most toxic compounds were the most avid Ah receptor 
binders. The coplanar PCB, 3 ,3 ’4 ,4 ’-tetrachlorobiphenyl, and its hydroxy 
metabolites, were shown by Wehler et al. (1990) to bind to an Ah receptor in chick 
embryos.
Variable responses to PB and PB-like inducers such as DDT and dieldrin, have been 
reported in avian species. The chicken has been shown to be readily induced by PB 
and the pattern of induction is similar to that of the rat (Walker and Ronis, 1989). 
Other species that have been demonstrated to be sensitive to PB induction include the 
homing pigeon, ring dove, Khaki Campbell duck and mallard duck (Husain, et al.,
1981; Husain, et a l., 1984; Patterson and Roberts, 1971; Peakall, et a l., 1970; Sifri, 
et al., 1975). In contrast to these species, the Japanese quail and fish-eating birds, 
such as the cormorant, are reported to be refractory to induction by PB (Ronis, et al., 
1987; Walker and Ronis, 1989). It is also noteworthy that the chicken, although 
observed to be responsive to PB, was not shown to be responsive to DDT and dieldrin 
which are PB-type inducers (Walker and Ronis, 1989). In addition, Davison, et al. 
(1976) showed that mirex, another organochlorine compound, did not induce the MFO 
systems of the chicken and quail. The mallard duck, on the other hand, was readily 
induced by PB as well as DDT and dieldrin (Davison and Sell, 1972; Walker and 
Ronis, 1989). In fact, in one study, PB was shown to increase ANH activity in the 
Khaki Campbell duck twice as much as in the rat (Patterson and Roberts, 1971). It 
is interesting to note that, in another study, Buynitzky and coworkers (1978) 
demonstrated that induction following exposure to DDT was greater in mallard ducks 
infected with the duck hepatitis virus than in control ducks. Other compounds that 
have been demonstrated to produce PB-like patterns of induction in birds include 
allylisopropylacetamide (Rifkind, et al., 1982) and organophosphorus pesticides 
(Lapadula, et al., 1964).
Unlike the mammal, PB induction has been observed in birds at very early stages of 
development (Lorr and Bloom, 1987; Ronis and Walker, 1989; Strittmatter and 
Umberger, 1969; Topp and Bladeren, 1986). In addition to PB, other compounds that 
have produced PB-type induction in the chick embryo include the porphyria-causing
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drugs 2-propyl-2-isopropylacetamide (Althaus, et a l., 1972) and 3,5-diethylcarbonyl- 
1,4-dihydrocollidine (Rifkind, 1979) and the in vitro inhibitors metyrapone, SKF525A, 
and nicotinamide (Rifkind, et al., 1974; Giger and Meyer, 1982).
Compounds such as polychlorinated biphenyls (PCBs), polybrominated biphenyls 
(PBBs), and hexachlorobiphenyl (HCB), which are classified as mixed-type inducers, 
have also been studied in avian species. Induction has been observed with these 
inducers in the Japanese quail (Bunyan and Page, 1978; Carpenter, et a l., 1985; 
Riviere, et al., 1985), adult chicken (Ehrich and Larsen, 1983), chick (Rinsky and 
Perry 1981), chick embryo (Rifkind, et al., 1984; Topp and van Bladeren, 1986), 
nestling and adult barn owl (Rinsky and Perry 1981; Rinsky and Perry 1983) and 
Eider duck (Brouwer, 1991). In addition, the carcinogen 2-acetylaminofluorene was 
shown to produce a mixed-type induction in the chick embryo (Darby, et al., 1984).
Other compounds that have been investigated for their effect upon the avian MFO 
monooxygenases include ergosterol biosynthesis inhibiting fungicides, glucocorticoids, 
ethanol, glutethimide, aflatoxin Bl5 fenbendazole, and pyrethroids. Prochloraz, an 
ergosterol biosynthesis inhibiting fungicide, has been shown to be a potent inducer of 
hepatic and duodenal MFO activity in a variety of birds including the Japanese quail 
(Riviere, et a l., 1983), chicken, grey partridge (Perdixperdix), pheasant (Phasianus 
colchicus) (Riviere, et al., 1984) and the red-legged partridge (Alectoris rufa) 
(Johnston, et al., 1989). Other fungicides of the same class were also shown to
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induce the hepatic and duodenal MFO activities of the Japanese quail (Riviere, et al., 
1983; Riviere, et al., 1984). In contrast, prochloraz pretreatment in the rat was 
shown to produce only small increases in hepatic cytochrome P-450 content and 
activity (Riviere, et al., 1983). Increases in avian hepatic MFO activity have been 
observed in chick embryos following glucocorticoid treatment (Leakey, et al., 1979). 
Ethanol and glutethimide were investigated in the chicken embryo and shown to be 
inducers of hepatic microsomal activity (Sinclair, et a l., 1989). A comparative study 
with aflatoxin Bi showed that the hepatic cytochrome P-450 content and activity were 
decreased in the rat and quail but that no change in either parameter occurred in the 
chicken upon administration of this toxin (Gawai, et al., 1992). Studies which 
examined the effects of fenbendazole on the hepatic microsomal enzymes found no 
increase in activity in the rat and chicken while enhanced MFO activity was seen in 
the quail (Dalvi, 1989; Dalvi, et al., 1991). The pyrethroid pesticides examined did 
not produce an inductive response in the Japanese quail (Riviere, et al., 1983).
2.3 Cytochrome P-450 Biomarkers in Avian Species
A number of studies have been conducted to evaluate the response o f the avian 
cytochrome P-450 system to chemical exposure and to assess the applicability of 
utilizing this system as a biomarker in environmental monitoring programs. In 
general, two approaches have been used for these studies: field investigations and 
laboratory studies. Field investigations, for the most part, have been based on 3 
approaches: (1) determining if correlations exist between contaminant burdens and
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MFO activity; (2) monitoring alterations in MFO activity subsequent to a chemical 
release or the introduction of a migratory species to a contaminated area; and (3) 
comparing the MFO activities of birds residing in areas of chemical contamination 
with those of birds obtained from "clean" areas, i.e., controls (Rattner, et al., 1989). 
Laboratory studies have been directed at characterizing hepatic cytochrome P-450 in 
avian species with respect to metabolic capacity for environmentally-relevant 
chemicals, biotransformation mechanisms related to chemical toxicity, changes in the 
system resulting from exposure to environmental chemicals, and the identification of 
specific activities for application in biomonitoring programs.
Much of the research that has been conducted on the use o f biomarkers in avian 
species has focused on assessing the response of the MFO system to environmentally 
persistent constituents such as organochlorines. Early field and laboratory studies 
provided evidence that these types of pollutants were bioaccumulating in raptor species 
and that this effect was related to the population decline of such species as the 
peregrine, sparrowhawk, osprey, and bald eagle (Walker, e ta / . ,  1991; Walker, e ta /. ,  
1987). This work lead researchers to question the ability of these and other birds to 
metabolize environmental contaminants and subsequently, a number of studies were 
undertaken to characterize the MFO system of avian species. A variety of species, 
environmental chemicals and MFO activities were investigated by a number of 
researchers (Table 2-1). Results of these efforts indicate: (1) there is significant 
variability in MFO activity within and between avian species; (2) the avian hepatic
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MFO system is readily induced by a range of environmental pollutants and a number 
of avian hepatic MFO activities have potential use as biomarkers of environmental 
exposure; (3) laboratory data indicated that MFO activity is correlated with tissue 
residues and other toxic effects in avian species; and (4) the monitoring of MFO 
activity in developmental stages, such as embryos and nestling, offers a number of 
advantages when using avian species in biomonitoring programs.
2.3.1 Variability of MFO Activity
High variability in MFO activity between avian species, as well as among individuals 
within a given species, has been documented by a number of researchers (Boersma 
et a l., 1986; Fossi, et al., 1990; Husain, et al., 1981; Knight and Walker, 1981; 
Peakall, et a l., 1987; Rattner et al., 1989; Walker, et al., 1981). Variations in 
genetic constitution, physiological factors, substrate specificity, and environmental 
influences make it difficult to compare cytochrome P-450 levels and activities between 
avian species (Riviere, et a l., 1985). Profound interspecies differences in avian MFO 
activity have been observed between the predators and other species of birds. This 
dramatic difference in MFO activity has been suggested to be related to the difference 
in feeding ecology of the two groups (Walker et a l., 1987). Predator species have 
narrow dietary ranges which are postulated to result in limited xenobiotic exposure 
and, thus, a reduced need for detoxification by the MFO system. For example, 
piscivorous birds, such as the razorbill (Alca torda), puffin (Fratercula arctica), shag
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Table 2-1
Avian Species and Cytochrom e P-450 Param eters 
Exam ined in Ecotoxicological Studies
Species
Potential Exposure, 
P retrea tm ent, or 
Tissue Residue
Param eter
C haracterized1 Reference
Puffin DDE ANH, BDM Bend et a l., 1987
Herring Gull, 
Cormorant, 
Eider Duck
PCBs EROD, P-450 Brouwer, 1991
Forster’s
Tern
PCBs, TCDD, 
PCDD
AHH Hoffman, et a l., 1987
Puffin Crude Oil EROD, AHH, 
AE
Peakall, et a l., 1987
Puffin,
Razorbill,
Guillemot,
Shag,
Cormorant,
Manx
Shearwater
PCBs HCE, AE
Knight et a l., 1981 
Walker et al., 1982a
Black-Headed 
Gull, Herring 
Gull, Rook
None
HCE, AE Knight et al., 1981 
Walker et al., 1982a
Herring Gull Organochlorines AHH Ellenton, et a l., 1985
Herring Gull Organochlorine 
Pesticides and PCBs
AHH, APDM, 
EROD, P-450
Peakall, et a l., 1986
Herring Gull Organochlorine 
Pesticides and PCBs
APDM, ANH, 
EROD
Boersma, et a l., 1986
Black- 
crowned 
Night Heron
Organochlorine 
Pesticides and PCBs AHH Hoffman, et a l . , 1986
(table continued)
48
Table 2-1
Avian Species and Cytochrom e P-450 Param eters 
Exam ined in Ecotoxicological Studies
Species
Potential Exposure, 
P re trea tm ent, or 
Tissue Residue
Param eter
C haracterized1 Reference
Pigeon Organochlorine
Pesticides
AHH Husain, et a l., 1981
Robin Dioxins AHH Martin, et a l., 1987
Black-necked
Grebe
Organochlorine 
Pesticides and PCBs
AE, EROD Fossi, et a l., 1986
Black-headed
Gull
PCBs AE, EROD Fossi, et a l., 1986
Pigeon, 
Crow, Kite, 
Vulture, 
Cattle Egret
None AHH, APDM Husain, et a l., 1981
Mallard Duck Crude Oil AHH, P-450 Gorsline, et a l., 1981
Barn Owl, 
Chicken
PCBs APDM, AE, 
P-450
Rinkzy and Perry 
1983
Chicken PCBs A H H ,ER O D Rifkind, et al., 1984
Chicken Crude Oil A H H ,ER O D Lee, et a l., 1986
Chicken PCBs, DDT ANH, APDM Cecil, et a l., 1978
Chicken Organophosphate
Pesticide
ANH, CADM Varshneya, et al., 
1986
Japanese
Quail
Pyrethroids,
Dicarbomide
Fungicide
AE, ANH, 
ECOD, EROD, 
P-450
Riviere, et a l., 1983
(table continued)
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Table 2-1
Avian Species and Cytochrom e P-450 Param eters 
Exam ined in Ecotoxicological Studies
Species
Potential Exposure, 
P retreatm ent, or 
Tissue Residue
Param eter
C haracterized1 Reference
Japanese
Quail,
Chicken,
Pheasant,
Partridge
Prochloraz AE, ANH, 
EROD, P-450
Riviere, et a l., 1985
Pigeon None AE, HCE Ronis and Walker, 
1985
Pigeon Organochlorines AHH Kaphalia, et a l., 1981
Kestral,
Sparrowhawk
None AE, HCE Walker, et al., 1987
Herring Gull Crude Oil AHH, ANH, 
APDM, EROD
Lee, et al., 1985
Japanese 
Quail, 
Chicken, 
Mallard Duck
DDT ANH, APDM Sifri, et al., 1975
'AE, aldrin epoxidase; AHH, aryl hydrocarbon hydrolase; ANH, aniline hydroxylase; 
APDM, aminopyrine demethylase; BDM, benzphetamine demethylase; CADM, 
p-chloromethyl aniline demethylase; ECOD, ethoxycoumarin dealkylase; EROD, 
ethoxyresorufin-D-deethylase; HCE, l,2 ,3 ,4 ,9 ,9-hexachloro-l,4 ,4a,5 ,6 ,7 ,8 ,8a- 
octahydro-exo-7,8-epoxy-1,4-methanonaphthalene hydroxylase; P-450, cytochrome 
P-450 level
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(Phalacrocorax aristotelis), cormorant (Phalacrocorax carbo), and guillemot (Uria 
aalge), have been shown to have MFO activities that are considerably lower than 
those of other avian species and in fact, activities have been noted to be comparable 
to those in fish (Knight and Walker, 1981; Walker, et a l., 1987). Omnivorous birds, 
on the other hand, have wide dietary ranges which are thought to result in a more 
varied exposure to xenobiotics thereby creating a need for a more active MFO system 
(Walker, et al., 1987; Knight and Walker, 1981). It has been argued that the hepatic 
cytochrome P-450 systems of birds with complex diets are more developed and have 
greater metabolic capacity than birds with specialized diets (Ronis and Walker, 1989). 
One exception to this finding is the puffin (Fratercula arctica). Although the puffin 
is a fish-eating bird, MFO activity (for organochlorine substrates) in this species has 
been shown to be greater than other avian species and is reported to be comparable 
to that seen in the rat (Knight and Walker, 1981).
Potential sources of intraspecies variation in MFO activity include age, sex, and 
reproductive status. With regard to age, changes in MFO activity have been 
documented in the herring gull (Larus argentatus), chicken, barn owl, kestrel 
(Accipiter nisus), and sparrowhawk (Falco tinmmculus) during various stages of 
development. Ellenton and co-investigators (Ellenton, et al., 1985) found that AHH 
and EROD activities increased with embryonic development whereas aminopyrine 
demethylase (APDM) activity decreased. In addition, AHH activity was more 
inducible at day 25 of incubation than at day 20. No consistent changes were
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apparent for other substrates. In nestlings, no consistent changes in MFO activity 
were noted in this study, but activity was higher than that of the embryos. Peakall 
and co-workers (Peakall, et a l., 1986) found that APDM activity decreased with age 
in herring gull (Larus argentatus) nestlings while no change was noted in EROD or 
AHH activities or cytochrome P-450 levels. In chickens, MFO activity has been 
demonstrated to be inducible at day 17 of incubation with constitutive activity peaking 
at day 1 following hatching (Ellenton, et al., 1985; Rinzky and Perry, 1983). In 
contrast, MFO activity in the barn owl was found to be lower at day 1 post-hatch than 
at any other age studied (Rinzky and Perry, 1983). In the sparrowhawk and kestrel, 
MFO activities were found to be lower in juvenile birds than in adults (Walker, et a l., 
1987). In another study, Ronis noted that aldrin epoxidase activity increased with age 
in cockerels (Walker, et al., 1987).
No significant differences in MFO activity between males and females have been 
observed for the puffin (Fratercula arctica), Leach’s petrel (Oceanodroma leucorhoa), 
or herring gull (Larus argentatus) (Knight and Walker, 1982; Peakall, et al., 1986; 
Peakall, et al., 1987). Also, no sex differences were demonstrated in the chicken 
embryo (Hamilton et al., 1983), chicken hatchling (Brunstrom, 1986), or in the adult 
wild pigeon (Husain et al., 1984). However, an increase in MFO activity has been 
reported in the female razorbill (Alca torda) at the onset of the breeding season and 
it is speculated that, in light of the known involvement of the MFO system in steroid 
metabolism, this increase is associated with the elevation of steroid levels that occurs
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at the time of egg laying (Knight and Walker, 1982a). Similar findings have been 
reported in the black-necked grebe (Podiceps nigricollis) (Fossi, et a l., 1986), wood 
pigeon (Columba palumbus), yellow-legged herring gull (Lams argentatus cachinnans) 
and herring gull (Larus argentatus smithsonainus) (Fossi, et a l., 1990). Differences 
between the sexes have been noted in the guillemot (Uria aalge) and cormorant 
(Phalacrocorax carbo) in which MFO activity in the female was half that in the male 
(Walker and Ronis, 1989). Sell and coworkers (1971) noted an inverse relationship 
between MFO activity and clutch length in the chicken. Rao and McKinley (1969) 
observed a difference in the rate of oxidation of organophosphorus insecticides in male 
and female chickens, however, no difference was seen between the sexes for the 
demethylating system.
It is interesting to note, that while high variability in MFO activity is observed 
between avian species, little variation is seen in cytochrome P-450 content (Knight and 
Walker, 1981). In addition, very little individual variation in MFO activity has been 
observed in the sparrowhawk, a specialized predator species with very low MFO 
activity (Walker, et al., 1987). The data available to date clearly indicate the 
importance of characterizing the potential sources of variation in the hepatic MFO 
activity of target species. It is imperative that these factors be taken into consideration 
when planning biomonitoring programs based on MFO biomarkers (Peakall, et al., 
1987; Rattner et al., 1989).
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2.3.2 Induction of MFO Activity
Characterization of the induction response of the cytochrome P-450 system is an 
essential area of research for the identification of specific enzyme activities to serve 
as biomarkers of exposure in avian species. The avian hepatic microsomal MFO has 
been demonstrated to be inducible by a number of environmental contaminants (Pan 
and Fouts, 1978). Polychlorinated biphenyls (PCBs), common environmental 
contaminants, have been demonstrated to induce APDM and aldrin epoxidation (AE) 
activities in the barn owl (Rinsky and Perry, 1983) and EROD activity in the Eider 
duck (Somateria mollissima) (Brouwer, 1991). Other persistent organochlorine 
compounds that have been reported to induce the hepatic MFO in avian species 
include TCDD [American robin (Turdus migratorius), AHH and EROD activities 
(Martin, et al., 1987)]; DDE [puffin (Fratercula arctica), aniline hydroxylase (ANH) 
activity (Bend, et a l., 1977)]; and p ,p ’-DDT [Mallard duck (Anas platyrhynchos), 
ANH and APDM activities (Sifri, et al., 1975)]. However, chicken (Gallus 
domesticus) MFO was not shown to be induced by PCBs (Rinsky and Perry, 1983) 
nor by p ,p ’-DDT (Sifri, et al., 1975). In fact, suppression of MFO activity has been 
noted in the chicken following exposure to p ,p ’-DDT (Sell, et al., 1971; Sifri, et al., 
1975; Stephen, et al., 1971). Similar results were found by Varshney and co-workers 
(1986) following exposure of the chicken to malathion, an organophosphate pesticide. 
In another Galliformes species, the Japanese quail (Courtnix japonica), inhibition of 
ANH and APDM activities were noted following pretreatment with p ,p  ’-DDT (Sifri, 
et al., 1975). Other researchers have also observed decreases in MFO activity in
Japanese quail following DDT pretreatment (Bunyan, et al., 1972; Cecil, et a l., 1978; 
Gillette and Arscott, 1969; Sell, et al., 1972). Exposure to another important class 
o f environmental compounds, PAHs, has been shown to induce MFO activity in a 
variety of avian species. Various types of crude oil administered to chickens (Lee, 
et a l., 1986), herring gulls (Larus argentatus) (Lee, et a l., 1985), mallard ducks 
(Gorseline, et a l., 1981), and puffins (Peakall, et a l., 1987) produced significant 
increases in the MFO activities of these species. Induced activities included AHH 
and EROD in the chicken; AHH, EROD, ANH, and APDM in the herring gull, AHH 
in the mallard; and AHH, EROD, and AE in the puffin. Prochloraz, an agricultural 
fungicide, has been documented as an efficient inducer of the MFO system of four 
Galliformes species: the Japanese quail, chicken, partridge (Perdix perdix), and 
pheasant (Phasianus colchicus) (Riviere, et a l., 1985). Specific activities induced in 
these birds included EROD, ANH, and AE. V-(3,5-dichlorophenyl) dicarboximide, 
another fungicide, has also been shown to induce the MFO system o f the Japanese 
quail (Riviere, et al., 1983). In field investigations based on comparisons of MFO 
activity in herring gull embryos collected from areas of organochlorine pesticides and 
TCDD contamination with embryos obtained from nonimpacted control areas, MFO 
activity in the exposed group demonstrated elevated AHH and EROD activities, 
depressed ANH activity, and similar APDM activity compared to the control group 
(Ellenton, et a l., 1985; Boersma et a l., 1986). In a similar study, Hoffman and co­
workers (Hoffman, et al., 1987) found elevated AHH activity in Forster’s tern 
embryos exposed to PCBs, TCDD, and dibenzo-/?-dioxins.
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As discussed above, a number of avian hepatic microsomal MFO activities have been 
demonstrated to be feasible biomarkers of environmental chemical exposure. In 
summary, the activities that have been most commonly examined in avian species for 
the assessment of environmental contamination include EROD, AHH, AE, APDM, 
and ANH. In field investigations, the most frequently monitored MFO activities 
include EROD and AHH. Among the species studied, the most consistent change in 
MFO activity following chemical exposure (PCBs, organochlorines, TCDD, crude 
oil), under laboratory and field conditions, was the induction of EROD and AHH 
activities. Laboratory studies indicate that HCE, aminopyrine and aldrin are relatively 
poor substrates for avian monooxygenases whereas ethoxyresorufin and aniline are 
relatively good substrates. Aniline, aldrin, aminopyrine and HCE are metabolized by 
a variety of P-450 isoforms and therefore are rather non-specific substrates in avian 
species. On the other hand, ethoxyresorufin is a specific substrate with metabolism 
being primarily attributable to the P-450 isoform (CYP1A1) inducible by 3MC-type 
inducers. In addition, the metabolic capacity of avian monooxygenases has been 
demonstrated to be much higher for ethoxyresorufin than with other non-specific 
substrates (Ronis and Walker, 1989).
2.3.3 Correlation of MFO Activity With Tissue Burden
An important area of ecotoxicological investigation has been the study of the potential 
relationship between tissue burdens and MFO activity in exposed birds. MFO activity 
is inversely related to the biological half-life of xenobiotics, and, thus, plays an
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important role in determining the degree of bioaccumulation o f persistent 
environmental pollutants and the potential susceptibility of certain avian species to 
xenobiotics that are detoxified by this system (Ronis and Walker, 1985). Low MFO 
activity in certain avian species towards such xenobiotics, as in the piscivorous birds, 
has been correlated with a marked tendency for these compounds to bioaccumulate in 
exposed birds (Knight and Walker, 1981; Walker et al., 1987). The correlation of 
MFO activity with specific chemical residue levels is used in field studies to determine 
if MFO induction is related to environmental chemical exposure (Peakall, et al., 
1980). However, to date, such field studies have been met with limited success. A 
study on herring gull {Larus argentatus) embryos obtained from areas of 
environmental contamination was conducted by Ellenton and co-investigators (Ellenton 
et a l . , 1985) to determine if there was a correlation between hepatic MFO activity and 
tissue residues in the exposed birds. The study demonstrated a significant positive 
correlation between the induction of AHH activity and TCDD tissue residues; 
however, MFO activity was not found to be correlated with other organochlorine 
(PCBs and DDE) residues present in the embryos. In a similar study conducted by 
Boersma and co-workers (1986), negative correlations were noted between APDM 
activity and PCB residues, APDM activity and hexachlorobenzene residues, and ANH 
activity and mirex residues in herring gull embryos. Peakall and co-workers (1986) 
examined the MFO activity and tissue burdens of nestling Herring gulls. No 
correlations were apparent between AHH, EROD, and AMPD activities and any of 
the organochlorine residues detected. However, cytochrome P-450 levels were
57
significantly correlated with levels of hexachlorobenzene and oxychlordane present in 
the tissues. Also, APDM and AHH activities were significantly correlated with each 
other suggesting that these enzymes are potential alternates for biological effects 
monitors (Peakall, et al., 1986). Other studies conducted on black-crowned night 
herons {Nycticorax nycticorax) (Hoffman et a l., 1986), razorbills (Alca torda), puffins 
(Fratercula arctica) (Knight and Walker, 1982) and black-headed gulls (Larus 
ridibundus) (Fossi, et al., 1986) obtained from areas of environmental contamination 
were not able to demonstrate a correlation between MFO activity (AHH; AE, and 
HCE hydroxylation; and EROD, and AE; respectively) and tissue burdens 
(organochlorine compounds). In another type of bioaccumulation study, marked 
variations in tissue residue levels were observed in puffins administered equal dosages 
of chemical and returned to the wild (Knight and Walker, 1982a). This intraspecies 
variability in bioaccumulation is thought to be due to the individual variation in MFO 
activity that has been documented in the puffin.
2.3 .4  Correlation of MFO Activity with Biological Effects
Additional research has focused on the toxicological implications of pollutant tissue 
residues (organochlorine and PAHs) and MFO induction (primarily CEP1A) in 
exposed birds and the establishment of a causal linkage between exposure and adverse 
effects observed in exposed avian populations (Gorsline, et a l., 1981; Lee, et al., 
1985; Lee et al., 1986; and Mineau, et al., 1984). Reproductive failure, congenital 
malformations, impaired growth and decreased survival have been documented in
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avian species inhabiting areas of environmental contamination (Hoffman, et a l., 1987; 
Mineau, et a l., 1984; Rattner, et al., 1989; and Walker and Ronis, 1989). 
Furthermore, laboratory studies have demonstrated that induction of the hepatic 
microsomal MFO system interferes with steroid metabolism in the mallard duck (Anas 
platyrhynchos), quail (Corturnix coturnix), ringdove (Streptopelia risoria) (Rattner et 
al., 1989), and white king pigeon (Peakall, et al., 1967). However, at the present, 
no direct evidence has been obtained from field studies to support the contention that 
MFO induction resulting from environmental pollution is associated with these 
biological effects (Rattner et a l., 1989).
2.3 .5  Use o f Avian Developmental Stages in Biomonitoring Programs
Birds of various ages and stages of embryonic development have been utilized for 
bioeffects monitoring. Adult birds have been used extensively in ecotoxicological and 
MFO research. As previously discussed, significant variation in MFO activity exists 
among individual birds within a given species and a number of sources of variation 
have been identified in certain avian species. Consequently, this variability has 
complicated the elucidation of exposure and induction relationships in adult birds 
(Rattner, et al,. 1989). The use of MFO induction as a biomarker of chemical 
exposure in adult birds requires further characterization of the MFO system and the 
those factors that influence it. Avian embryos are frequently chosen for use in field 
and laboratory studies for several reasons: egg collection is relatively simple and 
produces minimal disturbance within the population (Ellenton, et a l., 1985; Mineau
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et a l., 1984); individual variation in MFO activity potentially associated with 
differences in age, sex and reproductive status are reduced or eliminated; the hepatic 
MFO system of the embryo is readily induced (Ellenton, et a l., 1985); there is less 
variation in the lipid content, and thus in tissue burdens, of eggs than in other tissues; 
and the tissue burdens of eggs are comparable to those of the laying adult (Mineau et 
al., 1984). However, it should be noted that the removal of an embryo from its 
natural environment or the incubation of an embryo in vitro can profoundly affect the 
activities of the hepatic MFO enzymes (Hamilton, et a l., 1983). Nestlings are also 
frequently used in biomonitoring research. Nestlings are more easily collected than 
adults and more readily adapt to captivity for experimental purposes. Also, the 
collection of juveniles is less destructive to the population than the removal of adults 
since the mortality of nestlings and embryos is much greater than that of adults 
(Peakall, et a l., 1986). Based on the data available to date, the monitoring of MFO 
activity in embryos and hatchlings offers promise as a biomarker of chemical exposure 
in avian species (Rattner, et a l., 1989).
2.4 Representative Avian Species
Birds are classified into orders based on structural and anatomical likenesses. Within 
each order, birds are further classified into families based on the distinguishing 
characteristics of the species that have allowed for adaptation to a particular 
environment and way of life (Terres, 1980). Two orders of birds are represented in 
this study, the Galliformes and Anseriformes. The Galliformes include the chicken-
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or fowl-like terrestrial birds which are considered as game birds. Galliformes 
primarily feed on the ground obtaining seeds, grain, fruit, buds, nuts and vegetable 
matter as well as insects, spiders, snails, worms and other invertebrates. The 
Galliformes order is represented in this study by the chicken (Gallus gallus or Gallus 
domesticus), turkey (Melegris gallopavo) and Japanese quail (Coturnix coturnix). The 
domestic chicken belongs to the Phasianidae (Pheasant) family and is a descendant of 
the red jungle fowl which originated from Southeast Asia and India. The White 
Leghorn, which was utilized in this study, is classified as a Mediterrean breed 
(Phillips, et al., 1985). The Japanese quail is also a member of the Phasianidae 
family and is classified as an Old World species. This migratory bird is a native of 
Europe, Central Asia, Africa, and Japan (Terres, 1980; Reilly, 1968). The domestic 
turkey belongs to the Meleagrididae family and is a descendant of a cross between the 
Mexican wild turkey and the native turkeys of North America (Phillips, et al., 1985 
and Terres, 1980). The turkey is a gregarious, nonmigratory species found in wooded 
areas (Reilly, 1968).
The Anseriformes order includes the waterfowl (or wildfowl) which are classified as 
migratory game birds. Waterfowl are an ancient group of birds with their oldest fossil 
remains dating back 80 million years. Some orthinologists believe that the waterfowl 
evolved from an ancestor related to the gallinaceous birds (Terres, 1980). These birds 
are found on every continent but Antarctica. The Anseriformes represented in this 
study include the duck (Anser platyrhynchos), represented by the Khaki Campbell and
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Pekin breeds, Muscovy duck (Cairina moschata), and goose (Anser anser). Each of 
these species is member of the Anatidae family. The Khaki Campbell and Pekin 
ducks were derived from the wild mallard duck in England and China, respectively 
(Kear, 1985 and Terres, 1980). These birds are classified as dabbling or surface- 
feeding ducks and are found in marshy habitats. They are gregarious feeders and 
consume primarily aquatic plants (Terres, 1980). The Muscovy duck is a native of 
Mexico and Central and South America (Terres, 1980) and is related to the Mandarin 
and Carolina (or North American Wood Duck) ducks (Kear, 1985). This species is 
classified as a perching duck due to their ability to perch on branches and similar 
structures. The Muscovy duck is nonmigratory and is found as a permanent resident 
of coastal bottomland timbers along waterways and marsh lands. These birds feed on 
small fish, aquatic insects, mollusks, aquatic plants, grain, seeds, reptiles, worms and 
snails (Terres, 1980). The Muscovy duck is not considered by many breeders to be 
a true duck due to a number of unique characteristics exhibited by this species. 
Unlike other ducks, the Muscovy cannot spend extended amounts of time on the water 
because their feathers are not as water repellant as those of true ducks and they may 
become soaked, causing the ducks to drown. They are also less tolerant of wet and 
cold weather. When crossed with other species of ducks, the offspring are typically 
sterile. Also, as mentioned above, they are perching ducks (Holderread, 1978). The 
domestic goose is a descendant of the wild European Greylag goose (Terres, 1980). 
These birds are gregarious and nest in large colonies. Their diets exist primarily of 
plant materials and they frequently graze on land (Terres, 1980; Reilly, 1968).
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The most important species from an economic point of view are the domestic chicken, 
turkey and duck. The chicken and turkey are produced commercially for both egg 
and meat production. The Khaki Campbell duck is utilized for egg production while 
the Pekin and Muscovy are utilized for meat production. The quail is raised 
commercially for both egg and meat production and the goose is raised primarily for 
meat production (Phillips, et al. 1985).
3.0  EX PERIM ENTAL GOALS AND DESIGN
This study was conducted to characterize the oxidative biotransformation capacity of 
the hepatic microsomal system of selected avian species representing the Galliformes 
and Anseriformes orders. The hepatic cytochrome P-450 systems of seven avian 
models and a mammalian model were investigated. The Galliformes order was 
represented by the chicken, turkey and Japanese quail. The Anseriformes order was 
represented by the goose, Pekin duck, Khaki Campbell duck, and Muscovy duck. 
The male rat was utilized for the mammalian model. Two groups of animals for each 
species were evaluated and these consisted of a control group, which received no 
treatment, and a treatment group which was administered /Tnaphthoflavone (50 
mg/kg) intraperitoneally once a day for 3 days (Figure 3-1) prior to microsomal 
isolation on the fourth day. Each group consisted of six animals and investigations 
were conducted on hepatic microsomes prepared from individual animals.
The goal of this research was to initiate a database on the hepatic cytochrome P-450- 
dependent mixed function monooxygenases of domestic avian species for the purpose 
of addressing two objectives. The first objective of this study was to obtain 
fundamental information on the cytochrome P-450-dependent metabolic capacity of 
certain economically major and minor food-producing avian species for a given class 
of xenobiotics and to characterize the differences in metabolism of a model compound 
between the species. The goal of this objective was to provide biotransformation 
information relating to the hepatic cytochrome P-450 system of major and minor
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Figure 3-1 Structure o f beta-naphthoflavone.
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6species to support the interpretation of data submitted to the FDA for the purpose of 
obtaining approval for minor use avian drugs. For this study, the chicken and turkey 
represented economically major species while the Japanese quail, Pekin duck, Khaki 
Campbell duck, Muscovy duck and goose represented minor species. The second 
objective of this study was to characterize selective constitutive and inducible 
isozymes of the avian hepatic cytochrome P-450 system, determine the inducibility of 
the system utilizing a classical inducer of environmental relevance and investigate the 
metabolism of an environmentally relevant compound via the quantitation of individual 
metabolites. The goal of this objective was to evaluate the potential use of the 
representative avian species as sentinel organisms utilizing induction of the hepatic 
cytochrome P-450 system as a biomarker of environmental chemical exposure.
To achieve these objectives a series of investigations were undertaken:
(1) The components of the avian cytochrome P-450 system were quantitated 
including microsomal protein yield, cytochrome P-450 content, NADPH- 
and NADH-cytochrome c reductase activities.
(2) Ethoxyresorufin-O-deethylase activity (Figure 3-2) was determined to 
characterize the response of the avian hepatic cytochrome P-450 system to 
/3-naphthoflavone treatment. Presently, five isozymes of cytochrome P-450 
have been isolated from hepatic microsomes of rats treated with
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Figure 3-2 O-deethylation ofethoxyresorufin.
(8-naphthoflavone (and other 3MC-type inducers). Of these, two major 
forms, CYP1A1 and CYP1A2 have been identified (Ioannides and Parke, 
1987; Lau and Strobel, 1982; Sesardic et al., 1990; Thomas, et al., 1983). 
Ethoxyresorufin (an alkoxyphenoxazone derivative) has been demonstrated 
to be an isozyme-selective substrate for the CYP1A1 isozyme and an 
increase in the O-deethylation of ethoxyresorufin has been shown to be 
associated with induction of this isozyme (Burke, et al., 1985; Burke and 
Mayer, 1975; Guengerich, et al., 1982). The CYP1A1 and CYP1A2 
isozymes have been shown to be inducible by certain classes of 
environmental pollutants in laboratory animals and man. In addition, they 
have been demonstrated to increase the toxicity of a number of compounds 
via the formation of highly reactive intermediates (Sesardic, et al., 1990).
The hepatic microsomal oxidative biotransformation of benzo[a]pyrene was 
examined. Four metabolites, 3-hydroxybenzo[a]pyrene, 9-hydroxy- 
benzo[a]pyrene, benzo[a]pyrene-7,8-dihydrodiol, and benzo[a]pyrene-9,10- 
dihydrodiol, were identified and quantitated by HPLC analysis. These 
metabolites were selected based the pathways of hepatic oxidative 
metabolism identified in control and in /3NF-treated chicken embryos and 
rats (Figure 3-3). In primary cultures of chick embryo hepatocytes, Topp 
and van Bladeren (1986) observed the formation of tetrahydrotetrols, 3- 
hydroxybenzo[o]pyrene, 9-hydroxybenzo[a]pyrene, benzo[u]pyrene 7,8-
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Figure 3-3 Pathways of benzo[ajpyrene metabolism (Grover, 1986).
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dihydrodiol, and benzo[a]pyrene 9,10-dihydrodiol by control and /3NF- 
treated cells. Control and induced rat hepatic microsomes have been shown 
to metabolize B[a]P to a variety of phenols, dihydrodiols, and quinones. 
The major metabolites formed in the rat include 3- and 9- 
hydroxybenzo[ajpyrene, benzo[a]pyrene 4,5-, 7,8-, and 9,10-dihydrodiols 
and benzo[a]pyrene 1,6-, 3,6-, and 6,12-diones (Cavalieri, et al., 1988; 
Grover, 1986; Jongeneelen, et al., 1985; Levin, et al., 1982; Winston, et 
al., 1991; Wong, et a l., 1986). Benzo[a]pyrene was selected as a substrate 
for this metabolic study for two reasons. First, the oxidative metabolic 
pathways of this compound have been well described in a number of 
species. Secondly, benzo[ajpyrene is a representative substrate of an 
environmentally important class of compounds, the polycyclic aromatic 
hydrocarbons. The /3NF-inducible isozymes CYP1A1 and CYP1A2 have 
both been demonstrated to be involved in the metabolism of benzo[a]pyrene 
in the rat but CYP1A1 has been shown to be approximately 50 times more 
active than CYP1A2.
These investigations of the cytchrome P-450 system were conducted on hepatic 
microsomes of both control and /3NF-treated birds to determine the effects of 
induction on cytochrome P-450 content, catalytic activity and pathways of oxidative 
metabolism. Comparisons were sought between the avian species, between avian 
orders, and between avian species and the rat. Ethoxyresorufin-O-deethylase and
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benzo[ajpyrene hydroxylase activities were evaluated based on specific activity 
(pmoles of product produced/min/mg of microsomal protein) and on molar activity 
(pmoles of product produced/min/nmole of cytochrome P-450 also known as turnover 
number).
4.0 MATERIALS AND METHODS
4.1 Animals
The avian species used in this study included the White Leghorn chicken (Gallus 
gallus or Gallus domesticus), Japanese quail (Corturnix coturnix), turkey (Melegris 
gallopavo), goose {Anser anser), duck (Anser platyrhynchos) represented by the Pekin 
and Khaki Campbell breeds, and Muscovy duck (Cairina moschata). Twelve adult 
female birds of each species and breed were obtained from local vendors, with the 
exception of 2 quail, which were obtained from the Department of Veterinary Science, 
Louisiana State University, Baton Rouge, Louisiana. The birds were group-housed 
by species in enclosed outdoor stalls containing dried hardwood shavings purchased 
from Purvis Forest Products o f Carmen, Mississippi. The quail were kept in groups 
in small metal cages with grid mesh bottoms and were housed within a stall. All birds 
received tap water and a 50:50 ration of cracked corn and Purina Layena mash 
(obtained from Orcola, Louisiana) ad libitum. The birds were acclimated for 2 weeks 
prior to being utilized in the study. Twelve male Sprague-Dawley rats, weighing 
approximately 200 g, were obtained from Hilltop Lab Animals, Inc. (Scottsdale, 
Pennsylvania). The rats were group caged in a controlled environment defined by a 
temperature of 21-24° C, humidity of 40-60% and a light/dark cycle of 12 hours. 
The rats were given water and Purina rat chow free choice.
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4.2  Chemicals
Ethoxyresorufin (resorufin ethyl ether) (98%) was obtained from Molecular Probes, 
Inc. (Eugene, Oregon). Resorufin (75% dye content) was purchased from Aldrich 
Chemical Company, Inc. (Milwaukee, Wisconsin). /3-Naphthoflavone (90-95%), 
cytochrome c type III from horse heart (95-100%), NADPH (/3-nicotinamide adenine 
dinucleotide phosphate, tetrasodium salt, type III, reduced form) (98%), NADH ((3- 
nicotinamide adenine dinucleotide, reduced form) (98%), glucose-6-phosphate 
dehydrogenase (crystalline suspension in 3.2M (NH4)2S 0 4, pH7, activity 300-400 
units/mg protein), glucose-6-phosphate (crystalline, monosodium salt), nicotinamide 
adenine dinucleotide phosphate (sodium salt) (98-100%), and benzo[ajpyrene (98%) 
were purchased from Sigma Chemical Company (St. Louis, Missouri). 3- 
Hydroxybenzo[a]pyrene (>  98% purity by HPLC), 9-hydroxybenzo[a]pyrene (>  
98% purity by HPLC), benzo[a]pyrene-trans-7,8-dihydrodiol(-) ( >  99% purity by 
HPLC), and benzo[a]pyrene-trans-9,10-dihydrodiol ( > 9 9 %  purity by HPLC) were 
obtained from the NCI Chemical Carcinogen Repository, Midwest Research Institute 
(Kansas City, Missouri). Water used for the HPLC solvent system was triple-distilled 
and passed through a Modular Polisher I water purifying system (Continental Water 
Systems Corp., San Antonio, Texas). All other chemicals and biochemical agents 
used in this study were obtained from commercial suppliers and were of a quality that 
met or exceeded analytical grade standards.
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4.3  Treatment
A suspension of /3-naphthoflavone (5,6-benzoflavone) was prepared in peanut oil at 
a concentration of 50 mg/ml. The suspension was stored a 4° C and brought to room 
temperature prior to use. The birds and rats were randomly divided into control and 
treatment groups consisting of six animals each. The treatment groups were 
administered 50 mg/kg /3-naphthoflavone intraperitoneally once a day for three 
consecutive days and the animals were sacrificed on the fourth day. The control 
groups received no treatment.
4.4 Microsomal Preparation
The animals were sacrificed by decapitation and microsomes were prepared from 
livers of individual animals. All steps involved in the microsomal preparation were 
carried out at 4° C. The livers were removed, weighed and placed in 1.15% M KC1. 
The livers were minced with scissors, rinsed with 1.15% M KC1 and homogenized in 
STE buffer (0.25M sucrose, 10 niM Trizma HC1 and 1 mM EDTA; pH 7.4) at a 1:4 
tissue weight/ buffer volume ratio using a Potter-type Teflon-glass motor driven pestle 
homogenizer. Microsomal pellets were prepared from the homogenates by differential 
centrifugation (Lake, 1987). The homogenates were centrifuged (Beckman J-21B) for 
three 10 minute intervals at 600 x g, 8000 x g and 14,500 x g. The post- 
mitochondrial supernatant fractions were then centrifuged (Sorvall OTD-65 
Ultracentrifuge Oil Turbine Drive, Dupont Instruments) at 105,000 x g for 60 minutes 
to obtain the microsomal fractions. The post-105,000 x g microsomal pellets were
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resuspended in 0.125 M KC1 and recentrifuged at 105,000 x g for 60 minutes. The 
final microsomal pellets were resuspended with a glass hand-held homogenizer in a 
solution of 0.125 M KC1 in 20 percent v/v glycerol and stored at -80° C in 1 ml 
aliquots. Fresh aliquots of microsomes were brought to 4° C just prior to use for 
each investigation conducted (except for the determination of cytochrome P-450 
content which was conducted prior to microsomal storage).
4.5 Protein Determination
The microsomal protein concentrations were determined by the method of Lowry et 
al. (1951). A standard curve was constructed for each set of samples utilizing a series 
of concentrations of bovine serum albumin (BSA). The microsomal suspensions were 
diluted 1:100 with triple-distilled water. Four buffer solutions consisting of the 
following constituents were prepared: Buffer A, Na2C 0 3 (20 mg/1) and NaOH (4 
mg/1); Buffer B,, 2% sodium potassium tartrate; Buffer B2, 1% C uS04-7H20 ; and 
Buffer C, 1 part each of Buffers B, and B2 and 100 parts Buffer A. To 0.1 ml of the 
diluted microsomal suspensions, 2 ml of Buffer C were added and the sample was 
vortexed. Following a 10. minute incubation period at room temperature, 0.2 ml of 
Folin reagent was added and the sample was again vortexed. After a 30-minute 
incubation period at room temperature, the absorbance of each sample at 750 run was 
measured with a Shimadzu UV-160 spectrophotometer, and the protein concentration 
was automatically determined from the standard curve generated by the 
spectrophotometer. A representative standard curve for the analysis of microsomal
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protein concentration using BSA is presented in Figure A -l in the Appendix. All 
samples and standard curve BSA solutions were prepared and measured in duplicate. 
The yield of microsomal protein/g liver was determined by dividing the microsomal 
fraction o f protein (mg/ml) by the microsomal fraction tissue concentration (g of fresh 
liver/ml) (Lake, 1987).
4.6 Cytochrome P-450 Content
The cytochrome P-450 content of the hepatic microsomes was determined by the 
method of Omura and Sato (1964a). The microsomal suspensions were diluted 1:20 
in 0.1M  potassium phosphate buffer (pH 7.5). A few crystals (1-2 mg) of sodium 
dithionate were added and the solution was gently mixed. A reference and a sample 
cuvette containing 1 ml of the reduced microsomal solution were placed in a split- 
beam spectrophotometer (Shimadzu UV-160). A baseline of equal absorbance 
between the cuvettes was recorded from 350 to 490 nm. The sample cuvette was then 
saturated with carbon monoxide by gently bubbling carbon monoxide (1 bubble/sec 
~  40 sec) through the solution. A difference spectrum of the reduced cytochrome 
P-450 bound to carbon monoxide versus the non-bound reduced cytochrome P-450 
was then recorded from 350 nm to 490 nm. The difference in absorbance observed 
at 350 nm relative to 490 nm (AA450.490) and an extinction coefficient of 91 mM 'Icm '1 
(Omura and Sato, 1964a) were used to quantitate the total content of cytochrome P- 
450 (nmoles of cytochrome P-450/ml of microsomes). This value was divided by the 
protein concentration of the microsomal suspension (mg/ml) to obtain the specific
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content of cytochrome P-450 in units of nmoles o f cytochrome P-450/mg of 
microsomal protein.
4.7  NADH- and NADPH-Dependent Cytochrom e c Reductase
The activities of the microsomal flavoprotein reductases were determined using 
cytochrome c as an artificial electron acceptor due to the relative difficulty involved 
in measuring the actual NADH- and NADPH-cytochrome P-450 reductase activities. 
This assay is based on the reduction of ferric cytochrome c to ferrous cytochrome c 
which has a characteristic maximum absorption at A =  550 nm (Lake, 1967). The 
method of Phillips and Langdon (1962), as modified by Yasukochi and Masters 
(1976), was used to determine NADH- and NADPH-dependent cytochrome c 
reductase activities. A solution of cytochrome c was prepared by combining 31 mg 
cytochrome c type III from horse heart, 33 ml triple-distilled water and 17 ml of 1 M 
phosphate buffer. For measurement of the NADH-cytochrome c reductase activity, 
the microsomal suspensions were diluted (1:5 for the avian species and 1:10 for the 
rat) in 1 M phosphate buffer (pH 7.7). For the determination of NADPH-cytochrome 
c reductase activity, the microsomal suspensions were used at full concentration for 
the avian species and diluted 1:10 in 1 M phosphate buffer (pH 7.7) for the rat. 
Aliquots (2.5 ml) of cytochrome c solution were placed into reference and sample 
cuvettes. To the cytochrome c solution, microsomes (0.005 ml for the birds and 0.01 
ml for the rat) were added, the solutions were gently mixed and the cuvettes were 
place in a dual-beam Shimadzu UV-160 spectrophotometer. The spectrophotometer
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was set in the kinetic mode with a lag time of 5 sec, rate time of 75 sec, interval time 
of 15 sec, and X =  550 nm. The spectrophotometer was balanced between the two 
cuvettes. The reaction was initiated by adding 10 /d of freshly prepared NADPH (10 
mM) or NADH (lOmM) to the sample cuvette and gently mixing the solution. The 
cuvette was immediately returned to the sample chamber and the change in absorbance 
over the course of the reaction time was recorded. The AA550 in conjunction with an 
extinction coefficient of 21.1 m M 'Icm '1 (Lake, 1967; VanGelder and Slater, 1962) was 
used to quantitate NADH- and NADPH-cytochrome c reductase activities (nmole of 
cytochrome c reduced/min/ml microsomes). This value was divided by the protein 
concentration of the microsomes (mg/ml) to obtain the activities in nmole of 
cytochrome c reduced/min/mg of microsomal protein.
4.8 Ethoxyresorufin-O-Deethylase
Ethoxyresorufin-D-deethylase activity was determined by the method of Lake (1987). 
Trial assays at varying protein levels were conducted to establish reaction linearity 
with regard to protein level for the rat and the avian microsomes of the control and 
/3NF treatment groups (Figures A-2 through A-5). The results of the trial assays 
indicated that the appropriate microsomal protein contents for the reaction mixture 
were 0.4 mg for the avian species and 0.15 mg for the rat. The reaction mixture (1.8 
ml), which consisted of 50 mM tris hydroxy methyl aminomethane (Tris) HC1 buffer 
(pH 8.4), 5 mM M gS04, 3 units of glucose-6-phosphate dehydrogenase, 5 mM 
glucose-6-phosphate, 0.5 mM N ADP+ and hepatic microsomes, was prepared and
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maintained at 4° C until used. The reaction tubes were preincubated at 37° C for 5 
minutes and 0.5 /xM 7-ethoxyresorufin (0.2 ml 0.5 mM) was added to the mixture to 
initiate the reaction. The reaction was carried out at 37° C for 10 min in a shaking 
water bath. The reaction mixture was placed on ice and the reaction was stopped by 
the addition of 1 ml of zinc sulfate (5 % w/v) followed by 1 ml of a saturated barium 
hydroxide solution. The reaction mixture was centrifuged (Beckman J-21B) for 10 
min at 2000 x g at 4° C. To 1.5 ml of the supernatant, 3 ml of 0.5 M glycerine- 
NaOH buffer (pH 8.5) were added and the mixture was vortexed. Resorufin 
formation was measured on a spectrofluorometer (Farrand Optical Col, Valhalla, New 
York) with the excitation and emission wavelengths set at 535 nm and 582 nm, 
respectively, and quantitated using resorufin as a standard. A standard curve was 
constructed for each set of samples utilizing a series of concentrations of resorufin. 
A typical resorufin standard curve for the determination of ethoxyresorufin O- 
deethylase activity is presented in Figure A-6 in the Appendix. All samples were run 
in duplicate.
4.9 Benzo[a]pyrene Hydroxylase
Aryl hydrocarbon hydroxylase activity was determined as described by Guengerich 
(1982). All samples were run in duplicate. Linear enzymatic kinetics based on the 
formation of 3-OH B[a]P, 9-QH B[a]P, 7,8-diol B[a]P, and 9,10-diol B[a]P were 
determined with regard to protein concentration and incubation time for the avian and 
rat microsomes (Figures A-7 through A -12 in the Appendix). The reaction mixture
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(0.9 ml) consisted of 50 mM potassium phosphate buffer (pH 7.4), 5 mM MgCl2, 1 
mM N AD P+, 80 jiM  benzo[ajpyrene, and 0.5 mg microsomal protein. Following a 
3 min preincubation period at 37° C, the reaction was initiated by the addition o f 3 
units of glucose-6-phosphate dehydrogenase and 10 mM glucose-6-phosphate (0.1 ml). 
The reaction mixture was incubated for 20 min at 37° C in a water bath. The mixture 
was then placed on ice and the reaction was terminated by the addition of 1 ml of cold 
acetone followed by vortexing. The mixture was extracted twice with ethyl acetate. 
The extraction procedure included the addition of 1.5 ml of ethyl acetate to the 
reaction mixture followed by vortexing and then centrifugation at high speed for 5 
min. The top layer was removed and retained for analysis. This procedure was then 
repeated. The extracts were evaporated to dryness with nitrogen and reconstituted in 
250 /xl of acetonitrile.
Metabolite separation was achieved by high pressure liquid chromatography (HPLC) 
(Hewlett Packard HP 1090 HPLC system - HP 79994A Chemstation) utilizing a 
reversed-phase octadecylsilyl derivatized silica (ODS) column (Vydac 201 TP, 5/x, 4.6 
mm I.D . x 15 cm) (The Sep/a/ra/tions Group, Hesperia, California) with a replaceable 
guard column. Column temperature was maintained at 40° C. Trial runs were 
conducted with standards and microsomal extracts to refine the HPLC parameters for 
optimization of metabolite separation and detection. The solvent system utilized for 
the analyses was isocratic and consisted of water and acetonitrile (65:35 v/v) at a flow
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rate of 2.0 ml/min. An injection volume of 10 /xl was used via an automated injection 
system.
Detection of B[a]P, 3-OH B[a]P, 9-OH B[a]P, B[a]P-trans-7,8-dihydrodiol (-), and 
B[a]P-trans-9,10-dihydrodiol was achieved through the use of a programmable 
fluorescence detector and a photodiode array detector operating in series. The 
fluorescence detector was set at an excitation wavelength of 260 nm and an emission 
wavelength of 420 nm. The photodiode array detector was set at a wavelength of 254 
nm with a bandwidth of 20 nm, a reference spectrum of 550 nm with a bandwidth of 
100 nm, and a spectrum range of 210-500 nm. Wavelength selection was based on 
data provided in the NCI Analytical Datasheets.
Benzo[ajpyrene and the B[a]P metabolites were identified by retention time through 
the UV diode array detector and the fluorescence detector, respectively. Quantitation 
of the metabolites was achieved through the use of external standard calculations. 
Standards were prepared from stock solutions of B[a]P and each of the metabolites. 
The concentration ranges of the standard solutions were based on the anticipated levels 
of metabolite production as determined by preliminary assay runs for protein and 
reaction time determinations. Peak areas were used to establish standard curves for 
each analyte by plotting the integration areas of the generated peaks. Standard curves 
were established for each compound being analyzed by utilizing a series o f four 
concentrations which were 1.95, 3.90, 5.85 and 7.80 ng//ul for B[a]P 9,10-diol; 0.25,
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0.50, 0.75 and 1.00 ng//d for B[a]P 7,8-diol; 0.73, 1.46, 2.19 and 2.92 ng/^tl for 9- 
OH B[a]P; 1.99, 3.99, 5.98 and 7.93 ng//xl for 3-OH B[a]P; and 20.0, 40.0, 60.0 and
80.0 ng/jttl for B[a]P. A representative standard curve for each analyte and the 
respective correlation coefficients are presented in Figures A-13 through A-17 in the 
Appendix.
A method blank was prepared for each analyte to determine if there were any 
components in the reaction mixture which might interfere with the identification and 
quantitation of the compounds of interest. Each method blank consisted of 50 mM 
potassium phosphate buffer (pH 7.4), 5 mM MgCl2, 1 mM NADP+, 80 /^M 
benzo[a]pyrene, glucose-6-phosphate dehydrogenase, 10 mM glucose-6-phosphate (1.0 
ml total), acetone (1 ml), and 21.46 fig of B[a]P or one of the metabolites. The 
quantity of analyte selected for the method blank was equivalent to the amount of 
B[fl]P used in the aryl hydrocarbon hydroxylase assay. The blank mixture was 
extracted twice with 1.5 ml of ethyl acetate as described for the B[a]P hydroxylase 
assay. The extract was evaporated to dryness with nitrogen, reconstituted in 250 fil 
of acetonitrile and analyzed by HPLC. The method blank chromatograms for each 
analyte are presented in Figures A-18 through A-22 in the Appendix.
A microsomal blank was prepared for each species to determine if there were any 
microsomal components which may interfere with the identification and quantitation 
of the compounds of interest. Each microsomal blank consisted of 50 mM potassium
phosphate buffer (pH 7.4), 5 mM MgCl2, 1 mM NAD P+, 0.5 mg of microsomal 
protein, glucose-6-phosphate dehydrogenase, 10 mM glucose-6-phosphate (1.0 ml 
total), and acetone (1 ml). The blank mixture was extracted twice with 1.5 ml of 
ethyl acetate as described for the B[a]P hydroxylase assay. The extract was 
evaporated to dryness with nitrogen, reconstituted in 250 /xl of acetonitrile and 
analyzed by HPLC. The chromatograms of microsomal blanks for each species are 
presented in Figures A-23 through A-30 in the Appendix. These chromatograms and 
the method blank chromatograms demonstrated that the assay process was relatively 
free from interfering substances and that the analytical method employed had the 
ability to adequately resolve and detect the metabolites of interest from the 
assay/microsomal components.
To determine recovery, a known quantity of each analyte was added to the reaction 
mixture which consisted of 50 mM potassium phosphate buffer (pH 7.4), 5 mM 
MgCl2, 1 mM NADP+, glucose-6-phosphate dehydrogenase, 10 mM glucose-6 
phosphate and acetone. The mixture was extracted twice with 1.5 ml of ethyl acetate 
as described for the B[a]P hydroxylase assay. The extract was evaporated to dryness 
with nitrogen, reconstituted in 250 /xl of acetonitrile and analyzed by HPLC. The 
recovery response was then compared to the external standard response to determine 
the percent recovery of the analytes. The recovery for B[a]P and its metabolites was 
determined to be greater than 95 percent. Percent recovery for B[a]P was also 
determined during subsequent analyses to monitor extraction efficiency.
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All analyses were conducted in duplicate. A calibration curve was constructed for 
each set of samples analyzed. In addition, a method blank was run with each set of 
samples. Standards were analyzed after every six samples to serve as a check on the 
resolving capability of the column throughout the run. Representative chromatograms 
of B[a]P and microsomal metabolite formation for each species are presented in 
Figures A-31 through A-38 in the Appendix.
4.10 Statistical Analysis
Significant differences between control and /3NF-treated groups for each species and 
for each order were determined utilizing the Student’s t test (SAS,Institute, Inc., 
1988). Avian orders were also compared within each treatment group with a 
Student’s t test. The t test procedure is based on a single comparison of two group 
means. Three levels of significance, p <  0.05, p <  0.01, and p <  0.001, were used 
for the t test.
Analysis of variance was used to determine the significance of treatment group, 
species and the interaction of treatment group by species. To test the significance of 
differences between species within each treatment group, two multiple comparison 
techniques were employed, Scheffe’s test and Tukey’s test (SAS,Institute, Inc., 1988). 
These methods are multiple comparison tests for pairs of group means which arise in 
an analysis of variance. Scheffe’s test is more conservative, i.e ., it is more likely not 
to find a significant difference between groups, than Tukey’s test. Three levels of
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significance were examined in the statistical analysis of multiple comparisons, p <  
0.05, p <  0.01, and p <  0.001. These statistical analyses were conducted utilizing 
the SAS statistical package version 6.03 (SAS,Institute, Inc., 1988).
5.0  RESULTS
The components of the hepatic microsomal cytochrome P-450 system, including 
microsomal protein, specific content of cytochrome P-450, NADPH-dependent 
cytochrome c reductase activity and NADH-dependent cytochrome c reductase 
activity, were quantitated for the control and /3-naphthoflavone treatment groups of 
each species. The effects of /3-naphthoflavone (/3NF) treatment on ethoxyresorufin-0- 
deethylase and benzo[a]pyrene hydroxylase activities were evaluated on a basis of 
specific activity (quantity of product formed per milligram of microsomal protein) and 
molar activity (quantity of product formed per nmole of cytochrome P-450, also 
referred to as turnover number) for the representative avian species and the rat. 
Statistical comparisons were conducted to determine significant differences between:
• Control and /3NF-treatment groups of each species,
• Control groups of the avian species,
• /3NF-treatment groups of the avian species,
• Control and /3NF-treatment groups of each avian order (Galliformes 
and Anseriformes),
• Control groups o f each avian order,
• /3NF-treatment groups of each avian order, and
•  Avian and mammalian species (rat).
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Statistical differences for each of these comparisons are presented for three levels of 
significance: p <  0.05, p <  0.01, and p <  0.001. The acronyms utilized to 
designate the species and treatment group are presented in Table 5-1.
5.1 Components of the Hepatic Microsomal Cytochrome P-450 System
5.1.1 Microsomal Protein Content
Comparison of Control and /3NF-Treatment Groups.
The differences observed in the microsomal protein content (expressed as milligrams 
of microsomal protein per gram of liver) between the control and /3-naphthoflavone 
treatment groups ranged from no difference in content to an increase of 90 percent 
with an average increase in microsomal protein of 50 percent for the avian species. 
No significant difference in the content of microsomal protein was seen in the male 
rat. Significant increases in the content of microsomal protein were detected in the 
/3NF-treatment groups compared to the respective control groups for the goose (1.9- 
fold) and Pekin duck (1.6-fold) (p <  0.01) and for the chicken (1.6-fold), turkey 
(1.3-fold), and Khaki Campbell duck (1.4-fold) (p <  0.05).
Comparison of Avian Species.
The constitutive levels of microsomal protein per gram of liver were comparable 
among the avian species. The microsomal protein levels for the /3NF-treatment 
groups were significantly greater in the Pekin duck (p <  0.01) and Khaki Campbell 
duck (p <  0.05) compared to the quail.
87
Table 5-1 
T reatm ent G roup Designations
CC CHICKEN CONTROL
CT CHICKEN TREATMENT
QC QUAIL CONTROL
QT QUAIL TREATMENT
GC GOOSE CONTROL
GT GOOSE TREATMENT
TC TURKEY CONTROL
TT TURKEY TREATMENT
PDC PEKIN DUCK CONTROL
PDT PEKIN DUCK TREATMENT
KDC KHAKI CAMPBELL DUCK CONTROL
KDT KHAKI CAMPBELL DUCK TREATMENT
MDC MUSCOVY DUCK CONTROL
MDT MUSCOVY DUCK TREATMENT
ANC ANSERIFORMES CONTROL
ANT ANSERIFORMES TREATMENT
GAC GALLIFORMES CONTROL
GAT GALLIFORMES TREATMENT
MRC MALE RAT CONTROL
MRT MALE RAT TREATMENT
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Comparison of Avian Orders.
For the avian orders, the Anseriformes jSNF-treatment group had significantly higher 
microsomal protein per gram of liver than the Anseriformes control group (p <  
0.001) and the Galliformes (SNF-treatment group (p <  0.05). There was no 
significant difference noted (p <  0.05) between the Galliformes control and treatment 
groups.
Comparison of Avian Species and Male Rat.
In a comparison of the avian and mammalian species, the average constitutive level 
o f microsomal protein per gram of liver for the avian species was approximately 60 
percent of that detected in the male rat. The male rat control group had significantly 
higher (p <  0.001) microsomal protein per gram of liver than the quail, chicken, 
goose and Muscovy duck control groups. For the (3NF-treatment groups, the levels 
of microsomal protein in the avian species were comparable to the levels of the treated 
male rat. The only significant (p <  0.05) difference between the male rat and the 
avian species was with the quail.
The content of hepatic microsomal protein in the avian species and the rat are 
presented in Table 5-2.
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Table 5-2
Content o f M icrosom al Protein in Avian and  R at H epatic M icrosomes
T reatm ent G roup mg of microsomal protein  
per gram  of liver
CC 7 +  2
CT 1 1 + 4
QC 7 + 4
QT 7 +  3
GC 7 +  2
GT 13 ±  3
TC 9 +  3
TT 12 +  3
PDC 9 +  2
PDT 14 +  3
KDC 9 +  2
KDT 13 +  3
MDC 6 + 4
MDT 1 1 + 6
ANC 8 +  3
ANT 1 3 + 4
GAC 8 +  3
GAT 10 +  4
MRC 14 +  2
MRT 14 +  2
(table continued)
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Table 5-2
Content of Microsomal Protein in Avian and Rat Hepatic Microsomes
Significant Differences Between Control and /SNF-Trcatment Groups
p <  0.05 p <  0.01 p <  0.001
CT >  CC - -
GT >  GC GT >  GC -
TT >  TC - -
PDT >  PDC PDT >  PDC -
KDT >  KDC - -
Significant Differences Between Avian Species
p <  0.05 p <  0.01 p <  0.001
KDT > QT* - -
PDT >  QT * PDT >  QT* -
Significant Differences Between Avian Orders
p <  0.05 p <  0.01 p <  0.001
ANT > ANC ANT > ANC ANC >  ANT
ANT >  GAT - -
Significant Differences Between Avian Species and M ale Rat
p <  0.05 p <  0.01 p <  0.001
MRC >  QC MRC >  QC MRC >  QC*
MRC >  CC MRC >  CC MRC >  CC*
MRC >  GC MRC >  GC MRC >  GC*
MRC >  MDC MRC >  MDC MRC >  MDC*
MRT >  QT* - -
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test
5.1.2 Specific Content of Cytochrome P-450
Comparison of Control and ffNF-Treatment Groups.
Within the avian species, significant increases detected in cytochrome P-450 content 
(nmoles of cytochrome P-450 per milligram of microsomal protein) of the /3NF- 
treatment groups ranged from 1.7- to 3.2-fold with an average increase of 2.7 times 
the levels of P-450 detected in the respective control groups. The greatest increase 
in the specific content of cytochrome P-450 was seen in the Pekin duck (3.2-fold) 
treatment group (p <  0.05). Significant increases in the specific content of P-450 
were also noted in the jSNF-treatment groups for the goose (2.6-fold), Muscovy duck 
(2.2-fold), turkey (1.7-fold), and male rat (1.4-fold) (p <  0.001); and the chicken 
(1.8-fold) (p <  0.01) when compared to the respective control groups for each 
species.
Comparison of Avian Species.
The specific content of cytochrome P-450 was comparable among the control groups 
of the avian species. For the /3NF-treatment groups, the specific content of 
cytochrome P-450 for the turkey was significantly higher (p <  0.05) than that of the 
Khaki Campbell duck and the chicken. No other significant differences in cytochrome 
P-450 content were noted.
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Comparison of Avian Orders.
The Anseriformes /3NF-treatment group (p <  0.001) and the Galliformes /3NF- 
treatment group (p <  0.01) had significantly higher P-450 content than their 
respective control groups. There was no significant difference in the P-450 content 
between the Galliformes and Anseriformes for either the control or treatment groups.
Comparison of Avian Species and Male Rat.
There were no significant differences (p <  0.05) noted between the levels of 
cytochrome P-450 in the avian species and the male rat for either the control or /3NF- 
treatment groups.
The specific content of cytochrome P-450 of the avian and rat hepatic microsomes are 
presented in Table 5-3.
5.1.3 NADH-Dependent Cytochrom e c Reductase
Comparison Control and ffNF-Treatment Groups.
There were no significant differences in the NADH-dependent cytochrome c reductase 
activity between the control and jSNF-treatment groups of any of the species studied.
Comparison of Avian Species.
There were numerous significant differences noted in NADH-dependent cytochrome 
c reductase activity between the avian control groups and between the avian treatment
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Table 5-3
Cytochrome P-450 Content of Avian and Rat Hepatic Microsomes
Treatment Group nmoles of P-450 per mg 
of microsomal protein
CC 0.5 +  0.2
CT 0.9 ±  0.3
QC 1.2 ±  1.4
QT 2.0 ±  1.4
GC 0.6 +  0.2
GT 1.6 ±  0.3
TC 0.6 ±  0.1
TT 2.1 ±  0.5
PDC 0.5 ±  0.1
PDT 1.6 ±  0.7
KDC 0.5 ±  0.2
KDT 0.9 ±  0.5
MDC 0.6 ±  0.3
MDT 1.3 ±  0.2
ANC 0.5 ±  0.2
ANT 1.4 ±  0.5
GAC 0.8 ±  0.8
GAT 1.7 ±  1.0
MRC 0.9 ±  0.2
MRT 1.3 ±  0.1
(table continued)
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Table 5-3
Cytochrome P-450 Content of Avian and Rat Hepatic Microsomes
Significant Differences Between Control and j8NF-Treatment Groups
p <  0.05 p <  0.01 p <  0.001
CT >  CC CT >  CC -
GT >  GC GT >  GC GT >  GC
TT >  TC TT >  TC TT >  TC
PDT >  PDC - -
MDT >  MDC MDT > MDC MDT > MDC
MRT > MRC MRT >  MRC MRT >  MRC
Significant Differences Between Avian Species
p <  0.05 ■ B f l i H i p <  0.001
TT >  KDT* - -
TT > CT* - -
Significant Differences Between Avian Orders
p <  0.05 p <  0.01 p <  0.001
ANT > ANC ANT >  ANC ANT >  ANC
GAT >  GAC GAT >  GAC -
Significant Differences Between Avian Species and Male Rat
p <  0.05 p <  0.01 p <  0.001
- - -
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test
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groups. The most significant differences in activity (p <  0.001) between the control 
groups included goose >  turkey, goose >  chicken, Khaki Campbell duck >  turkey, 
and Khaki Campbell duck >  chicken. For the treatment groups, the most significant 
differences (P <  0.001) included a greater reductase activity in the Khaki Campbell 
duck than in the turkey or chicken. Less significant differences (p <  0.01) included 
greater activity in the goose control group compared to the Muscovy control group, 
Pekin duck control group compared to the turkey and chicken control groups, the 
Muscovy treatment group compared to the chicken and turkey treatment groups, and 
(p <  0.05) Pekin duck treatment group compared to the turkey treatment group.
Comparison o f Avian Orders.
There were no significant differences between the reductase activities o f the control 
and /JNF-treatment Anseriformes groups or between the control and treatment 
Galliformes groups (p <  0.05). In comparison of the orders, the NADH-dependent 
cytochrome c reductase activity in the Anseriformes was significantly (p <  0.001) 
greater ( ~  2-fold) than that of the Galliformes for both the control groups and the 
treatment groups.
Comparison o f Avian Species and Male Rat.
The average constitutive reductase activity in the avian species was comparable to that 
o f the male rat. Comparison of the male rat versus the avian species indicated only 
one significant difference and that was between the goose and the male rat control
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groups. The reductase activity of the goose control was 1.9 times greater than that 
of the male rat control. In the /3NF-treatment groups, there were no significant 
differences in activity between the avian species and the rat.
The NADH-dependent cytochrome c reductase activities (expressed as nmoles of 
cytochrome c reduced per minute per mg of microsomal protein) for the avian and 
male rat hepatic microsome control and j8-naphthoflavone-treatment groups are 
presented in Table 5-4.
5 .1 .4  NADPH-Dependent Cytochrom e c Reductase
Comparison of Control and ffNF-Treatment Groups.
There were no significant differences in NADPH-dependent cytochrome c reductase 
activity between the control and /3NF-treatment groups for any of the species studied.
Comparison of Avian Species.
NADPH-dependent reductase activity was comparable among the avian control 
groups. For the jSNF-treatment groups, the only significant difference (p <  0.05) 
noted between the avian species was a greater reductase activity in the goose 
compared to the Muscovy duck.
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Table 5-4
NADH-Dependent Cytochrom e c Reductase Activity in 
Avian and  R at H epatic Microsomes
T reatm ent G roup nmoles of cytochrome c reduced 
per m inute per mg o f protein
CC 232 ±  98
CT 212 ±  95
QC 584 ±  299
QT 541 ±  135
GC 923 ±  247
GT 583 ±  302
TC 233 ±  85
TT 199 ±  47
PDC 641 ±  129
PDT 614 ±  780
KDC 759 ±  224
KDT 804 ±  391
MDC 461 +  208
MDT 746 +  283
ANC 696 ±  259
ANT 687 ±  296
GAC 349 ±  246
GAT 317 ±  188
MRC 488 ±  92
MRT 551 ±  85
(table continued)
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Table 5-4
NADH-Dependent Cytochrome c Reductase Activity in 
Avian and  R at H epatic M icrosomes
Significant Differences Between C ontrol and /SNF-Treatment G roups
p  <  0,05 p <  0.01 p <  0 .001
- - -
Significant Differences Between Avian Species
p  <  0.05 p <  0.01 p <  0.001
GC >  MDC GC >  MDC* -
GC >  TC GC >  TC GC >  TC
GC >  CC GC >  CC GC >  CC
KDC >  TC KDC >  TC KDC >  TC*
KDC >  CC KDC >  CC KDC >  CC*
PDC >  TC* PDC >  TC* -
PDC >  CC* PDC >  CC* -
KDT >  CT KDT >  CT* KDT >  CT*
KDT >  TT KDT >  TT* KDT >  TT*
MDT >  CT MDT >  CT* -
MDT >  TT MDT >T T * -
PDT >  TT* - -
Significant Differences Between Avian O rders
p <  0.05 p <  0.01 p <  0.001
ANC >  GAC ANC >  GAC ANC >  GAC
ANT >  GAT ANT >  GAT ANT >  GAT
Significant Differences Between Avian Species and M ale R at
p <  0.05 p <  0.01 p <  0.001
- - -
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test
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Comparison of Avian Orders.
There were no significant differences in reductase activity between the control and 
/3NF-treatment groups for either the Galliformes or the Anseriformes. Likewise, there 
were no significant differences in reductase activity between the Galliformes and 
Anseriformes control or /3NF-treatment groups.
Comparison of Avian Species and Male Rat.
Overall, NADPH-dependent cytochrome c reductase activity was comparable for all 
species studied for both the control and treatment groups. Therefore, there were no 
significant differences in activity between the avian species and the male rat.
The NADPH-dependent cytochrome c reductase activities (expressed as nmoles of 
cytochrome c reduced per minute per mg of microsomal protein) for the avian and 
male rat hepatic microsomal control and /3-naphthoflavone-treatment groups are 
presented in Table 5-5.
5.2 Ethoxyresorufin-O-Deethylase
5.2.1 Ethoxyresorufin-O-Deethylase - Specific Activity
Comparison of Control and i3NF-Treatment Groups.
Dramatically greater levels o f EROD activity (based on specific activity) were 
observed in the /3NF-treatment groups compared to the respective control groups for 
all species studied. The differences in activity level for each species, in order of
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Table 5-5
NADPH-Cytochrome c Reductase Activity in 
Avian and  R at Hepatic M icrosomes
T rea tm en t G roup nmoles of cytochrom e c reduced 
per m inute per mg of protein
CC 93 +  25
CT 109 ±  37
QC 165 ±  132
QT 162 ±  60
GC 160 ±  33
GT 176 ±  48
TC 1 1 7 + 2 4
TT 110 +  35
PDC 117 ±  25
PDT 123 +  18
KDC 114 + 13
KDT 121 +  21
MDC 84 +  14
MDT 98 ±  23
ANC 119 +  35
ANT 129 +  40
GAC 130 ±  80
GAT 126 ±  50
MRC 168 ±  32
MRT 137 ±  42
(table continued)
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Table 5-5
NADPH-Cytochrome c Reductase Activity in 
Avian and Rat Hepatic Microsomes
Significant Differences Between Control and j8NF-Treatment Groups
p <  0.05 p <  0.01 p <  0.001
- - -
Significant Differences Between Avian Species
p <  0.05 p <  0.01 p <  0.001
GT >  MDT* - -
Significant Differences Between Avian Orders
p <  0.05 p <  0.001
- - -
Significant Differences Between Avian Species and M ale Rat
p <  0.01 p <  0.001
- - -
*Denotes a significant difference for Tukey’s test but not for Scheffe's test
decreasing magnitude, included: male rat (69-fold) >  chicken (39-fold) >  goose ~  
turkey =  Pekin duck (20-fold) >  quail ~  Khaki Campbell duck (16-fold) >  
Muscovy duck (9-fold). All differences in activity were significant at the p <  0.001 
level except for the quail which was significant at the p <  0.01 level. Although the 
Muscovy duck had the smallest difference in activity between groups, it should be 
noted that this species demonstrated the highest constitutive level of EROD activity 
among the species studied (including the male rat) and that in the /3NF-treatment
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groups, the activity of the Muscovy was comparable to the activity of the other avian 
treatment groups.
Comparison of Avian Species.
Constitutive ethoxyresorufin-O-deethylase activity was comparable among the avian 
species studied. For the treatment groups, significant differences in activity included 
Pekin duck >  quail (p <  0.001) and the turkey >  quail (p <  0.01). Other 
differences of lesser significance (p <  0.05, differences significant for Tukey’s test 
but not for Scheffe’s test) between the avian treatment groups included greater EROD 
activity in the Khaki Campbell duck, chicken and Muscovy duck compared to that 
observed in the quail.
Comparison of Avian Orders.
The EROD activities of the Anseriformes and Galliformes /JNF-treatment groups were 
significantly (p <  0.001) increased over the activities of their respective control 
groups. The Anseriformes and the Galliformes /3NF-treatment groups demonstrated 
a 15-fold and 25-fold greater activity, respectively, than the constitutive activities of 
the respective control groups. Constitutive EROD activity of the Anseriformes was 
significantly (p <  0.05) higher than that of the Galliformes. No significant difference 
in activity was detected between the Anseriformes and Galliformes |3NF-treatment 
groups.
103
Comparison of Avian Species and Male Rat.
The avian species had constitutive EROD activities comparable to those of the male 
rat. Therefore, there were no significant differences (p <  0.05) in EROD activity 
between the control groups of the avian species and the male rat. In contrast, the 
EROD activity demonstrated by the male rat treatment group was significantly greater 
(p <  0.001) than that seen in the treatment groups of each of the avian species 
studied. Statistical comparison of the activities of the control and (3NF treatment 
groups indicated that the male rat had a 4-times greater (69-fold vs. 17-fold) increase 
in EROD activity than the average increase exhibited by the avian species as a whole.
The ethoxyresorufin-O-deethylase activities (expressed as pmoles of resorufin 
produced per minute per mg of microsomal protein) for the avian and male rat hepatic 
microsomal control and /6-naphthoflavone-treatment groups are presented in Table 5-6.
5.2.2 Ethoxyresorufin-O-Deethylase - Molar Activity
Comparison of Control and 6NF-Treatment Groups.
As with specific activity, significant differences in EROD activity were seen between 
the control and /3NF-treatment groups for all the species studied. However, the 
increases noted in terms of turnover number were less pronounced than those noted 
in terms of specific activity. Differences in molar activity, between the control and 
/3NF-treated groups, presented in order of decreasing magnitude, included male rat
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Table 5-6
Ethoxyresorufin-O-D eethylase Activity in Avian and  R at 
H epatic Microsomes - Specific Activity
T reatm ent G roup pinoles of resorufin  produced per m inute per 
mg of protein
CC 14 +  7
CT 546 ±  205
QC 1 1 + 7
QT 178 +  92
GC 22 ±  11
GT 483 +  137
TC 31 +  28
TT 637 +  122
PDC 34 +  25
PDT 700 +  254
KDC 35 ±  19
KDT 558 +  124
MDC 64 +  65
MDT 544 +  149
ANC 39 ±  37
ANT 571 ±  181
GAC 18 +  19
GAT 454 +  247
MRC 2 5 + 5
MRT 1719 +  339
(table continued)
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Table 5-6
Ethoxyresorufin-O-Deethylase Activity in Avian and  R at 
H epatic M icrosomes - Specific Activity
Significant Differences Between Control and /SNF-Treatment G roups
p <  0.05 p <  0.01 p <  0.001
CT >  CC CT >  CC CT >  CC
QT >  QC QT >  QC -
GT >  GC GT >  GC GT >  GC
TT >  TC TT >  TC TT >  TC
PDT >  PDC PDT >  PDC PDT >  PDC
KDT >  KDC KDT >  KDC KDT >  KDC
MDT >  MDC MDT >  MDC MDT >  MDC
MRT >  MRC MRT >  MRC MRT >  MRC
Significant Differences Between Avian Species
p <  0.05 p <  0.001
PDT >  QT PDT >  QT PDT >  QT*
TT >  QT TT >  QT* -
KDT >  QT* - -
CT >  QT * - -
MDT >  QT * - -
Significant Differences Between Avian O rders
p <  0.05 p <  0.01 p <  0.001
ANC >  GAC - -
ANT >  ANC ANT >  ANC ANT > ANC
GAT >  GAC GAT >  GAC GAT >  GAC
(table continued)
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Table 5-6
Ethoxyresorufin-O-Deethylase Activity in Avian and Rat 
Hepatic Microsomes - Specific Activity
Significant Differences Between Avian Species and Male Rat
p <  0.05 p <  0.01 p <  0.001
MRT >  PDT MRT > PDT MRT > PDT
MRT >  TT MRT >  TT MRT > TT
MRT >  KDT MRT > KDT MRT > KDT
MRT >  CT MRT > CT MRT > CT
MRT >  MDT MRT > MDT MRT >  MDT
MRT >  GT MRT >  GT MRT > GT
MRT > QT MRT > QT MRT > QT
^Denotes a significant difference for Tukey’s test but not for Scheffe’s test
(47.5-fold) >  chicken (21.4-fold) >  Khaki Campbell duck (9.3-fold) >  Pekin duck 
=  Japanese quail (7.8-fold) >  goose ~  turkey (7.2-fold) >  Muscovy duck (3.7- 
fold). These differences were significant at the p <  0.001 level for the Muscovy 
duck and the male rat, at the p <  0.01 level for the turkey, quail, and chicken, and 
at the p <  0.05 level for the goose, Pekin duck, and Khaki Campbell duck. As 
discussed in terms of specific activity, the Muscovy duck had the highest constitutive 
level o f EROD activity but had the smallest difference in EROD activity between the 
control and treatment groups based on turnover number. However, for the |3NF
107
treatment group, EROD activity in the Muscovy duck was comparable to the levels 
observed by the treatment groups of the other species.
Comparison of Avian Species.
Only a few significant differences in EROD activity were noted between the avian 
species. For the control groups, EROD activity was comparable among the avian 
species except for a significant difference between the Muscovy duck and the quail (p
<  0.05, the difference was significant for Tukey’s test but not for Scheffe’s test). 
Between the (JNF-treatment groups, significant differences in EROD activity included 
greater activity in the Khaki Campbell duck (p < 0.01) and the chicken (p <  0.05, 
the difference was significant for Tukey’s test but not for Scheffe’s test) compared to 
the quail.
Comparison of Avian Orders.
The EROD activities were significantly (p <  0.001) greater in the Anseriformes (6.6- 
fold) and Galliformes (12-fold) /3NF-treatment groups compared to the respective 
control groups. The activity o f the Anseriformes control group was significantly (p
<  0.01) greater (2.6-fold) than that of the Galliformes control group. However, there 
were no significant differences in EROD activity between the Anseriformes and 
Galliformes /3NF-treatment groups.
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Comparison of Avian Species and Male Rat.
The level of constitutive EROD activity for the avian species was equivalent to that 
of the male rat. In contrast, the /3NF-treatment group for the male rat demonstrated 
EROD activities that were significantly greater (3-fold) than the activities, on average, 
o f the j8NF-treatment avian groups. Levels of significance for these differences 
included p <  0.001 for the Pekin duck, Muscovy duck, turkey, goose, and quail, p 
<  0.01 for the chicken, and p <  0.05 (difference was significant for Tukey’s test but 
not for Scheffe’s test) for the Khaki Campbell duck.
The ethoxyresorufin-O-deethylase activities (expressed as pmoles of resorufin 
produced per minute per nmole of cytochrome P-450) for the avian and male rat 
hepatic microsomal control and 0-naphthoflavone-treatment groups are presented in 
Table 5-7.
5.3 Benzo[a]pyrene Hydroxylase
5.3.1 3-Hydroxybenzo[a]pyrene - Specific Activity
Comparison of Control and ffNF-Treatment Groups.
Based on specific activity, significant increases in the formation o f 3- 
hydroxybenzo[a]pyrene (3-OH B[tf]P) were observed in the j3NF-treatment groups, 
compared to the respective control groups, for the chicken (4-fold) (p <  0.001) and 
the quail (2-fold) (p <  0.05). No significant difference in 3-OH B[a]P formation was 
detected in the other species studied.
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Table 5-7
Ethoxyresorufin-O-D eethylase Activity in Avian and  R at 
H epatic M icrosomes - M olar Activity
T reatm ent G roup pmoles of resorufin  produced 
per m inute per nmole of P-450
CC 30 ±  15
CT 644 ±  341
QC 13 +  10
QT 102 +  49
GC 44 +  34
GT 310 ±  117
TC 46 +  38
TT 330 +  130
PDC 69 ±  49
PDT 544 +  345
KDC 80 ±  61
KDT 747 ±  472
MDC 114 +  114
MDT 424 ±  110
ANC 77 ±  71
ANT 506 ±  328
GAC 30 ±  27
GAT 359 ±  304
MRC 28 ±  2
MRT 1280 ±  224
(table continued)
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Table 5-7
Ethoxyresorufin-O-Deethylase Activity in Avian and  R at 
H epatic Microsomes - M olar Activity
Significant Differences Between Control and  /JN F-Treatinent G roups
p <  0.05 p <  0.01 p <  0.001
CT >  CC CT >  CC -
QT > QC QT >  QC -
GT > GC - -
TT >  TC TT >  TC -
PDT >  PDC - -
KDT >  KDC - -
MDT >  MDC MDT >  MDC MDT >  MDC
MRT >  MRC MRT >  MRC MRT >  MRC
Significant Differences Between Avian Species
p <  0.05 p <  0.001
MDC >  QC* - -
KDT >  QT KDT >  QT* -
CT > QT* - -
Significant Differences Between Avian O rders
p <  0.05 p <  0.01 p <  0.001
ANT >  ANC ANT > ANC ANT >  ANC
ANC > GAC ANC > GAC -
GAT >  GAC GAT >  GAC GAT >  GAC
(table continued)
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Table 5-7
Ethoxyresorufin-O-Deethylase Activity in Avian and Rat 
Hepatic Microsomes - Molar Activity
Significant Differences Between Avian Species and Male Rat
p < 0.05 p < 0.01 p < 0.001
MRT > KDT* - -
MRT >  CT MRT > CT* -
MRT > PDT MRT > PDT MRT >  PDT*
MRT > MDT MRT > MDT MRT >  MDT
MRT >  TT MRT >  TT MRT >  TT
MRT >  GT MRT > GT MRT >  GT
MRT >  QT MRT > QT MRT >  QT
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test
Comparison of Avian Species.
Significant differences in the formation of 3-OH B[a]P between the avian control 
groups included turkey >  chicken (p <  0.001) and quail (p <  0.01), and Khaki 
Campbell duck >  chicken (p <  0.01). Less significant (p <  0.05, difference 
significant for Tukey’s test but not significant for Scheffe’s test) differences between 
control groups included turkey >  Pekin duck and turkey > goose. It is interesting 
to note that the greatest production of 3-OH B |a]P was by the turkey for both the 
control and |3NF-treated groups. In addition, the level of 3-OH B[a]P produced by 
the turkey control was greater than the levels produced by the treatment groups of the
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other avian species and, in spite of the outstanding production of 3-OH B[a]P by the 
turkey, only a 13% increase in 3-OH B[a]P formation was present in the treatment 
group compared to the control. In contrast, the chicken had the lowest 3-OH B[a]P 
formation among the avian species, but had the greatest increase (4.3-fold) in 
formation between the control and /3NF-treatment groups. In comparison of the avian 
/3NF-treatment groups, the formation of 3-OH B[a]P by the turkey was significantly 
greater than that of the chicken. Less significant (p <  0.05, difference significant for 
Tukey’s test but not significant for Scheffe’s test) differences between the treatment 
groups included greater 3-OH B[«]P production by the turkey, Khaki Campbell duck 
and quail compared to the goose.
Comparison of Avian Orders.
The formation of 3-OH B[a]P by the Galliformes treatment group was significantly 
(p <  0.05) greater (2-fold) than that of the Galliformes control group. The 
Anseriformes control and treatment groups were not significantly different. 
Production of 3-OH B[o]P by the Galliformes treatment group was significantly (p <  
0.05) greater than that of the Anseriformes treatment group but there was no 
significant difference detected between the control groups.
Comparison of Avian Species and Male Rat.
Significant differences in the production of 3-OH B[a]P between the avian and male 
rat controls included greater 3-OH B[a]P formation in the turkey (3.2-fold) (p <
113
0.01) and Khaki Campbell duck (2.7-fold) (p <  0.05, difference significant for 
Tukey’s test but not significant for Scheffe’s test) compared to that of the male rat. 
Formation of 3-OH B[a]P by the jSNF-treatment groups was also significantly greater 
in the turkey (2.9-fold) (p <  0.01) and the Khaki Campbell duck (2.1-fold) (p <  
0.05, difference significant for Tukey’s test but not significant for Scheffe’s test) than 
in the male rat.
The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f 3-OH B[a]P 
produced per minute per mg of microsomal protein) for the avian and male rat hepatic 
microsomal control and 0-naphthoflavone-treatment groups are presented in Table 5-8.
5.3.2 3-Hydroxybenzo[a]pyrene - Molar Activity
Comparison of Control and Treatment Groups.
In comparison with the control groups, significantly (p <  0.05) greater quantities of 
3-OH B[a]P were produced (based on turnover number) by the treatment groups of 
the chicken (2.4-fold) and quail (1.7-fold). In contrast, significantly (p <  0.05) lower 
levels of 3-OH B[a]P formation were produced by the treatment groups of the goose 
(4-fold), turkey (3-fold), and Muscovy duck (1.6-fold) respective to their control 
groups. No difference in 3-OH production was seen between the control and /3NF- 
treatment groups of the Pekin duck, Khaki Campbell duck, and male rat.
114
Table 5-8
Benzo[a]pyrene Hydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of 3-H ydroxybenzo[a]pyrene - Specific Activity
T reatm ent G roup pinoles of 3-OH B[a]P produced 
per m inute per mg of protein
CC 102 +  51
CT 436 ±  97
QC 236 ±  264
QT 534 ±  184
GC 317 ±  174
GT 232 ±  80
TC 714 +  256
TT 805 ±  244
PDC 323 ±  264
PDT 481 ±  93
KDC 595 +  237
KDT 577 ±  139
MDC 381 ±  196
MDT 520 ±  133
ANC 404 ±  236
ANT 453 ±  172
GAC 351 +  337
GAT 592 ±  237
MRC 221 ±  112
MRT 280 ±  130
(table continued)
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Table 5-8
Benzo[a]pyrene H ydroxylase Activity in Avian and R at H epatic 
Microsomes: Form ation of 3-H ydroxybenzo[a]pyrene - Specific Activity
Significant Differences Between C ontrol and T reatm ent G roups
p <  0.05 p < 0.01 p <  0.001
CC >  CT CC >  CT CC >  CT
QT >  QC - -
Significant Differences Between Avian Species
p <  0.05 p < 0.01 p <  0.001
TC >  PDC* - -
TC >  GC* - -
TC >  QC TC > QC* -
TC >  CC TC > CC TC >  CC*
KDC >  CC KDC >  CC* -
TT > PDT* - -
TT >  CT* TT > CT* -
TT > GT* - -
KDT >  GT* - -
QT > GT* - -
Significant Differences Between Avian O rders
p <  0.05 p < 0.01 p <  0.001
GAT > ANT - -
GAT > GAC - -
(table continued)
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Table 5-8
Benzo[a]pyrene Hydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of 3-H ydroxybenzo[a]pyrene - Specific Activity
Significant Differences Between Avian Species and M ale R a t
p <  0.05 p < 0.01 p <  0.001
TC >  MRC TC > MRC* -
KDC >  MRC* - -
TT >  MRT TT >  MRT TT >  MRT
KDT >  MRT* - -
^Denotes a significant difference for Tukey’s test but not for Scheffe’s test. 
Comparison of Avian Species.
Significant differences between the avian control groups included greater 3-OH B[a]P 
formation by the Khaki Campbell duck compared to the chicken, quail (p <  0.001), 
and goose (p <  0.05, difference significant for Tukey’s test but not significant for 
Scheffe’s test) and by the turkey compared to the chicken and quail (p <  0.001). In 
terms of molar activity, the Khaki Campbell duck control and treatment groups had 
the greatest formation of 3-OH B[a]P rather than the turkey as was seen when the 
statistical analysis was based on specific activity.
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Comparison of Avian Orders.
The Anseriformes control group produced a significantly (p <  0.01) greater quantity 
(2-fold) of 3-OH B[a]P than the treatment group. There was no significant difference 
in 3-OH B[a]P metabolite formation seen between the Galliformes control and /JNF- 
treatment groups. In addition, no significant difference was detected between the 
avian orders for either the control or treatment groups.
Comparison of Avian Species and Male Rat.
Comparisons between the avian and male rat control groups indicated the turkey (p 
<  0.001) and the Khaki Campbell duck (p <  0.01) produced significantly greater 
quantities of 3-OH B[a]P than the male rat. Constitutive production of 3-OH B[n]P 
by the remaining species was comparable to that of the male rat. Of the treatment 
groups, the only species significantly different from the male rat were the Khaki 
Campbell duck (p < 0.001) and the chicken (p <  0.05, difference significant for 
Tukey’s test but not significant for Scheffe’s test). The Khaki Campbell duck and 
chicken treatment groups produced greater quantities of 3-OH B[a]P, 3.2- and 2.4- 
fold, respectively, than was produced by the male rat. Formation o f the 3-OH B[a]P 
metabolite by the treatment groups of the other species was similar to that observed 
in the male rat.
118
The benzo[a]pyrene hydroxylase activities (expressed as pmoles of 3-OH B[a]P 
produced per nmole of cytochrome P-450) for the avian and male rat hepatic 
microsomal control and (3-naphthoflavone-treatment groups are presented in Table 5-9.
5.3.3 9-Hydroxybenzo[a]pyrene - Specific Activity
Comparison of Control and ffNF-Treatment Groups.
Evaluation o f the results of the 6 individual animals within each control group 
indicated that 9-hydroxybenzo[a]pyrene (9-OH B[<a]P) was produced by only 5 of the 
male rats, 5 of the Pekin ducks, and 4 of the Muscovy ducks. Six out of 6 animals 
produced 9-OH B[<?]P within the control groups of the other species. Based on 
specific activity, the formation of 9-OH B[a]P in the /JNF-treatment groups was 
significantly greater than that of the control groups for all the species studied. The 
greatest increases following jSNF-treatment were present in the Pekin duck (4.4-fold) 
and the chicken (4-fold), followed by the male rat (3.3-fold), goose (3-fold), Khaki 
Campbell duck (3-fold), Muscovy duck (3-fold), quail (2-fold), and the turkey (1.5- 
fold). Levels of significance for these increases included p <  0.001 for the chicken, 
goose, Pekin duck, and Khaki Campbell duck and p <  0.05 for the quail, Muscovy, 
and male rat.
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Table 5-9
Benzo[a]pyrene Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of 3-Hydroxybenzo[a]pyrene - M olar Activity
T rea tm en t G roup pmoles of 3-OH B[a]P 7,8-produced 
per m inute per nmole o f P-450
CC 219 ±  113
CT 516 ±  221
QC 192 ±  58
QT 317 ±  106
GC 568 +  333
GT 144 +  46
TC 1201 ±  553
TT 422 ±  132
PDC 639 ±  426
PDT 339 ±  113
KDC 1293 ±  669
KDT 702 ±  276
MDC 663 ±  152
MDT 415 ±  154
ANC 791 ±  517
ANT 440 ±  262
GAC 537 ±  580
GAT 409 ±  175
MRC 245 ±  112
MRT 219 ±  89
(table continued)
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Table 5-9
Benzo[a]pyrene Hydroxylase Activity in Avian and  R at H epatic 
Microsomes: Form ation of 3-H ydroxybenzo[a]pyrene - M olar Activity
Significant Differences Between Control and /JN F-Treatm ent G roups
p <  0.05 p <  0.01 p <  0.001
CT >  CC - -
QT >  QC - -
GT >  GC - -
TC >  TT - -
MDC >  MDT - -
Significant Differences Between A vian Species
p <  0.05 p <  0.01 p <  0,001
KDC >  GC* ■ - -
KDC >  CC KDC >  CC KDC >  CC*
KDC >  QC KDC >  QC KDC >  QC*
TC >  CC TC >  CC* TC >  CC*
TC >  QC TC >  QC* i > QC*
KDT >  PDT* KDT >  PDT* -
KDT >  QT KDT >  QT* -
KDT >  GT KDT >  GT KDT >  GT
CT >  GT* CT >  GT* -
Significant D ifferences Between Avian O rders
p <  0.05 p <  0.01 p <  0.001
ANC >  ANT ANC > ANT -
(table continued)
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Table 5-9
Benzo[a]pyrene Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of 3-H ydroxybenzo[a]pyrene - M olar Activity
Significant Differences Between Avian Species and  th e  M ale R at
p <  0,05 p <  0.01 p <  0.001
KDC >  MRC KDC >  MRC KDC >  MRC*
TC >  MRC TC >  MRC* -
KDT >  MRT KDT >  MRT KDT >  MRT
CT >  MRT* - -
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test 
Comparison of Avian Species.
Ranking of the avian species based on the formation of 9-OH B[a]P resulted in 
following sequences: turkey >  chicken =  quail ~  goose =  Muscovy duck =  Khaki 
Campbell duck >  Pekin duck for the control groups and turkey ~  chicken >  goose 
>  quail >  Pekin duck >  Muscovy duck >  Khaki Campbell duck for the treatment 
groups. It should be noted that the turkey had the greatest formation of 9-OH B[a]P 
among the control groups and among the treatment groups, yet had the 
smallestdifference (1.5-fold) in formation between the control and treatment groups. 
It is also interesting to note that the constitutive level of 9-OH formation for the 
turkey was greater ( ~  2-fold) than the treated levels of the other avian species 
(excluding the chicken). Numerous significant (p <  0.001) differences were noted 
between the avian species. For the control groups, significant (p <  0.001)
122
differences were noted between the turkey and each of the other avian species. 
Production of the 9-OH B[a]P metabolite was similar among the remaining avian 
control groups. Between the treatment groups, 9-OH B[n]P formation by the turkey 
and the chicken was significantly (p <0 .001) greater than formation by the goose, 
quail, Muscovy duck, Pekin duck, and Khaki Campbell duck. No significant 
differences were observed between the treatment groups of the other avian species.
Comparison o f Avian Orders.
Significant differences were detected between the control and treatment groups of both 
the Anseriformes (p <  0.001) and the Galliformes (p <  0.01). Production of 9-OH 
B[#]P by the j8NF-treatment groups were significantly greater (Anseriformes 3-fold, 
Galliformes, 2-fold) than that of the respective control groups. Significant differences 
between orders included greater formation of 9-OH B[a]P by the Galliformes control 
group (3.9-fold) compared to the Anseriformes control group (p <  0.01) and greater 
production in the Galliformes treatment group (2.4-fold) compared to the 
Anseriformes treatment group (p <  0.001).
Comparison of the Avian Species and Male Rat.
In general, 9-OH B[a]P production by the avian species equaled or exceeded that of 
the male rat for both the control groups and the treatment groups. Significant (p <  
0.001) differences in 9-OH B[a]P formation were present between the turkey and the 
male rat control groups, chicken and male rat treatment groups and the turkey and the
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male rat treatment groups. The differences in 9-OH B[a]P formation between the 
control and /3NF-treatment groups for the avian species (1.5- to 4-fold) were 
comparable to that o f the male rat (3-fold).
The benzo[a]pyrene hydroxylase activities (expressed as pmoles of 9-OH B[fl]P 
produced per minute per mg of microsomal protein) for the avian and male rat hepatic 
microsomal control and (S-naphthoflavone-treatment groups are presented in Table 5- 
10.
5.3 .4  9-Hydroxybenzo[a]pyrene - Molar Activity
Comparison of Control and ffNF-Treatment Groups.
The only significant (p <  0.05) difference in 9-OH B[a]P formation detected between 
the control and treatment groups, based on molar activity, was for the chicken (2-fold 
increase in the treatment group respective to the control group).
Comparison of Avian Species.
The levels of 9-OH B[tf]P formation among the avian species included turkey >  
chicken ~  Muscovy duck ~  goose ~  Khaki Campbell duck =  quail =  Pekin duck 
for the control groups and chicken >  turkey =  Khaki Campbell duck ~  Muscovy 
duck ~  goose *  quail *  Pekin duck for the /3NF-treatment groups. There were 
numerous significant differences in 9-OH formation between the avian species.
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Table 5-10
Benzo[a]pyrene H ydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of 9-H ydroxybenzo[a]pyrene - Specific Activity
T reatm ent G roup pinoles of 9-OH B[a]P produced 
per m inute per mg of protein
CC 49 ±  21
CT 195 +  53
QC 41 ±  41
QT 78 ±  19
GC 28 +  16
GT 83 ±  22
TC 154 ±  74
TT 232 +  70
PDC 14 +  8
PDT 61 ±  17
KDC 20 +  9
KDT 59 +  20
MDC 23 +  29
MDT 73 +  34
ANC 21 +  17
ANT 69 +  25
GAC 81 +  71
GAT 168 ±  83
MRC 24 ±  14
MRT 78 +  48
(table continued)
125
Table 5-10
Benzo[a]pyrene Hydroxylase Activity in Avian and  R at H epatic 
Microsomes: Form ation of 9-H ydroxybenzo[a]pyrene - Specific Activity
Significant Differences Between C ontrol and  j8NF-Treatment G roups
p <  0.05 p <  0.01 p <  0.00J
CT >  CC CC >  CT CC >  CT
QT >  QC - -
GT >  GC GT >  GC GT >  GC
PDT >  PDC PDT >  PDC PDT >  PDC
KDT >  KDC KDT >  KDC KDT >  KDC
M DT >  MDC - -
MRT >  MRC - -
Significant Differences Between Avian Species
p <  0.05 p <  0.001
TC >  CC TC >  CC TC >  CC*
TC >  QC TC >  QC TC >  QC
TC >  GC TC >  GC TC >  GC
TC >  MDC TC >  MDC TC >  MDC
TC >  KDC TC >  KDC TC >  KDC
TC >  PDC TC >  PDC TC >  PDC
TT >  GT TT >  GT TT >  GT
TT >  QT TT >  QT TT >  QT
TT >  MDT TT >  MDT TT >  MDT
TT >  PDT TT >  PDT TT >  PDT
TT >  KDT TT >  KDT TT >  KDT
CT >  GT CT >  GT* CT >  GT*
(table continued)
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Table 5-10
Benzo[a]pyrene H ydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of 9-Hydroxybenzo[a]pyrene - Specific Activity
CT >  QT CT >  QT CT >  QT*
CT >  MDT CT >  MDT CT >  MDT*
CT >  PDT CT >  PDT CT >  PDT
CT >  KDT CT >  KDT CT >  KDT
Significant Differences Between Avian O rders
p <  0.05 p <  0.01 p <  0.001
ANT >  ANC ANT >  ANC ANT >  ANC
GAT >  GAC GAT >  GAC -
GAT >  ANT GAT >  ANT GAT >  ANT
GAC >  ANC GAC >  ANC -
Significant Differences Between Avian Species an d  th e  M ale R a t
p <  0.05 p <  0.001
TC >  MRC TC >  MRC TC >  MRC
TT >  MRT TT >  MRT TT >  MRT
CT >  MRT CT >  MRT CT >  MRT*
^Denotes a significant difference for Tukey’s test but not for Scheffe’s test
Comparisons of the control groups indicated that 9-OH B[a]P formation by the turkey 
was significantly (p <  0.001) greater than that of the other avian species. For the 
treatment groups, 9-OH B[a]P formation by the chicken was significantly greater than
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than that of the other avian treatment groups (p <  0.01 for the turkey and p <  0.001 
for the other species).
Comparison of Avian Orders.
The Anseriformes treatment group produced a significantly (p <  0.05) greater level 
of 9-OH B[a]P than the control group. No significant difference was seen between 
the Galliformes control and treatment groups. 9-Hydroxybenzo[a]pyrene formation 
in the Galliformes control and treatment groups was significantly (p <  0.01) greater 
than the formation seen in the Anseriformes control and treatment groups, 
respectively.
Comparison of Avian Species and Male Rat.
In the avian species, the formation of 9-OH B[a]P by the control and treatment groups 
was equivalent to or greater than that of the male rat control. Significant (p <  0.001) 
differences between the avian species and the male rat included greater 9-OH B[a]P 
formation in the turkey control compared to the male rat control and in the chicken 
treatment group compared to the male rat treatment group.
The benzo[a]pyrene hydroxylase activities (expressed as pmoles of 9-OH B[a]P 
produced per nmole of cytochrome P-450) for the avian and male rat hepatic 
microsomal control and /3-naphthoflavone-treatment groups are presented in Table 5-
1 1 .
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Table 5-11
Benzo[a]pyrene Hydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of 9-Hydroxybenzo[a]pyrene - M olar Activity
T reatm ent G roup pinoles of 9-OH B[a]P produced 
per m inute per nmole of P-450
CC 105 +  38
CT 231 +  103
QC 38 ±  11
QT 47 ±  18
GC 45 +  20
GT 52 +  15
TC 256 +  142
TT 124 ±  50
PDC 29 ±  17
PDT 45 ±  18
KDC 42 ±  24
KDT 71 ±  27
MDC 51 ±  62
MDT 59 ±  35
ANC 38 ±  25
ANT 57 ±  26
GAC 132 ±  126
GAT 132 ±  100
MRC 28 ±  19
MRT 60 ±  35
(table continued)
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Table 5-11
Benzo[a]pyrene Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of 9-H ydroxybenzo[a]pyrene - M olar Activity
Significant Differences Between Control and  /SNF-Treatment G roups
p <  0.05 p <  0.01 p <  0.001
CC >  CT - -
Significant Differences Between Avian Species
p <  0.05 p <  0.01 p  <  0.001
TC >  CC TC >  CC* TC >  CC*
TC >  GC TC >  GC TC >  GC
TC >  KDC TC > KDC TC >  KDC
TC >  QC TC >  QC TC >  QC
TC >  MDC TC > MDC TC >  MDC
TC >  PDC TC >  PDC TC >  PDC
CT >  TT CT >  TT* -
CT >  KDT CT > KDT CT >  KDT
CT >  MDT CT >  MDT CT >  MDT
CT >  GT CT >  GT CT >  GT
CT >  QT CT >  QT CT >  QT
CT >  PDT CT >  PDT CT >  PDT
Significant Differences Between Avian O rders
p <  0.01 p <  0.01 p <  0.001
GAC >  ANC GAC > ANC -
GAT >  ANT GAT > ANT - -
ANT >  ANC - -
(table continued)
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Table 5-11
Benzo[a]pyrene H ydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of 9-H ydroxybenzo[a]pyrene - M olar Activity
Significant Differences Between Avian Species and  th e  M ale R at
p <  0.05 p <  0.01 p <  0.001
TC >  MRC TC > MRC TC >  MRC
CT >  MRT CT >  MRT CT >  MRT
^Denotes a significant difference for Tukey’s test but not for Scheffe’s test.
5 .3 .5  Benzo[a]pyrene 7,8-D ihydrodiol - Specific Activity
Comparison of Control and ffNF-Treatment Groups.
Significant increases in benzo[o]pyrene 7,8-dihydrodiol (B[<s]P 7,8-diol) formation 
were present in treatment groups, compared to the respective control groups, for all 
of the species studied. The most significant increases were seen in the chicken (22- 
fold), turkey (10-fold), Pekin duck (7-fold), and male rat (3-fold) (p <  0.001) 
followed by the Khaki Campbell duck (7-fold) (p <  0.01), quail (9-fold) and the 
goose (p <  0.05). It should be noted that B[a]P 7,8-diol was not produced by any 
member of the goose control group. In addition, B[a]P 7,8-diol was not produced by 
2 animals within the Muscovy control group. However, all 6 animals within the 
goose and Muscovy duck treatment groups did produce B[a]P 7,8-diol.
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Comparison of Avian Species.
Within the avian control groups, and within the avian treatment groups, the greatest 
production of B[a]P 7,8-diol was by the Muscovy duck. In comparison of the avian 
control groups, the only significant (p <  0.05, difference significant for Tukey’s test 
but not significant for Scheffe’s test) difference in B[a]P 7,8-diol formation was 
between the Muscovy duck and goose. In contrast, numerous significant differences 
were detected between the avian jSNF-treatment groups. The most significant 
differences in B[a]P 7,8-diol formation included Muscovy >  quail and goose (p <  
0.001) followed by Khaki Campbell duck >  quail and goose (p <  0.01). Less 
significant (p <  0.05, difference significant for Tukey’s test but not significant for 
Scheffe’s test) differences included the Muscovy >  chicken and turkey and the Pekin 
duck >  quail and goose.
Comparison of Avian Orders.
Both the Anseriformes and Galliformes treatment groups produced significantly (p <  
0.001) greater (5-fold and 11-fold, respectively) levels of B[a]P 7,8-diol than their 
respective control groups. There was also a significantly greater formation of 7,8-diol 
by the Anseriformes control (4-fold) (p <  0.05) and treatment ( 2-fold) (p <  0.01) 
groups compared to the respective Galliformes control and treatment groups.
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Comparison of Avian Species and Male Rat.
In general, the formation of B[a]P 7,8-diol by the avian control and treatment groups 
was equivalent to that of the male rat control and treatment groups, respectively. 
Therefore, there were no significant differences in B[a]P 7,8-diol formation between 
the avian species and the male rat for either the control or treatment groups. 
However, the difference in formation of B[a]P 7,8-diol between the control and /3NF- 
treatment groups was much more pronounced (7 to 21.5-fold) in the avian species than 
in the male rat (3.3-fold) except for the Muscovy duck (3.3-fold).
The benzo[a]pyrene hydroxylase activities (expressed as pmoles of B[a]P 7,8-diol 
produced per minute per mg of microsomal protein) for the avian and male rat hepatic 
microsomal control and /3-naphthoflavone-treatment groups are presented in Table 5-
12.
5.3 .6  Benzo[a]pyrene 7,8-Dihydrodiol - Molar Activity
Comparison of Control and ffNF-Treatment Groups.
In terms of molar activity, B[a]P 7,8-diol formation by the /3NF-treatment groups was 
significantly greater than that for the control groups for the quail, Khaki Campbell 
duck (p <  0.001), chicken, goose, turkey (p <  0.01), and male rat ( p <  0.05). 
The most pronounced difference was seen in the quail (48-fold), followed by the 
chicken (13-fold), turkey (3-fold), and Khaki Campbell duck (3.3-fold).
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Table 5-12
Benzo[a]pyrene H ydroxylase Activity in Avian and  R at H epatic 
Microsomes: Form ation of Benzo[a]pyrene 7,8-dihydrodiol
Specific Activity
T reatm ent G roup pmoles of B[a]P 7,8-dihydrodiol produced
per m inute per mg of protein
CC 2 + 2
CT 43 ±  14
QC 2 +  4
QT 18 ±  12
GC ND1
GT 17 +  9
TC 4 ±  5
TT 40 +  9
PDC 10 +  7
PDT 66 +  22
KDC 11 ±  9
KDT 76 ±  39
MDC 27 +  38
MDT 89 +  36
ANC 12 +  21
ANT 61 +  38
GAC 3 + 4
GAT 34 +  16
MRC 14 +  11
MRT 46 +  16
(table continued)
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Table 5-12
Benzo[a]pyrene Hydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of Benzo[a]pyrene 7,8-dihydrodiol
Specific Activity
Significant Differences Between Control and  j5NF-Treatment G roups
p <  0.05 p <  0.01 p <  0.001
CT >  CC CT >  CC CT >  CC
QT >  QC - -
GT >  GC - -
TT >  TC TT >  TC TT >  TC
PDT >  PDC PDT >  PDC PDT >  PDC
KDT >  KDC KDT >  KDC -
MDT >  MDC - -
MRT >  MRC MRT >  MRC MRT >  MRC
Significant Differences Between A vian Species
p <  0,05 p <  0,001
MDC >  GC* - -
MDT >  CT* - -
MDT >  TT* - -
MDT >  QT MDT >  QT MDT >  QT*
MDT >  GT MDT >  GT MDT >  GT*
KDT >  QT KDT >  QT* -
KDT >  GT KDT >  GT* -
PDT >  QT* - -
PDT >  GT* - -
(table continued)
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Table 5-12
Benzo[a]pyrene Hydroxylase Activity in Avian and Rat Hepatic 
Microsomes: Formation of Benzo[a]pyrene 7,8-dihydrodioI
Specific Activity
Significant Differences Between Avian Orders
p <  0,05 p <  0.01 p <  0.001
ANT >  ANC ANT >  ANC ANT >  ANC
GAT >  GAC GAT >  GAC GAT >  GAC
ANT >  GAT ANT >  GAT -
ANC >  GAC - -
Significant Differences Between Avian Species and M ale Rat
p <  0.05 p <  0.001
- - -
'ND  indicates a nondetectable value
^Denotes a significant difference for Tukey’s test but not for Scheffe’s test
Comparison of Avian Species.
Between the avian control groups, there was a significantly greater formation of B[a]P
7,8-diol in the Muscovy compared to the goose and the quail (p <  0.05, difference 
significant for Tukey’s test but not significant for Scheffe’s test). Numerous 
differences were noted between the avian treatment groups. The most significant 
differences in B[a]P 7,8-diol formation for the /3NF-treatment groups were between 
the Khaki Campbell duck and the turkey, quail, and goose (p <  0.001) and between 
the Muscovy and the turkey (p <  0.01), quail and goose (p <  0.001), and between
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the Muscovy and turkey (p <  0.01). Less significant differences (p <  0.05, 
difference significant for Tukey’s test but not significant for Scheffe’s test) were 
present between the chicken and the quail, the chicken and the goose, the Pekin duck 
and the quail, and the Pekin duck and the goose.
Comparison of Avian Orders.
Both the Anseriformes (p <  0.01) and Galliformes (p <  0.001) treatment groups 
produced significantly greater (2-fold and 7-fold, respectively) levels of B[a]P 7,8-diol 
than their respective control groups. There was also a significantly (p <  0.01) 
greater production of B[a]P 7,8-diol metabolite by the Anseriformes control (6-fold) 
and treatment (2-fold) groups over the respective Galliformes groups.
Comparison of Avian Species and Male Rat.
In general, the avian control and treatment groups produced levels of B[<j]P  7,8-diol 
comparable to that of the male rat. The only significant (p <  0.01) difference in 
B[a]P 7,8-diol formation between the avian and male rat groups was between the 
treatment groups of the Khaki Campbell duck and the male rat.
The benzo[a]pyrene hydroxylase activities (expressed as pmoles of B[a]P 7,8-diol 
produced per nmole of cytochrome P-450) for the avian and male rat hepatic 
microsomal control and /3-naphthoflavone-treatment groups are presented in Table 5- 
13.
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Table 5-13
Benzo[a]pyrene Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of Benzo[a]pyrene 7,8-dihydrodiol
M olar Activity
T reatm ent G roup pinoles o f B[a]P 7,8-dihydrodiol produced 
per m inute per nmole of P-450
CC 4 ±  6
CT 51 ±  23
QC 0.4 ±  1
QT 19 +  5
GC N D 1
GT 10 +  5
TC 6 +  7
TT 20 ±  8
PDC 23 +  16
PDT 51 ±  25
KDC 25 +  25
KDT 82 +  20
MDC 42 ±  50
MDT 69 +  38
ANC 23 +  32
ANT 53 ±  36
GAC 4 +  5
GAT 27 +  23
MRC 14 +  11
MRT 33 +  13
(table continued)
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Table 5-13
Benzo[«]pyrene H ydroxylase Activity in Avian and  R at H epatic 
M icrosomes: Form ation of Benzo[a]pyrene 7,8-dihydrodiol
M olar Activity
Significant Differences Between Control and /3NF-Treatment G roups
p <  0.05 p <  0.01 p <  0.001
CC >  CT CC >  CT -
QT >  QC QT >  QC QT >  QC
GT >  GC GT >  GC -
TC >  TT TC >  TT -
KDC >  KDT KDC >  KDT KDC >  KDT
MRT >  MRC - -
Significant Differences Between A vian Species
p <  0.05 p <  0.01 p <  0.001
MDC >  QC* - -
MDC >  GC* - -
KDT >  TT K D T > TT KDT >  TT*
KDT >  GT KDT >  GT KDT >  GT
KDT >  QT KDT >  QT KDT >  QT
MDT >  TT MDT >  TT* -
MDT >  GT MDT >  GT MDT >  GT*
MDT >  QT MDT >  QT MDT >  QT*
CT >  GT* - -
CT >  QT* - -
PDT >  GT* - -
PDT >  QT* - -
(table continued)
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Table 5-13
Benzo[a]pyrene Hydroxylase Activity in Avian and Rat Hepatic 
Microsomes: Formation of Benzo[o]pyrene 7,8-dihydrodiol
Molar Activity
Significant Differences Between Avian Orders
p <  0,05 p <  0.01 p < 0.001
ANC >  GAC ANC > GAC -
ANT > GAT ANT >  GAT -
ANT >  ANC ANT >  ANC -
GAT >  GAC GAT >  GAC GAT >  GAC
Comparison o f Avian Species and Male Rat
p <  0.05 p <  0.01 p <  0.001
KDT > MRT KDT >  MRT* -
*ND indicates a nondetectable value
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test.
5 .3 .7  Benzo[a]pyrene 9,10-Dihydrodiol - Specific Activity
Comparison of Control and ffNF-Treatment Groups.
Of the control groups, the only species which formed the B[a]P 9,10-dihydrodiol 
(B[tf]P 9,10-diol) metabolite were the Khaki Campbell duck and the male rat. Within 
the Khaki Campbell duck control group, only 2 of the 6 animals formed B[a]P 9,10- 
diol. In the /3NF-treatment groups, B[a]P 9,10-diol was formed by all the species 
studied. However, only 20 to 40 percent of the animals within each of the avian
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treatment groups formed the metabolite. The only significant difference between 
control and treatment groups for this metabolite was for the goose (p < 0 .05).
Comparison of Avian Species.
Metabolite formation among the avian species was comparable for both the control 
and treatment groups. Hence, there were no significant differences between the 
control groups nor between the /3NF-treatment groups of the avian species.
Comparison of Avian Orders.
Benzo[a]pyrene 9,10-dihydrodiol formation was significantly greater in the (i- 
treatment groups compared to the respective control groups for both the 
Anseriformes (p < 0.001) and the Galliformes (p < 0.05). It should be noted that 
within the control groups o f the Galliformes order, none o f the species formed B[o]P
9,10-diol and within the Anseriformes order, only the Khaki Campbell duck formed 
the metabolite. There were no significant differences in B[a]P 9,10-diol formation 
between the Anseriformes and Galliformes.
Comparison o f Avian Species and Male Rat.
Benzo[o]pyrenc 9,10-dihydrodiol formation by the male rat control and treatment 
groups was significantly (p < 0.001) greater than that o f the respective avian groups.
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The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f B[a]P 9,10-diol 
formed per minute per mg o f microsomal protein) in avian and male rat hepatic 
microsomes o f control and P-naphthoflavone treatment groups are presented below 
in Table 5-14.
5.3.8 Bcnzo[a]pyrene 9,10-Dihydrodiol - Molar Activity
Comparison o f Control and BNF-Treatment Groups.
In terms o f molar activity, the only species that had a significant difference in B[a]P
9,10-diol formation between the control and pNF-treatment groups were the goose 
and the male rat. Comparable quantities of B[a]P 9,10-diol were formed by the 
control and treatment groups o f the remaining avian species.
Comparison of Avian Species.
Benzo[a]pyrene 9,10-dihydrodiol production was similar among the control groups 
and among the treatment groups of the avian species. There were no significant 
differences in B[a]P 9,10-diol formation (p < 0.05) between the control groups nor 
between the pNF-treatment groups o f the avian species.
Comparison o f Avian Orders.
Benzo[fl]pyrene 9,10-dihydrodiol formation by the Galliformes PNF-treatment group 
was significantly (p < 0.05) greater than that of the control group. No other 
significant differences were noted within or between the orders.
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Table 5-14
Benzo[fl]pyrcnc Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of Benzo[o]pyrene 9,10-dihydrodiol -
Specific Activity
T reatm ent G roup pmoles of B[«]P 9,10-dihydrodiol produced 
per m inute per mg of protein
CC N D 1
CT 25 ± 24
QC ND
QT 10 ± 22
GC ND
GT 25 ± 25
TC ND
TT 4 ± 8
PDC ND
PDT 20 ± 20
KDC 7 ± 14
KDT 23 ± 21
MDC ND
MDT 13 ± 16
ANC 2 ± 7
ANT 20 ± 20
GAC ND
GAT 13 ± 20
MRC 96 ± 29
MRT 204 ± 51
(table continued)
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Table 5-14
Benzo[fl]pyrene Hydroxylase Activity in Avian and R at Hepatic 
M icrosomes: Form ation of Bcnzo[n]pyrene 9,10-dihydrodiol -
Specific Activity
Significant Differences Between Control and /5NF-Trcatmcnt C roups
p < 0.05 p < 0.01 p < 0.00!
GT > GC - -
Significant Differences Between Avian Species
p < 0.05 p < 0.01 p < 0.001
- - -
Significant Differences Between Avian O rders
p < 0.05 p < 0.01 p <  0.001
ANT > ANC ANT > ANC ANT > ANC
GAT > GAC - -
Significant Differences Between Avian Species and M ale R a t
p < 0.05 p < 0.01 p <  0.001
MRC > KDC MRC > KDC MRC > KDC
MRC > TC MRC > TC MRC > TC
MRC > CC MRC > CC MRC > CC
MRC > PDC MRC > PDC MRC > PDC
MRC > MDC MRC > MDC MRC > MDC
MRC > QC MRC > QC MRC > QC
MRC > GC MRC > GC MRC > GC
MRT > GT MRT > GT MRT > GT
MRT > CT MRT > CT MRT > CT
MRT > KDT MRT > KDT MRT > KDT
MRT > PDT MRT > PDT MRT > PDT
(table continued)
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Table 5-14
Benzo[fl]pyrene Hydroxylase Activity in Avian and Rat Hepatic 
Microsomes: Formation of Benzo[«]pyrene 9,10-dihydrodiol -
Specific Activity
MRT > MDT MRT > MDT MRT > MDT
MRT > QT MRT > QT MRT > QT
MRT > TT MRT > TT MRT > TT
‘ND indicates a nondetectable value
Comparison of Avian Species and Male Rat.
In terms o f molar activity, significant differences in the formation o f B[n]P 9,10-diol 
between the avian species and the male rat were identical to those based on specific 
activity as discussed in Section 5.3.7.
The benzo[o]pyrene hydroxylase activities (in terms o f molar activity - pmoles of 
B[a]P 9,10-diol formed per minute per nmoles o f cytochrome P-450) in avian and 
male rat hepatic microsomal o f control and p-naphthoflavone treatment groups are 
presented in Table 5-15.
5.3.9 Total Metabolite Formation - Specific Activity
Total metabolite formation is represented by the sum of the four B[n]P metabolites 
identified and quantitated in this study: 3-hydroxybenzo[r/]pyrene, 9-
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hydroxybenzo[a]pyrene, benzo[a]pyrene 7,8-dihydrodiol, and benzo[a]pyrene 9,10- 
dihydrodiol.
Comparison o f Control and BNF-Treatment Groups.
Significant increases in total B[a]P metabolite formation by the treatment groups, 
compared to the respective control groups, were seen for the chicken (5-fold) (p < 
0.001), quail (2-fold), Pekin duck (2-fold), and male rat (1.7-fold) (p < 0.05). For 
the turkey, Khaki Campbell duck, Muscovy duck, and goose, no significant 
differences in total B[a]P metabolite formation were observed between the control 
and treatment groups.
Comparison o f Avian Species.
The most significant (p < 0.001) differences in total metabolite formation between 
the avian species were present between the turkey and chicken control groups and 
the turkey and goose treatment groups. Significant (p < 0.01) differences were also 
detected between the turkey and the Pekin duck, goose, and quail control groups. 
Less significant differences (p < 0.05, difference significant for Tukey’s test but not 
significant for Scheffe’s test) were seen between the turkey and Muscovy duck 
control groups, the Khaki Campbell duck and chicken control groups, the turkey and 
quail treatment groups, and the turkey and Pekin duck treatment groups. The 
rankings of total B[o]P metabolite formation for the avian control groups included 
turkey > Muscovy duck « Pekin duck « goose « quail « chicken and Khaki
146
Table 5-15
Benzo[«]pyrene Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of Bcnzo[«]pyrene 9,10-dihydrodiol -
M olar Activity
T reatm ent G roup pmoles of B[fl]P 9,10-dihydrodiol produced 
per m inute per nmole of P-450
CC ND1
CT 32 ± 31
QC ND
QT 3 ± 5
GC ND
GT 14 ± 13
TC ND
TT 2 ± 4
PDC ND
PDT 14 ± 12
KDC 27 ± 58
KDT 20 ± 15
MDC ND
MDT 10 ± 14
ANC 7 ± 28
ANT 14 ± 14
GAC ND
GAT 12 ± 23
MRC 110 + 29
MRT 151 ± 32
(table continued)
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Table 5-15
Benzo[«]pyrene H ydroxylase Activity in Avian and R at Hepatic 
M icrosomes: Form ation of Benzo[«]pyrene 9,10-dihydrodiol -
M olar Activity
Significant Differences Between Control and jSNF-Trcatmcnt G roups
p < 0.05 p <  0.01 p < 0.001
GT > GC - -
MRT > MRC - -
Significant Differences Between Avian Species
p < 0.05 p < 0.01 p < 0.001
- - -
Significant Differences Between Avian O rders
p < 0.05 p < 0.01 p < 0.001
GAT > GAC - -
Significant Differences Between Avian Species and M ale R at
p < 0.05 p < 0.01 p < 0.001
MRC > KDC MRC > KDC MRC > KDC
MRC > TC MRC > TC MRC > TC
MRC > CC MRC > CC MRC > CC
MRC > PDC MRC > PDC MRC > PDC
MRC > MDC MRC > MDC MRC > MDC
MRC > QC MRC > QC MRC > QC
MRC > GC MRC > GC MRC > GC
MRT > KDT MRT > KDT MRT > KDT
MRT > TT MRT > TT MRT > TT
MRT > CT MRT > CT MRT > CT
MRT > PDT MRT > PDT MRT > PDT
(table continued)
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Table 5-15
Benzo[«]pyrene Hydroxylase Activity in Avian and R at H epatic 
M icrosomes: Form ation of Benzo[flJpyrene 9,10-dihydrodiol -
M olar Activity
MRT > MDT MRT > MDT MRT > MDT
MRT > QT MRT > QT MRT > QT
MRT > GT MRT > GT MRT >GT
'ND indicates a nondetectable value
Campbell duck > chicken. For the avian treatment groups, the ranking o f formation 
included turkey > chicken = quail « goose. It is interesting to note, that among the 
avian species, the turkey produced the greatest quantity o f total B[a]P metabolites 
for both the control and treatment groups but had the smallest difference in 
metabolite formation between the control and treatment groups.
Comparison o f Avian Orders.
There was a significant increase in total B[o]P metabolite formation in the treatment 
groups compared to the control groups for both the Anseriformes (p < 0.05) and 
Galliformes (p < 0.01). While there was no significant difference between the 
control groups, metabolite formation by the Galliformes treatment group was 
significantly (p < 0.05) greater than that o f the Anseriformes treatment group.
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Comparison o f Avian Species and Male Rat.
Comparison o f total B[a]P metabolite formation between the avian species and male 
rat indicated that all o f the avian species, with the exception o f the turkey, produced 
total metabolite levels that were equivalent to those o f the male rat. The only 
significant differences in total B[a]P metabolite formation between the avian species 
and the male rat were for the turkey and male rat control groups (p < 0.01) and for 
the turkey and male rat treatment groups (p < 0.05, difference significant for Tukey’s 
test but not significant for Scheffe’s test). Metabolite formation by the avian 
treatment groups was 2-fold to 5-fold greater than that o f the respective control 
groups. For the male rat a 1.7-fold greater metabolite production was seen in the 
treatment group compared to the control group.
The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f total metabolites 
formed per minute per mg o f microsomal protein) in avian and male rat hepatic 
microsomal control and P-naphthofiavone treatment groups are presented in Table 
5-16.
5.3.10 Total M etabolite Form ation - M olar Activity
Comparison of Control and pNF-Treatment Groups.
Based on molar activity, a significantly (p < 0.05) greater level of total B[a]P 
metabolites were formed by the chicken (2.5-fold) and quail (1.7-fold) treatment 
groups compared to their respective control groups. Significant (p < 0.05) decreases
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Table 5-16
Benzo[«]pyrene Hydroxylase Activity in Avian and R at H epatic 
Microsomes: Total M etabolite1 Form ation - Specific Activity
T reatm ent G roup pmoles of total B[«]P metabolites produced per 
m inute per mg of protein
CC 153 ± 73
CT 699 ± 176
QC 278 ± 308
QT 640 ± 233
GC 345 ± 183
GT 358 ± 125
TC 872 ± 324
TT 1081 ± 309
PDC 347 + 264
PDT 628 ± 128
KDC 634 ± 254
KDT 735 ± 210
MDC 431 ± 248
MDT 690 ± 216
ANC 439 ± 254
ANT 603 ± 222
GAC 434 ± 406
GAT 806 ± 306
MRC 353 ± 159
MRT 608 ± 208
(table continued)
151
Table 5-16
Benzo[o]pyrene Hydroxylase Activity in Avian and R at H epatic 
Microsomes: Total M etabolite1 Form ation - Specific Activity
Significant Differences Between C ontrol and /3NF-Trcatmcnt G roups
p < 0.05 p < 0.01 p < 0.00!
CT > CC CT > CC CT > CC
QT > QC - -
PDT > PDC - -
MRT > MRC - -
Significant Differences Between Avian Species
p < 0.05 p < 0.01 p < 0.001
TC > MDC* - -
TC > PDC* TC > PDC* -
TC > GC* TC > GC* -
TC > QC TC > QC* -
TC > CC TC > CC TC > CC*
KDC > CC* - -
TT > QT* - -
TT > GT TT > GT TT > GT*
TT > PDT* - -
Significant Differences Between Avian O rders
p < 0.05 p < 0.01 p < 0.001
GAT > ANT - -
ANT > ANC - -
GAT > GAC GAT > GAC -
(table continued)
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Table 5-16
Benzo[a]pyrene Hydroxylase Activity in Avian and Rat Hepatic 
Microsomes: Total Metabolite' Formation - Specific Activity
Significant Differences Between Avian Species and Male Rat
p < 0.05 p < 0.001
TC > MRC* TC > MRC* -
TT > MRT* - -
’Total metabolite formation includes the metabolites B[a]P 9,10-dihydrodiol, B[a]P
7,8-dihydrodiol, 9-hydroxy-B[a]P, and 3-hydroxy-B[a]P 
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test.
in total metabolite formation were detected in the treatment groups o f the goose (2.8- 
fold) and turkey (2.7-fold) relative to their control groups. No significant differences 
were seen between the control and treatment groups of the remaining avian species.
Comparison o f Avian Species.
Comparison of the avian control groups indicated significant differences in the 
metabolism o f B[a]P between the turkey and the chicken (p < 0.001), the turkey and 
the quail (p < 0.001), the Khaki Campbell duck and the quail (p < 0.001) and the 
Khaki Campbell duck and the chicken (p < 0.01). Significant differences in total 
metabolite formation between the treatment groups included the Khaki Campbell 
duck and the goose (p < 0.001), the chicken and the goose (p < 0.001), the Khaki 
Campbell duck and the quail (p < 0.01), the Khaki Campbell duck and the Pekin
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duck (p < 0.05, difference significant for Tukey’s test but not significant for 
Scheffe’s test), and the chicken and the quail (p < 0.05, difference significant for 
Tukey’s test but not significant for Scheffe’s test).
Comparison o f Avian Orders.
A significantly (p < 0.05) lower level o f total metabolite formation was present in 
the Anseriformes treatment group (1.6-fold) compared to the control group. No 
significant difference was observed in the Galliformes treatment group respective to 
the control group. No significant differences between the orders were noted.
Comparison o f Avian Species and Male Rat.
Comparison o f total metabolite formation in the avian controls and the male rat 
control indicated that total formation by the turkey and the Khaki Campbell duck 
control groups were significantly (p <0.01) greater (3.7- and 3.5-fold, respectively) 
than that o f the male rat control group. Total metabolite formation in the avian 
treatment groups was comparable to that o f the male rat treatment group for all the 
species studied.
The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f total metabolite 
formed per minute per nmole o f cytochrome P-450) in avian and male rat hepatic 
microsomal control and p-naphthoflavone treatment groups are presented in Table 
5-17.
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Table 5-17
Benzo[fl]pyrene Hydroxylase Activity in Avian and Rat Hepatic 
Microsomes: Total Metabolite Formation - Molar Activity
Treatment Group pmoles of total B[a]P metabolites produced 
per minute per nmole of P-450
CC 327 ± 149
CT 830 ± 369
QC 229 ± 68
QT 386 ± 99
GC 613 ± 348
GT 222 ± 70
TC 1463 ± 716
TT 542 ± 200
PDC 692 ± 444
PDT 445 ± 155
KDC 1387 ± 793
KDT 876 ± 306
MDC 741 ± 209
MDT 554 ± 248
ANC 858 ± 561
ANT 542 ± 313
GAC 672 ± 701
GAT 580 ± 305
MRC 396 ± 167
MRT 453 ± 148
(table continued)
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Table 5-17
Benzo[fl]pyrene Hydroxylase Activity in Avian and Rat Hepatic 
Microsomes: Total Metabolite Formation - Molar Activity
Significant Differences Between Control and /SNF-Trcatmcnt Groups
p < 0,05 p < 0.01 p < 0.001
TC > TT - -
CT > CC - -
QT > QC - -
GC > GT - -
Significant Differences Between Avian Species
p < 0.05 p < 0.01 p < 0.001
TC > CC TC > CC* TC > CC*
TC > QC TC > QC TC > QC*
KDC > CC KDC > CC* -
KDC > QC KDC > QC* KDC > QC*
KDT > PDT* - -
KDT > QT* KDT > QT* -
KDT > GT KDT > GT KDT > GT*
CT > QT* - -
CT > GT CT > GT* CT > GT*
Significant Differences Between Avian Orders
p < 0.05 p < 0.01 p < 0.001
ANC > ANT - -
Significant Differences Between Avian Species and Male Rat
p < 0.05 p < 0.01 p < 0.001
TC > MRC TC > MRC* -
KDC > MRC* KDC > MRC* -
'Total metabolite formation includes the metabolites B[t?]P 9,10-dihydrodiol, B[a]P
7,8-dihydrodiol, 9-hydroxy-B[a]P, and 3-hydroxy-B[a]P 
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test.
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5.3.11 Overview of Bcnzo[«]pyrene Metabolism
This section provides an overview o f the hepatic microsomal oxidative metabolism 
o f B[a]P by each species and each avian order. The B[a]P metabolite profiles 
produced by each species and each order are represented by a ranking of the 
metabolites in order o f decreasing magnitude o f formation; 3-hydroxybenzo[a]pyrene 
is designated by 3-OH, 9-hydroxybenzo[a]pyrene is designated by 9-OH, 
benzo[a]pyrene 7,8-dihydrodiol is designated by 7,8-diol, and benzo[a]pyrene 9,10- 
dihydrodiol is designated by 9,10-diol. The changes observed in the metabolic 
profiles associated with pNF-treatment are also summarized. In addition, shifts in 
the profiles due to relative changes in metabolite formation in the treatment group 
compared to the control group are presented as the percent change observed for each 
metabolite based on the percent each metabolite contributed to the total metabolite 
formation.
Chicken.
The metabolic profiles for the chicken were as follows:
Control: 3-OH > 9-OH > 7,8-diol
Treatment: 3-OH > 9-OH > 7,8-diol > 9,10-diol
Changes in the profile associated with PNF-treatment included:
A significant increase in the formation o f 3-OPI, 4.3-fold (specific 
activity) and 2.4-fold (molar activity)
A significant increase in the formation of 9-OH, 4-fold (specific 
activity) and 2.2 fold (molar activity)
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A significant increase in the formation o f 7,8-diol, 22-fold (specific 
activity) and 12.8-fold (molar activity)
Formation o f 9,10-diol (no significant increase)
In terms o f specific activity, a relative increase in the formation of
9,10-diol (3.6%) and 7,8-diol (4.9%) and a relative decrease in the 
formation o f 9-OH (4.1%) and 3-OH (4.4%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (3.9%) and 7,8-diol (4.9%) and a relative decrease in the 
formation o f 9-OH (4.2%) and 3-OH (4.6%)
A significant increase in B[a]P hydroxylase activity (based on total 
metabolite formation)
Quail.
The metabolic profiles for the quail were as follows: 
Control: 3-OH > 9-OH > 7,8-diol
Treatment: 3-OH > 9-OH > 7,8-diol > 9,10-diol
Changes in the profile associated with pNF-treatment included:
A significant increase in the formation o f 3-OH, 2.3-fold (specific 
activity) and 1.7-fold (molar activity)
A significant increase in the formation o f 9-OH (1.9-fold) based on 
specific activity and no change based on molar activity
A significant increase in the formation o f 7,8-diol, 9-fold (specific 
activity) and 47.5-fold (molar activity)
Formation o f 9,10-diol (no significant increase)
In terms o f specific activity, a relative increase in the formation of
9,10-diol (1.6%) and 7,8-diol (2.1%) and a relative decrease in the 
formation o f 9-OH (2.5%) and 3-OH (1.2%)
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In terms o f molar activity, a relative increase in the formation o f 9,10-
diol (0.8%) and 7,8-diol (4.7%) and a relative decrease in the
formation o f 9-OH (4.3%) and 3-OH (1.2%)
A significant increase in B[a]P hydroxylase activity (based on total 
metabolite formation)
Goose.
The metabolic profiles for the goose were as follows:
Control: 3-OH > 9-OH
Treatment: 3-OH > 9-OH > 9,10-diol « 7,8-diol
Changes in the profile associated with PNF-treatment included:
A significant decrease in the formation o f 3-OH, 3.9-fold based on 
molar activity and no significant change based on specific activity
A significant increase in the formation o f 9-OH, 3-fold based on 
specific activity and no change based on molar activity
Formation o f 7,8-diol (increase significant)
Formation of 9,10-diol (increase significant)
In terms o f specific activity, a relative increase in the formation of
9,10-diol (7%), 7,8-diol (4.8%), and 9-OH (15.1%) and a relative 
decrease in the formation o f 3-OH (26.9%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (6.4%), 7,8-diol (4.5%), and 9-OH (16.3%) and a relative 
decrease in the formation o f 3-OH (27.2%)
A significant decrease in B[c/]P hydroxylase activity in terms o f molar 
activity, no change in terms o f specific activity (based on total 
metabolite formation)
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Turkey.
The metabolic profiles for the turkey were as follows:
Control: 3-OH > 9-OH > 7,8-diol
Treatment: 3-OH > 9-OH > 7,8-diol > 9,10-diol
Changes in the metabolic profile associated with (3NF-treatment included:
A significant decrease (2.8-fold) in 3-OH formation in terms o f molar 
activity, no significant change in terms of specific activity
No significant change in 9-OH formation
A significant increase in 7,8-diol formation, 10-fold (specific activity) 
and 3.3-fold (molar activity)
Formation o f 9,10-diol (increase not significant)
In terms o f specific activity, a relative increase in the formation of
9,10-diol (0.3%), 7,8-diol (3.2%), and 9-OH (3.8%) and a relative 
decrease in the formation o f 3-OH (7.4%)
In terms of molar activity, a relative increase in the formation o f 9,10- 
diol (0.4%), 7,8-diol (3.1%), and 9-OH (4.3%) and a relative decrease 
in the formation o f 3-OH (7.8%)
A significant decrease in B[a]P hydroxylase activity in terms o f molar 
activity, no change in terms o f specific activity (based on total 
metabolite formation)
Pekin Duck.
The metabolic profiles for the Pekin duck were as follows:
Control: 3-OH > 9-OH * 7,8-diol
Treatment: 3-OH > 7,8-diol w 9-OH > 9,10-diol
Changes in the metabolic profile associated with pNF-treatment included:
No significant change in 3-OH formation
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A significant increase (4.4-fold) in 9-OH formation in terms o f 
specific activity and no significant change in terms o f molar activity
A significant increase in 7,8-diol formation, 6.6-fold based on specific 
activity and no significant change based on molar activity
Formation o f 9,10-diol (increase not significant)
In terms o f specific activity, a relative increase in the formation of
9,10-diol (3.2%), 7,8-diol (7.6%), and 9-OH (9.3%) and a relative 
decrease in the formation o f 3-OH (16.5%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (3.1%), 7,8-diol (8.1%), and 9-OH (5.8%) and a relative decrease 
in the formation o f 3-OH (7.8%)
A significant increase in B[«]P hydroxylase activity in terms of 
specific activity, no change in terms o f molar activity (based on total 
metabolite formation)
Khaki Campbell Duck.
The metabolic profiles for the Khaki Campbell duck included:
Control: 3-OH > 9-OH « 7,8-diol ~ 9,10-diol
Treatment: 3-OH > 7,8-diol « 9-OH > 9,10-diol
Changes in the metabolic profile associated with pNF-treatment included:
No significant change in 3-OH formation
A significant increase (3-fold) in 9-OH formation in terms o f specific 
activity and no significant change in terms of molar activity
A significant increase in 7,8-diol formation, 6.9-fold (specific activity) 
and 3.3-fold (molar activity)
No significant change in the formation o f 9,10-diol
In terms o f specific activity, a relative increase in the formation of
9,10-diol (2%), 7,8-diol (8.6%), and 9-OH (4.8%) and a relative 
decrease in the formation o f 3-OH (15.5%)
161
In terms o f molar activity, a relative increase in the formation o f 9,10-
diol (0.3%), 7,8-diol (7.6%), and 9-OH (5.1%) and a relative decrease
in the formation of 3-OH (13%)
Muscovy Duck.
The metabolic profiles for the Muscovy duck included:
Control: 3-OH > 7,8-diol * 9-OH
Treatment: 3-OH > 7,8-diol w 9-OH > 9,10-diol
Changes in the metabolic profile associated with PNF-treatment included:
A significant decrease in the formation o f 3-OH, 1.6-fold (molar 
activity) and no significant change based on specific activity
A significant increase in the formation o f 9-OH, 3.2-fold (specific 
activity) and no change based on molar activity
A significant increase in the formation o f 7,8-diol, 3.3-fold (specific 
activity) and 1.6-fold (molar activity)
Formation of 9,10-diol (increase not significant)
In terms o f specific activity, a relative increase in the formation of
9,10-diol (1.9%), 7,8-diol (6.5%), and 9-OH (5.2%) and a relative 
decrease in the formation of 3-OH (13.6%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (1.9%), 7,8-diol (6.9%), and 9-OH (4%) and a relative decrease 
in the formation o f 3-OH (27.2%)
Anseriformes.
The metabolic profiles for the Anseriformes were as follows: 
Control: 3-OFI > 9-OH * 7,8-diol > 9,10-diol
Treatment: 3-OH > 9-OH « 7,8-diol > 9,10-diol
Changes in the profile associated with PNF-treatment included:
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A significant decrease in the formation o f 3-OH, 1.8-fold (molar 
activity) and no significant change based on specific activity
A significant increase in the formation o f 9-OH, 3.3-fold (specific 
activity) and 1.5 fold (molar activity)
A significant increase in the formation o f 7,8-diol, 5.1-fold (specific 
activity) and 2.3-fold (molar activity)
A significant increase in the formation of 9,10-diol, 10-fold based on 
specific activity and no significant change based on molar activity
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (2.8%), 7,8-diol (7.4%), and 9-OH (6.6%) and a relative 
decrease in the formation o f 3-OH (16.9%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (1.7%), 7,8-diol (6.7%), 9-OH (5.7%) and a relative decrease in 
the formation o f 3-OH (14.1%)
A significant increase in B[a]P hydroxylase activity (based on total 
metabolite formation)
Galliformes.
The metabolic profiles for the Galliformes were as follows:
Control: 3-OH > 9-OH > 7,8-diol
Treatment: 3-OH > 9-OH > 7,8-diol > 9,10-diol
Changes in the profile associated with PNF-treatment included:
A significant decrease in the formation o f 3-OH, 1.7-fold (specific 
activity) and no significant change based on molar activity
A significant increase in the formation o f 9-OH, 2.1-fold (specific 
activity) and no significant change based on molar activity
A significant increase in the formation o f 7,8-diol, 11.3-fold (specific 
activity) and 6.8-fold (molar activity)
Formation o f 9,10-diol (increase significant)
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In terms of specific activity, a relative increase in the formation of
9,10-diol (1.6%), 7,8-diol (3.5%), and 9-OH (2.2%) and a relative
decrease in the formation of 3-OH (7.4%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (2.1), 7,8-diol (4%), 9-OH (3.1%) and a relative decrease in the 
formation o f 3-OH (9.3%)
A significant increase in B[a]P hydroxylase activity in terms of 
specific activity, no change in terms of molar activity (based on total 
metabolite formation)
Male Rat.
The metabolic profiles for the male rat were as follows:
Control: 3-OH > 9,10-diol > 9-OH > 7,8-diol
Treatment: 3-OH > 9,10-diol > 9-OH > 7,8-diol
Changes in the profile associated with PNF-treatment included:
No significant changes in the formation o f 3-OH
A significant increase in the formation of 9-OH, 3.3-fold (specific 
activity) and no significant change in terms o f molar activity
A significant increase in the formation o f 7,8-diol, 3.3-fold (specific 
activity) and 2.3-fold (molar activity)
A significant increase in the formation o f 9,10-diol, 1.4-fold based on 
molar activity, no significant change based on specific activity
In terms o f specific activity, a relative increase in the formation of
9,10-diol (6.6), 7,8-diol (3.7%), and 9-OH (6%) and a relative 
decrease in the formation o f 3-OH (16.2%)
In terms o f molar activity, a relative increase in the formation o f 9,10- 
diol (4.9%), 7,8-diol (3.6%), 9-OH (6%) and a relative decrease in the 
formation of 3-OH (14.4%)
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A significant increase in B[a]P hydroxylase activity in terms o f 
specific activity , no change in terms o f molar activity (based on total 
metabolite formation)
The metabolic profiles for the control and treatment groups o f each species and avian 
order are presented in Table 5-18. The percent contribution of each metabolite to 
the total metabolite formation (based on the four metabolites quantitated in this 
study) is presented in Table 5-19 in terms o f specific activity and in Table 5-20 in 
terms o f molar activity.
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Table 5-18
Metabolism of Benzo[a]pyrene by Avian and Rat Hepatic Microsomes 
Ranking of Metabolite Formation
CC 3-OH1 >  9-OH2 >  7,8-diol3
CT 3-OH >  9-OH >  7,8-diol >  9,10-diol4
QC 3-OH >  9-OH > 7,8-diol
QT 3-OH >  9-OH > 7,8-diol >  9,10-diol
GC 3-OH >  9-OH
GT 3-OH >  9-OH >  9,10-diol ~  7,8-diol
TC 3-OH >  9-OH >  7,8-diol
TT 3-OH >  9-OH >  7,8-diol >  9,10-diol
PDC 3-OH >  9-OH *  7,8-diol
PDT 3-OH >  7,8-diol ~  9-OH >  9,10-diol
KDC 3-OH >  9-OH «  7,8-diol «  9,10-diol
KDT 3-OH > 7,8-diol «  9-OH >  9,10-diol
MDC 3-OH > 7,8-diol *  9-OH
MDT 3-OH >  7,8-diol «  9-OH >  9,10-diol
ANC 3-OH >  9-OH «  7,8-diol >  9,10-diol
ANT 3-OH > 9-OH «  7,8-diol >  9,10-diol
GAC 3-OH >  9-OH >  7,8-diol
GAT 3-OH > 9-OH >  7,8-diol >  9,10-diol
MRC 3-OH > 9,10-diol >  9-OH >  7,8-diol
MRT 3-OH > 9,10-diol >  9-OH >  7,8-diol
'3-Hydroxybenzo[a]pyrene 
29-Hydroxybenzo[a]pyrene 
3Benzo[a]pyrene 7,8-dihydrodiol 
4Benzo[a]pyrene 9,10-dihydrodiol
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Table 5-19
Metabolism of Benzo[a]pyrene by Avian and Rat Hepatic Microsomes 
Percent o f Total Metabolites1 Formed - Specific Activity
Treatment Group 3-OH2 9-OH3 7,8-Diol4 9,10-Diol5
CC 66.7 32.0 1.3 0
CT 62.3 27.9 6.2 3.6
QC 84.6 14.7 0.7 0
QT 83.4 12.2 2.8 1.6
GC 91.9 8.1 0 0
GT 65 23.2 4.8 7
TC 81.9 17.7 0.5 0
TT 74.5 21.5 3.7 0.3
PDC 93. L 4.0 2.9 0
PDT 76.6 9.7 10.5 3.2
KDC 94.0 3.2 1.7 1.1
KDT 78.5 8.0 10.3 3.1
MDC 88.4 5.3 6.3 0
MDT 74.8 10.5 12.8 1.9
ANC 92.0 4.8 2.7 0.5
ANT 75.1 11.4 10.1 3.3
GAC 80.7 18.6 0.7 0
GAT 73.3 20.8 4.2 1.6
MRC 62.2 6.8 3.9 27.0
MRT 46.0 12.8 7.6 33.6
'Total Metabolites refers to the four metabolites quantitated in this study
23-Hydroxybenzo[a]pyrene
39-Hydroxybenzo [a] py rene
4Benzo[a]pyrene 7,8-dihydrodiol
5Benzo[a]pyrene 9,10-dihydrodiol
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Table 5-20
Metabolism of Benzo[a]pyrene by Avian and Rat Hepatic Microsomes 
Percent of Total Metabolites1 Formed - Molar Activity
Treatment Group 3-OH2 9-OH3 7,8-Diol4 9,10-DioI5
CC 66.8 32.0 1.2 0
CT 62.2 27.8 6.1 3.9
QC 83.3 16.5 0.2 0
QT 82.1 12.2 4.9 0.8
GC 92.7 7.3 0 0
GT 65.5 23.6 4.5 6.4
TC 82.1 17.5 0.4 0
TT 74.3 21.8 3.5 0.4
PDC 92.5 4.2 3.3 0
PDT 75.5 10.0 11.4 3.1
KDC 93.2 3.0 1.8 2.0
KDT 80.2 8.1 9.4 2.3
MDC 87.7 6.7 5.6 0
MDT 75.0 10.7 12.5 1.9
ANC 92.1 4.4 2.7 0.8
ANT 78.0 10.1 9.4 2.5
GAC 79.8 19.6 0.6 0
GAT 70.5 22.7 4.6 2.1
MRC 61.7 7.0 3.5 27.7
MRT 47.3 13.0 7.1 32.6
'Total Metabolites refers to the four metabolites quantitated in this study
23-Hydroxybenzo[a]pyrene
39-Hydroxybenzo[a]pyrene
4Benzo[a]pyrene 7,8-dihydrodiol
5Benzo[tf]pyrene 9,10-dihydrodiol
6.0 DISCUSSION OF RESULTS
The following sections 6.1 to 6.3 are a discussion of the results reported in Section
5.1 to 5.3.
6.1 Components of the Hepatic Cytochrome P-450 Monooxygenase System
6.1.1 Microsomal Protein and Cytochrome P-450 Content
6.1.1.1 Galliformes
This study demonstrated a yield of 7 mg microsomal protein/g liver for both the 
chicken and the quail. A review of the literature revealed that the reported yield of 
hepatic microsomal protein ranged from 4.3 to 19.8 mg protein/g liver for the chicken 
(Banton, 1990; Rinsky and Perry, 1983; Dalvi, et al., 1987; Manning, et a l., 1990; 
Buynitzky, et al., 1978; Buckpitt and Boyd, 1982; Riviere, et a l., 1985; Davison and 
Sell, 1972; Sifri, et al., 1975) and from 4.8 to 31.2 mg/g for the quail (Carpenter, 
et a l., 1985; Buckpitt and Boyd, 1982; Riviere, et al., 1983; Sifri, et a l., 1975; 
Riviere, et a l., 1985; Dalvi, et a l., 1987). These ranges represent data collected from 
birds of varying breed, age and sex. For the turkey, a single value of 6.5 ±  0.4 
mg/g (Dalvi, et al., 1987) was found in the literature which was comparable to the 
yield o f 9 +  3 mg/g observed in this study.
In the present study, the hepatic microsomal cytochrome P-450 levels observed for the 
chicken and quail were 0.5 and 1.2 nmoles/mg microsomal protein, respectively. 
Reported values ranged from 0.12 to 0.48 nmoles cytochrome P-450/mg microsomal 
protein for the chicken (Banton, 1989; Rinsky and Perry, 1983; Poland and Glover,
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1977; Haug, et al., 1980; Sell, et al., 1971; Buckpitt and Boyd, 1982; Erich and 
Larsen, 1983; Manning, et a l., 1990; Buynitzky et a l., 1978; Riviere, et a l., 1985; 
Lapadula, et a l., 1984) and from 0.1 to 1.1 nmoles/mg for the quail (Carpenter, et 
al., 1985; Buckpitt and Boyd, 1982; Riviere, et a l., 1983; Riviere, et a l., 1985; 
Dalvi, et a l., 1987). Only one study was found in the literature in which the hepatic 
P-450 content was characterized for the turkey (Dalvi et al., 1987). These 
investigators observed a cytochrome P-450 content of 0.36 +  0.03 nmoles/mg which 
is slightly lower than the 0.6 ± 0 . 1  nmoles/mg measured in this study.
The constitutive levels of microsomal protein and cytochrome P-450 were similar 
among the Galliformes species studied. Riviere et al. (1985) found similar yields of 
hepatic microsomal protein from the chicken and Japanese quail. Sifri and coworkers 
(1975) demonstrated a higher level of microsomal protein in the Japanese quail than 
in the White Leghorn chicken but observed comparable levels of P-450 for these 
species. Dalvi et al. (1987) found significantly (p <  0.05) greater constitutive levels 
of microsomal protein in the quail (Bobwhite) compared to the chicken (Rock-type) 
and turkey (white) but no significant difference was noted between the chicken and 
turkey. Quantitation of hepatic microsomal cytochrome P-450 content in the same 
study indicated significantly greater (p <  0.05) levels in the turkey compared to the 
chicken and quail and in the chicken compared to the quail (Dalvi, et a l., 1987).
170
Following /JNF treatment, comparable levels of hepatic microsomal protein and 
cytochrome P-450 were observed among the Galliformes birds with the exception of 
a significantly (p <  0.05, significant for Tukey’s test but not for Scheffe’s test) 
greater (1.3 times) content of P-450 in the turkey compared to the chicken. The only 
notable difference seen between the species of this order was a significant induction 
of microsomal protein and P-450 content following /3NF administration in the chicken 
and turkey but not in the quail. In the present study, microsomal protein yield in the 
chicken and turkey was 1.6- and 1.3-fold, respectively, the basal levels. For 
cytochrome P-450 content, a 1.8-fold increase was observed in the chicken and a 3.5- 
fold increase was seen in the turkey which was the largest increase observed among 
all the species examined. Two studies were found in the literature in which the yield 
of microsomal protein was determined for control and /3NF- or 3MC-treated chickens. 
Buynitzky et al. (1978) demonstrated an increase amounting to 1.1- to 1.6-fold that 
of controls for microsomal protein following treatment with 3MC while no change 
was observed by Manning et al. (1990) following 0NF treatment. Previous studies 
on the effects of /3NF or 3MC administration on hepatic microsomal cytochrome P- 
450 content in the chicken demonstrated increases in P-450 content ranging from 1.7- 
to 4-fold (Banton, 1990; Ilaug et al., 1980; Manning et a l., 1990; Powis, et al., 
1976; Buynitzky, et a l., 1978; Althaus, et al., 1972; Darbey, et a l., 1984; Darbey 
et al., 1985; Darbey, et al., 1986; Topp and van Bladeren, 1986). Past studies on 
the hepatic cytochrome P-450 system of the Japanese quail found no change in the 
yield of microsomal protein associated with /3NF or 3MC treatment while increases
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ranging from 280 to 473 % control values were reported for P-450 content (Buckpitt 
and Boyd, 1982; Carpenter, et al., 1985; Buckpitt, et a l., 1982; Riviere, 1984). Neal 
et a l., (1986) observed a 176% increase in protein and a 905% increase in P-450 
content of hepatic microsomes isolated from Japanese quail treated with 3MC. No 
studies were available which evaluated the response of the turkey hepatic microsomal 
system to /5NF or other 3MC-type inducers.
6.1 .1 .2  Anseriformes
Reported levels of microsomal protein in untreated ducks (mallard) of varying ages 
and sex ranged from 13.8 to 31.6 mg/g liver (Davison and Sell, 1972; Gorsline et al., 
1981; Sifri, et al., 1975; Dalvi, et a l., 1987). In comparison with these values, the 
levels determined in the present study were lower, 9 +  2 mg/g for the Pekin and 
Khaki Campbell ducks and 6 +  4 mg/g for the Muscovy duck. Only one study was 
found in the literature in which the components of the hepatic microsomal system of 
the goose (gray) were quantitated (Dalvi et al., 1987). These researchers found a 
basal microsomal protein level of 10 mg/g in this species which is consistent with the 
findings of this study.
Constitutive cytochrome P-450 levels observed in the present study for the Pekin, 
Khaki Campbell and Muscovy ducks are consistent with levels previously reported for 
other breeds of ducks. The cytochrome P-450 levels quantitated for hepatic 
microsomes isolated from mallard and Aylsebury x Pekin ducks ranged from 0.18 to
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0.53 nmole/mg (Bartlett and Kirinya, 1976; Sifri, et al., 1975; Dalvi, et al., 1987). 
Only one study in the literature reported hepatic microsomal cytochrome P-450 
content for the goose (Dalvi, et a l., 1987). These investigators observed a 
cytochrome P-450 level of 0.29 ±  0.04 nmoles/mg in the gray goose which is lower 
than the level observed in this study (0.6 +  0.2 nmoles/mg).
This investigation found that the hepatic microsomal protein yield and cytochrome P- 
450 content was similar among the Anseriformes species examined for both the 
untreated and 0N F treated birds. Dalvi et al. (1987) conducted a comparative study 
of these parameters for the gray goose and mallard duck. These researchers observed 
a significantly (p <  0.05) greater (1 .6-fold) yield of hepatic microsomal protein in the 
mallard duck compared to the goose and a significantly (p <  0.05) greater (1.6-fold) 
content of cytochrome P-450 in the goose compared to the duck. No other studies 
were found in which the cytochrome P-450 content o f the duck and goose were 
compared.
Induction of hepatic microsomal protein yield and cytochrome P-450 content was 
observed in the Anseriformes following treatment with /3NF. However, it is 
interesting to note that for microsomal protein, all species showed an increase (1.4 to
1.9-fold) except for the Muscovy, whereas for P-450 content, increases (2.2 to 3.2- 
fold) were seen in all but the Khaki Campbell duck. No studies could be found in the 
literature which compared the hepatic microsomal protein and cytochrome P-450
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content of control and /3NF- (or 3MC) treated microsomes of any of the Anseriformes 
species examined here. However, one study did report a 320 percent increase in 
cytochrome P-450 content in the Eider duck (Somateria mollissima) associated with 
exposure to 3 ,3 ’,4 ,4 ’ tetrachlorobiphenyl, a 3MC-type inducer (Brouwer, 1991). The 
Eider duck is a sea duck and is classified within the Mergini tribe of the Anatidae 
family within the Anseriformes order (Kear, 1985).
6.1 .1 .3  Comparison of Galliformes and Anseriformes
The constitutive hepatic microsomal protein and cytochrome P-450 levels observed in 
the present study were comparable among the species of the Galliformes and 
Anseriformes orders. However, following 0NF treatment, some differences were 
noted between the orders. The Anseriformes order demonstrated a 1.6-fold increase 
in protein in response to /3NF treatment whereas no change in protein yield was 
observed in the Galliformes order. Consequently, a significantly (p <  0.05) greater 
(1.3-fold) level of microsomal protein was seen in the j3NF treated Anseriformes 
compared to the /3NF treated Galliformes. Induction o f hepatic cytochrome P-450 
content by /3NF treatment was observed in both orders. However, the increase seen 
in the Anseriformes (3-fold) was slightly greater than that seen in the Galliformes (2- 
fold). No studies were found in the literature which compared microsomal protein 
levels for the Anseriformes and Galliformes species. Only one study was found in the 
literature which sought a comparison in cytochrome P-450 content between species of 
the Galliformes and Anseriformes orders. Sifri, Sell and Davison (1975) reported a
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lower hepatic cytochrome P-450 level in the Mallard duck compared to that of the 
chicken and Japanese quail.
In general, comparison of these orders indicated similar levels of hepatic microsomal 
protein and cytochrome P-450 for control and treatment groups of the represented 
species.
6 .1 .1 .4  Comparison of the Rat and the Avian Species
The present study demonstrated the rat hepatic microsomal protein and cytochrome 
P-450 levels, and the response of these parameters to /3NF administration, to be 
consistent with findings reported by other researchers. These results indicated that the 
yield of microsomal protein in the rat was significantly greater than that of the quail, 
chicken, goose and Muscovy duck but was not significantly different than that of the 
turkey, Pekin duck or Khaki Campbell duck. One study, which examined the 
components of the cytochrome P-450 system of a variety of species, found that the 
yield of microsomal protein per gram of liver was comparable for the chicken, Khaki 
Campbell duck and rat (Patterson and Roberts, 1970). Dalvi et a l., (1987) found that 
the observed yield of microsomal protein for the rat was significantly greater (1.5- to 
3.7-times) than that of the white turkey, chicken, gray goose and mallard duck but 
was comparable to that of the Bobwhite quail. The same group found a 1.5- to 3.3- 
fold greater cytochrome P-450 content in rat microsomes compared to microsomes 
isolated from the white turkey, Rock-type chicken, gray goose, mallard duck and
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Bobwhite quail. Bartlett and Kirinya (1976) observed a 400% greater cytochrome P- 
450 level in the rat compared to the duck (Aylesbury x Pekin). In contrast to the 
findings of Dalvi et al. and Bartlett and Kirinya, the present study found no significant 
difference in the cytochrome P-450 content of the hepatic microsomes isolated from 
the rat and the avian species used in this study.
In general, the induction of microsomal protein and cytochrome P-450 content 
associated with /3NF treatment was more marked in the avian species compared to the 
rat. Following |8NF treatment, no significant changes in microsomal protein yield 
were observed for the rat, quail, or Muscovy duck. In contrast, significant increases 
(ranging from 1.3 to 1.9-fold) in protein yield were observed for the chicken, turkey, 
goose, Pekin and Khaki Campbell ducks. Topp and van Bladeren (1986) observed 
comparable levels of hepatic cytochrome P-450 in the chicken and the rat following 
/3NF treatment as did this study. Induction of cytochrome P-450 content in the avian 
species (excluding the Japanese quail and Khaki Campbell duck) was approximately 
twice (2.7-fold greater than basal levels on average) the level of induction observed 
for the rat (1.4-fold greater than constitutive levels). This finding is consistent with 
the conclusions drawn from the literature review conducted by Ronis and Walker 
(1989) in which the effects of 3MC-type inducers on avian species were reviewed and 
summarized.
176
6.1.2 NADH- and NADPH-Cytochrome c Reductase
6.1.2.1 Galliform es
The observed hepatic microsomal NADH- and NADPH-cytochrome c reductase 
activities were similar among the Galliformes species examined. The NADH- and 
NADPH-cytochrome c reductase activities measured in the chicken and quail hepatic 
microsomes were consistent with activities reported for these species by other 
researchers (Banton, 1990; Buynitzky, et al., 1978; Buckpitt and Boyd, 1982; Pilch 
and Coomes, 1981; Rinsky and Perry, 1983; Carpenter, et a l., 1985; Riviere, 1983). 
No previously reported values for reductase activity could be found for the turkey. 
In the present study, no change in NADH- or NADPH-cytochrome c reductase 
activity was seen following treatment with /3NF. Banton (1990) and Buckpitt and 
Boyd (1982) also found no change in NADPH-cytochrome c reductase activity in 
chicken and quail microsomes following pretreatment of the birds with (3NF and 3MC, 
respectively. Banton (1990) also found no change in NADH-cytochrome c reductase 
activity in chicken hepatic microsomes associated with /3NF administration. Buynitzky 
et al. (1978) also observed no change in NADPH cytochrome c reductase in the 
chicken following administration of 3MC. In contrast, Powis et al. (1976) 
demonstrated an increase in hepatic microsomal NADPH-cytochrome c reductase 
activity associated with 3MC administration in chicken embryos and chicks. 
Similarly, Carpenter and coworkers found a significant increase in NADPH- 
cytochrome c reductase activity in hepatic microsomes isolated from /3NF-treated 
Japanese quail (Carpenter, et a l., 1985).
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6.1.2.2 Anseriformes
In general, comparable levels of NADH- and NADPH-cytochrome c reductase activity 
were seen for the Anseriformes species studied. Differences noted between the 
Anseriformes species included a greater level of constitutive NADH-cytochrome c 
reductase activity in the goose compared to the Muscovy and a greater level of 
NADPH-cytochrome c reductase activity in the goose compared to the Muscovy duck 
following treatment with /3NF. No change in NADH- or NADPH-cytochrome c 
reductase activity was noted in the Anseriformes species following 0NF treatment. 
No studies were found in the literature in which the hepatic microsomal NADH- or 
NADPH-cytochrome c reductase activity was quantitated for the goose or the duck.
6.1.2.3 Comparison of Galliformes and Anseriformes
The hepatic microsomal NADPH-cytochrome c reductase activity levels observed in 
the present study were comparable for the Galliformes and Anseriformes species 
evaluated for both the control and the $N F treated birds. In contrast, a significantly 
(p <  0.001) greater (=  2-fold) hepatic microsomal NADH-cytochrome c reductase 
activity was observed for the Anseriformes birds compared to the Galliformes birds.
6.1 .2 .4  Comparison of Rat and Avian Species
The NADH- and NADPH-cytochrome c reductase activity levels observed for the rat 
were consistent with levels reported in previous studies. As reported by other 
researchers, no change in hepatic microsomal NADH- or NADPH-cytochrome c
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reductase activity was associated with /3NF administration in the rat. This finding was 
also consistent with the observed response of the avian NADH- and NADPH- 
cytochrome c reductases. The NADH- and NADPH-reductase activity for both orders 
of birds were found to be comparable with that of the rat.
6.1.3 Overview
In summary, the constitutive components of the hepatic cytochrome P-450 
monooxygenase system (with the exception of NADH-cytochrome c reductase) were 
demonstrated to be present at comparable levels in the representative Galliformes and 
Anseriformes species. Basal NADH-cytochrome c reductase activity was observed 
to be greater in the Anseriformes than in the Galliformes. Comparison of the 
individual species indicated that basal NADH-cytochrome c reductase activity was 
greater in the goose and Khaki Campbell duck compared to the chicken and turkey. 
In addition, following jSNF, there was significantly greater NADH-cytochrome c 
reductase activity in the Khaki Campbell duck compared to the chicken and turkey. 
Other less significant differences between treatment groups included greater protein 
yield in the Khaki Campbell and Pekin ducks compared to the quail and greater P-450 
content in the turkey compared to the Khaki Campbell duck and chicken.
In comparison of the avian and rat hepatic microsomal systems, there were some 
similarities and differences noted. Basal levels for microsomal protein yield were, in 
general, greater in the rat than in the avian species (chicken, quail, goose and
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Muscovy duck). Constitutive cytochrome P-450 levels and NADH- and NADPH- 
cytochrome c reductase activities were comparable for the avian and mammalian 
classes. In response to /3NF treatment, increases in microsomal protein yield were 
observed for the avian species but no increase in the amount of protein per gram of 
liver was seen for the rat. More dramatic increases in cytochrome P-450 levels were 
observed in the avian species compared to the rat. No change in NADH- or NADPH- 
cytochrome c reductase activity was observed for the birds or the rat. These findings 
are consistent with those of other studies. Microsomal protein level, cytochrome P- 
450 content, NADH-cytochrome c reductase activity and NADPH-cytochrome c 
reductase activity are presented for each species in Figures 6-1, 6-2, 6-3, and 6-4, 
respectively.
Upon review of the available studies characterizing the avian hepatic microsomal 
cytochrome P-450 monooxygenase system, it is readily apparent that there is 
considerably greater interexperimental variability in avian data than in data collected 
on laboratory species such as the rat. Interexperimental variability in data obtained 
on the constitutive avian hepatic microsomal system appears to be quantitative rather 
than qualitative. Comparison of studies characterizing the response o f the avian 
hepatic microsomal system to treatment with /3NF or 3MC, indicates that there are 
qualitative as well as quantitative differences present between the data sets. 
Qualitative differences in the response of the avian cytochrome P-450 
system to 3MC-type inducers were noted for microsomal protein level (chicken and
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Figure 6-1 Hepatic microsomal protein content of control and BNF-treated 
avian species and male rats.
CC = Chicken Control; CT = Chicken Treated; QC = Quail Control; QT = Quail Treated;
TC = Turkey Control; TT = Turkey Treated; GC = Goose Control; GT = Goose Treated;
PDC = Pekin Duck Control; PDT = Pekin Duck Treated; KDC = Khaki Campbell Duck Control; 
KDT = Khaki Campbell Duck Treated; MDC = Muscovy Duck Control;
MDT = Muscovi Duck Treated; ANC =  Anseriformes Control; ANT = Anseriformes Treated; 
GAC = Galliformes Control; GAT = Galliformes Treated; MRC = Male Rat Control 
MRT = Male Rat Treated. These abbreviations are the same for Figures 6-2 through 6-16.
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Figure 6-2 Hepatic microsomal cytochrome P-450 content o f  control and
BNF-treated avian species and male rats. See Figure 6-1 for
species identifications.
nm
ol
es
 
cy
to
ch
ro
m
e 
c 
re
du
ce
d/
m
in
/m
g 
pr
ot
ei
n
182
320  - |  
300  -  
280  -  
260  -  
240  -  
220  -  
200  —  
180 —
Species and Treatment Group
Figure 6-3 Rate o f hepatic microsomal NADPH-cytochrome c reductase
activity in control and BNF-treated avian species and male rats.
See Figure 6-1 for species identifications.
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Figure 6-4 Rate o f hepatic microsomal NADH-cytochrome c reductase
activity in control and BNF-treated avian species and male rats.
See Figure 6- 1 for species identifications.
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quail), cytochrome P-450 content (quail), and NADPH-cytochrome c reductase 
activity (chicken and quail).
The interexperimental variability observed between studies presented in the literature 
may be attributable to greater genetic variability among birds; differences in the 
breed, sex or age of the birds studied; and differences in assay procedures or other 
experimental conditions such as the inducer used and/or the dosage administered and 
the degree of environmental control implemented (very limited data are available on 
the influences of temperature, light and seasonal variation on the cytochrome P-450 
system of birds). Male and female birds of different breeds and of ages ranging from 
embryos of a few days of incubation to adults were used in the cytochrome P-450 
studies present in the literature. A wide range of variability was also noted in the 
induction regimes employed by the various studies. Reported regimes for the 
administration of 3MC-type inducing agents included 50 mg/kg/day /3NF for 3 days 
(Banton, 1990), 80 mg/kg /3NF single dose (Haug, et al., 1980), 80 mg/kg/day /3NF 
for 2 days (Manning, et a l. , 1990), 150 mg/kg/day 0NF for 4 days (Carpenter, et a l., 
1985), 20 mg/kg/day 3MC for 2 days (Buynitzky, et al., 1978; Buckpitt and Boyd, 
1982; Riviere, 1984), 15 mg/kg/day 3MC for 3 days (Neal, et a l., 1986), 20-80 
mg/kg/day 3MC for 2 days (Buckpitt et a l., 1982) and 0.01-1000 /xg/kg/day TCDD 
for 3 days (Althaus, et a l., 1972). While no studies have been conducted in avian 
species to characterize dose-response relationships for the induction of cytochrome P- 
450 components by |3NF or other 3MC-type inducers, it has been demonstrated in the
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rat that different dose regimes produce different hepatic cytochrome P-450 system 
responses. For example, maximal induction of EROD activity has been demonstrated 
to require a dose of 20 mg/kg (3NF (Matthew and Houston, 1990) while maximal 
induction of AHH activity was observed to require a dose of 80 mg/kg /3NF (Boobis, 
et a l. , 1977). Similarly, Sawyer et al. (1986) found that the ED50 values for induction 
of AHH and EROD activities in the chicken by TCDD were 302 and 778 ng/kg, 
respectively. In addition, interspecies differences in the induction response have been 
observed. For example, Brunstrom and Lund (1988) found that the ED50 for the 
induction of AHH by 3 ,3’4 ,4 ’-tetrachlorobiphenyl was 10 times higher in the turkey 
than in the chicken. It was also noted during the literature review that there was 
considerable interexperimental variability in the time period allotted between treatment 
and microsomal isolation. Time periods for the various studies ranged from 24 hours 
to 10 days.
Observed interexperimental variability may also stem from the comparison of hepatic 
microsomal data obtained from birds treated with different inducers, i.e. /JNF, 3MC, 
TCDD, 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl, etc. Cytochrome P-450 studies conducted on 
the chicken suggest that the responses of the avian hepatic microsomal system to /3NF 
and 3MC may not be identical. For example, Ehrich and Larsen (1983) observed a 
greater increase in the microsomal cytochrome P-450 level with 3MC treatment 
compared to /3NF treatment whereas the reverse was noted for ANH activity. The 
same study also demonstrated that /3NF treatment induced a broader spectrum of
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hepatic cytochrome P-450 catalyzed activities than did 3MC. In the chicken embryo, 
Hamilton et al. (1983) and Althaus, et al. (1972) observed that the effective dose 
range for the induction of AHH activity by /JNF was similar to that for induction by 
3MC but that the maximal increase in activity produced by /3NF was approximately 
half of that produced by 3MC. In addition, Ehrich et al. (1984) observed a difference 
in the time lapse required between treatment and the achievement of maximal 
induction of malaoxon detoxification for /3NF (48 hours) and 3MC (96 hours).
6.2 Oxidative Activity of the Hepatic Cytochrome P-450 Monooxygenase 
System
6.2.1 Ethoxyresorufin 0-Deethylase Activity
6.2.1.1 Galliformes
This study found that constitutive EROD activity was comparable among the 
Galliformes species studied. Basal microsomal EROD activity (based on specific and 
molar activities) measured in the chicken was consistent with the activities observed 
by Banton et al. (1989) and Banton (1990) but was lower (approximately 10-fold) than 
the activities (pmoles of resorufin formed/inin/mg protein) reported by Sawyer et al. 
(1986), Riviere (1984), and Lee et al. (1986). The rate of metabolism of 
ethoxyresorufin (ER) (pmoles resorufin formed/inin/mg protein) observed in this study 
for the Japanese quail was 4 to 8 times lower than the values reported by Carpenter 
et al. (1985), Riviere et al. (1983) and Riviere et al. (1985). No previously published 
values for the hepatic microsomal metabolism of ER could be found for the turkey.
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Following (3NF treatment, EROD activity seen for the turkey was significantly greater 
than that demonstrated by the Japanese quail. The greatest induction of EROD 
metabolism among the Galliformes species was observed in the chicken (39-fold based 
on specific activity). This increase in activity is consistent with the findings of 
Sawyer et al. (1986) who reported a 37.5-fold increase in EROD activity in the 
chicken following treatment with TCDD. Banton (1990) demonstrated a slightly 
lower increase (27.5-fold) in hepatic EROD activity associated with j8NF treatment 
while Rifkind et al. (1984) reported a slightly higher increase (50-fold) following 
treatment with 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl. In contrast, Quilley and Rifkind (1986) 
demonstrated a dramatic increase in EROD activity in the chicken of 200-fold with 
TCDD administration while Brunstrom (1986) only observed a 2.5-fold increase 
following treatment with 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl. Based on turnover number, 
a 21.4-fold increase in the rate of ER deethylation was observed in the chicken which 
is considerably higher than the 7.1-fold increase reported by Banton (1990).
In the present study, the Japanese quail demonstrated a 16-fold increase in ER 
metabolism (based on specific activity) following treatment with /3NF. Similarly, 
Carpenter, et al. (1985) reported a 13-fold increase in the rate of ER metabolism in 
this species following treatment with (8NF. Riviere (1984) observed an increase in 
EROD activity of only 2.8-fold and 2.5-fold following administration of (3NF and 
3MC, respectively. In contrast to these observations, Neal et al. (1986) reported a 
53 percent decease in EROD activity in the Japanese quail following treatment with
188
3MC. No reports on the effects of 3MC-type inducers on hepatic microsomal ER 
metabolism were found in the literature for the turkey.
6.2 .1 .2  Anseriformes
In the present study, basal hepatic microsomal ER metabolism (based on specific and 
molar activities) was found to be similar among the Anseriformes species studied. 
Upon review of the literature, no reported values for constitutive EROD activity were 
located for any of the Anseriformes species examined in this study.
All of the Anseriformes species demonstrated induction of hepatic microsomal EROD 
activity following treatment with /3NF. Comparable increases in deethylase activity 
were observed for the goose, Pekin duck and Khaki Campbell duck while the increase 
in activity observed for the Muscovy duck was approximately half of that seen for the 
other species. No reported values for hepatic ER metabolism were discovered in the 
literature for the goose, Pekin duck, Khaki Campbell duck, or Muscovy duck. 
Brouwer (1991) reported a 57-fold increase in EROD activity (based on specific 
activity) in the Eider duck following exposure to 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl. This 
reported increase is considerably higher that the increases observed here with /3NF for 
the Pekin (20-fold), Khaki Campbell (16-fold) and Muscovy (9-fold) ducks.
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6.2 .1 .3  Comparison of Galliformes and Anseriformes
The constitutive rate of ER metabolism demonstrated by the Anseriformes order was 
approximately twice that seen for the Galliformes order. In contrast, induced EROD 
activities were similar for the two orders. However, when the treatment groups of 
each species were evaluated individually, some significant differences were observed 
between the minor species of these orders (Pekin duck >  quail). Both avian orders 
demonstrated an induction of EROD activity following treatment with /3NF but the 
level of induction was approximately twice as great in the Galliformes as in the 
Anseriformes.
6 .2 .1 .4  Comparison of Rat and Avian Species
Results of this study indicated that the constitutive EROD activities of the avian 
species were comparable to that of the rat. However, following /3NF treatment, the 
level of hepatic microsomal EROD activity demonstrated by the rat was significantly 
greater ( ~  3-fold) than that seen for the avian species. In addition, the degree of 
induction observed in the rat was 4 times greater than that shown by the avian species 
based on specific activity and 6 times greater based on turnover number. The increase 
in EROD activity observed in the present study for the rat is consistent with those 
seen by other researchers (Birgersson, et a l., 1985; Burke et a l., 1985; Burke and 
Mayer, 1974; Burke and Mayer 1983; Guengerich, et a l., 1982; Guengerich, et al., 
1982a; Ryan, et a l., 1982).
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Ethoxyresorufin O-deethylase activity for each species and order is presented in 
Figures 6-5.
6.2.2 Benzo[fl]pyrene Hydroxylase Activity and Metabolic Profile
6.2.2.1 Galliformes
Although similar patterns of B[a]P metabolism were observed for the Galliformes, 
quantitative differences in metabolite formation were noted between the species. In 
general, constitutive benzo[a]pyrene hydroxylase activity (based on total metabolite 
production) was observed to be significantly greater in the turkey than the chicken and 
quail. Specifically, significantly greater quantities of phenols (3-OH B[a]P and 9-OH 
B[a]P) were produced by the turkey hepatic microsomes than by microsomes isolated 
from the chicken and quail. The present study demonstrated that basal AHH activity 
in the turkey was 5.7-fold (based on specific activity) and 4.4-fold (based on turnover 
number) greater than activity levels observed for the chicken. Consistent with this 
finding, Brunstrom and Lund (1988) found that constitutive AHH activity in the turkey 
was 3.5 times greater than that of the chicken. It is also interesting to note that these 
researchers observed that the turkey required a greater dose of 3 ,3 ’,4 ,4 ’- 
tetrachlorobiphenyl to achieve maximal induction of AHH activity than did the 
chicken.
Induction of B[a]P metabolism was observed in the chicken and quail but not in the 
turkey. The greatest increase in total metabolite production was seen in the chicken
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Figure 6-5 Rate o f hepatic microsomal ethoxyresorufin O-deethylase activity
in control and BNF-treated avian species and male rats.
See Figure 6-1 for species identifications.
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(5-fold based on specific activity, 2.5-fold based on turnover number) followed by the 
quail (2.3-fold based on specific activity, 1.7-fold based on turnover number). Other 
researchers have reported increases in B[<r/]P hydroxylase activity following treatment 
of the chicken with 3MC-type inducers (3MC, TCDD, B[a]P, j3NF, and 3 ,3 ’,4 ,4 ’- 
tetrachlorobiphenyl). The reported increases ranged from 2 to 40-fold over control 
values (Buynitzky, et al., 1978; Brunstrom, et al., 1986; Dogra and Israels, 1987; 
Haug, et al., 1980; Poland and Glover, 1977; Althaus, et al., 1972; Hamilton, et al., 
1983; Ehrich and Larsen, 1983; Rosanoff, et al., 1984; Strittmatter and Umberger, 
1969; Powis, et a l., 1976; Sawyer, et al., 1986; Darbey, et a l., 1984; Darbey, e ta l.,  
1985; Darbey, et al., 1986; Rifkind, et al., 1984; Topp and van Bladeren, 1986). 
Only one study was found in the literature in which AHH activity was examined in 
the Japanese quail. Carpenter, et al. (1985) demonstrated a 13-fold increase in AHH 
activity over the basal level following /3NF administration. This reported increase is 
greater than the increase of 2.3-fold observed in the present study. In contrast to the 
chicken and quail, no change in total metabolite formation was seen for the turkey in 
terms of specific activity and based on turnover number, a significant decrease in 
metabolite production was observed. No studies were located in the literature which 
quantitated the increase in AHH activity in the turkey associated with the 
administration of 3MC-type inducers.
Following (3NF treatment, the metabolic profiles generated by the Galliformes species 
were qualitatively similar to each other and to the control profiles (with the addition
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of 9,10-diol formation). Specific quantitative changes observed in the metabolic 
profiles of the chicken and quail included significant increases in the production of 3- 
OH B[a]P, 9-OH B[a]P and B[a]P 7,8-diol. The only qualitative change noted was 
the formation of the 9,10-diol metabolite. For the turkey, changes in product 
distribution included a significant increase in B[a]P 7,8-diol, a significant decrease in 
3-OH B[a]P, no change in 9-OH, and the formation of 9,10-diol. Shifts in the 
metabolic profiles due to changes in the relative production of individual metabolites 
were noted following /?NF treatment. In the chicken and quail, there was a relative 
increase in the production of dihydrodiols and a relative decrease in the production of 
phenols. For the turkey, the shift in product distribution included a relative increase 
in the formation of dihydrodiols and 9-OH B[a]P and a relative decrease in 3-OH 
B[a]P production. Topp and van Bladeren (1986) examined the metabolism of B[a]P 
by primary cultures of control and /3NF-treated chick embryo hepatocytes. The 
product distributions observed by these researchers were similar, but not identical, to 
those of this study. For the control hepatocytes, metabolite formation, in order of 
decreasing magnitude, included 3-OH > 9-OH >  9,10-diol >  7,8-diol. For control 
chicken microsomes, this study found metabolite production of the following 
sequence: 3-OH >  9-OH >  7,8-diol with no 9,10-diol formation. Following /3NF 
administration, a metabolic profile of 3-OH ~  9-OH >  7,8-diol >  9,10-diol was 
observed by Topp and van Bladeren while a product distribution of 3-OH >  9-OH 
>  7,8-diol >  9,10-diol was seen in the present study.
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The results of this study illustrate a significant quantitative difference in the in vitro 
metabolism of B[a]P between the two major food-producing Galliformes species 
(chicken and turkey). In addition, the findings of this study suggest that the 
characteristics of B[a]P metabolism in control and /3NF-treated quail were qualitatively 
and quantitatively more similar to those of the chicken than to those of the turkey. 
Metabolite formation by the control and /3NF-treated Galliformes species is shown in 
Figures 6-6 through 6-8.
6.2 .2 .2  Anseriformes
Overall, basal AHH activity, based on total B[a]P metabolite formation, was 
comparable among the Anseriformes species studied. However, quantitative as well 
as qualitative differences in individual metabolite formation were noted between the 
Anseriformes birds. In general, the constitutive metabolic profiles were similar for 
the duck species examined. The most notable difference observed among these birds 
was the constitutive formation of the B[a]P 9,10-diol metabolite by the Khaki 
Campbell duck (the Khaki Campbell was the only avian species which produced this 
metabolite). Another notable difference in the metabolism of B[a]P among the 
Anseriformes was found in the goose. This species demonstrated a basal metabolic 
profile that did not include the formation of either of the dihydrodiol metabolites 
examined.
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Figure 6-6 Hepatic microsomal production o f  benzo[a]pyrene metabolites 
in control (CC) and BNF-treated (CT) chickens.
3-OH = 3-hydroxybenzo[a]pyrene; 9-OH = 9-hydroxybenzo[a]pyrene
7,8-Diol =  benzo[a]pyrene 7,8-dihydrodiol; 9,10-Diol = benzo[a]pyrene 9,10-dihydrodiol
These abbreviations are the same for Figures 6-6 through 6-15.
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Figure 6-7 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (QC) and BNF-treated (QT) Japanese quail. See Figure 6-6 
for metabolite identifications.
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Figure 6-8 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (TC) and BNF-treated (TT) turkeys. See Figure 6-6
for metabolite identifications.
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In response to /3NF administration, induction of AHH activity (pmoles of total 
metabolites produced/min/mg protein) was seen in only one Anseriformes species, the 
Pekin duck. A decrease in metabolite production was observed in the goose based on 
turnover number; however, no change in production was seen based on specific 
activity. For the Khaki Campbell and Muscovy ducks, no differences in activity were 
noted respective to control values. Profiles of metabolite formation following (3NF 
were similar among the duck species examined. The only differences noted were the 
quantities of individual metabolites produced. In contrast, the metabolic profile of the 
/5NF-treated goose was dissimilar to those observed for the ducks and for the control 
goose. Relative changes observed in metabolite formation for the Anseriformes 
included a relative increase in dihydrodiol and 9-OH B[a]P and a relative decrease in 
3-OH B[a]P. There were no studies found during the literature review which 
examined AHH activity in the Anseriformes species represented in this study. 
Metabolite formation by the control and jSNF-treated Anseriformes species is 
illustrated in Figures 6-9 through 6-12.
6.2 .2 .3  Comparison of Galliformes and Anseriformes
Basal B[a]P hydroxylase activities were comparable for the Anseriformes and 
Galliformes birds. In addition, categorization and comparison of the data based on 
order indicated that the constitutive profiles of B[a]P metabolism for the Anseriformes 
and Galliformes (with the exception of basal B[a]P 9,10-diol formation by the Khaki 
Campbell duck and the lack of 7,8-diol formation by the goose) were similar.
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Figure 6-9 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (GC) and BNF-treated (GT) geese. See Figure 6-6
for metabolite identifications.
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Figure 6-10 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (PDC) and BNF-treated (PDT) Pekin ducks. See Figure 6-6
for metabolite identifications.
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Figure 6-11 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (KDC) and BNF-treated (KDT) Khaki Campbell Ducks.
See Figure 6-6 for metabolite identifications.
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Figure 6-12 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (MDC) and BNF-treated (MDT) Muscovy ducks.
See Figure 6-6 for metabolite identifications.
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Following treatment with j3NF, induction of AHH activity (based on specific activity) 
was demonstrated for both orders. However, based on turnover number, a decrease 
in total metabolite production was noted for the Anseriformes. Benzo[a]pyrene 
hydroxylase activity following (3NF was significantly greater in the Galliformes than 
in the Anseriformes. The observed shift in metabolite formation was consistent 
between the avian orders (increased production of dihydrodiols and 9-OH B[a]P and 
decreased production of 3-OH B[a]P). Metabolite formation by the Galliformes and 
Anseriformes orders is illustrated in Figures 6-13 and 6-14, respectively.
Quantitative and qualitative differences in B[tf]P metabolism were noted between 
major and minor species of the Galliformes and Anseriformes orders and also between 
the minor species of these orders. Interspecies comparisons between these orders 
indicated that product distributions of B[a]P metabolism by control microsomes were 
similar for the chicken, turkey, Japanese quail, Pekin duck, and Muscovy duck (3-OH 
>  9-OH >  7,8-diol). Qualitative differences in metabolite formation were noted for 
the goose (3-OH >  9-OH) and the Khaki Campbell duck (3-OH >  9-OH >  7,8-diol 
=  9,10-diol). In 0NF-treated birds, the patterns of B[a]P metabolism were similar 
for the Galliformes species (3-OH >  7,8-diol >  9-OH >  9,10 diol) and for the 
Anseriformes duck species (3-OH >  7,8-diol =  9-OH >  9,10-diol). The metabolic 
profiles produced by the control (3-OH >  9-OH) and treated (3-OH >  9-OH >  
9,10-diol >  7,8-diol) goose were unlike any profiles produced by the other avian 
species.
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Figure 6-13 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (GAC) and BNF-treated (GAT) Galliformes species.
See Figure 6-6 for metabolite identifications.
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Figure 6-14 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (ANC) and BNF-treated (ANT) Anseriformes species.
See Figure 6-6 for metabolite identifications.
Species and Treatment Group
206
6.2 .2 .4  Comparison of Rat and Avian Species
Constitutive benzo[a]pyrene hydroxylase activities observed for the avian species were 
comparable to that of the rat with the exception of the turkey and Khaki Campbell 
duck which exhibited greater activities (pmole of metabolites/min/nmole P-450). In 
response to treatment with jSNF, a 1.7-fold increase in total metabolite formation 
(based on specific activity) was observed in the rat. This observation falls within the 
lower end of the range of values reported in the literature for increases (1.6 to 14.4- 
fold over controls) in AHH activity associated with the administration of 3MC-type 
inducers (Birgersson, et a l., 1985; Poland and Glover, 1977; Guengerich, et al., 
1982; Keller, et al., 1987; Winston, et a l., 1991; Wroblewski, et a l., 1988). In 
comparison to the rat, greater increases in total metabolite formation (pmoles of 
metabolites/min/mg of protein) following /3NF were observed in the chicken (5-fold) 
and Japanese quail (2.3-fold). When evaluated on the basis of turnover number, no 
change in benzo[a]pyrene hydroxylase activity was seen in the rat. In contrast, 
increases in turnover number were observed for the hepatic microsomes of the chicken 
(2.5-fold) and quail (1.7-fold) and decreases were seen for the turkey and goose 
microsomes.
For this study, the production of B[a]P metabolites by control and /3NF-treated rats 
included, in order of decreasing magnitude, 3-OH >  9,10-diol >  9-OH >  7,8-diol. 
Qualitative as well as quantitative differences were noted between the profiles of B[a]P 
metabolism published in the literature. For the purpose of comparison, the following
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review of the metabolic profiles presented in the literature focuses only on the four 
metabolites that were quantitated in the present study. The profile demonstrated by 
Wroblewski, et al. (1988) for basal B[a]P metabolism in the rat was consistent with 
the findings of this study. However, these researchers observed a shift in metabolite 
production (9,10-diol >  7,8-diol ~  3-OH >  9-OH) following TCDD administration 
which was not observed in the study presented here. Similar, but not identical, 
profiles (3-OH >  9,10-diol >  7,8-diol >  9-OH) were seen for control and treated 
(3MC-type inducing agents) rats by Wong, et al. (1986), Winston, et a l., (1991), and 
Sagami, et al., (1987). In contrast, the metabolic profiles reported by Cavaliere and 
coworkers (1988) were dissimilar to the findings of this study. For control rats, the 
profile included 3-OH >  9-OH >  7,8-diol ~  9,10-diol and following TCDD 
treatment, 9,10-diol >  7,8-diol =  3-OH >  9-OH (note - this profile is similar to the 
profile observed by Wroblewski presented above). Metabolite formation by the 
control and /3NF-treated rat is illustrated in Figure 6-15. Total metabolite formation 
for all the species studied is presented in Figure 6-16.
6.2.3 Overview
The results of this study indicate, that for the representative Galliformes and 
Anseriformes species, the avian hepatic cytochrome P-450 monooxygenase system has 
the capacity to perform O-deethylation of ethoxyresorufin and hydroxylation of 
benzo[a]pyrene and that changes in these cytochrome P-450-dependent activites are
Species and Treatment Group
Figure 6-15 Hepatic microsomal production ofbenzo[a]pyrene metabolites
in control (MRC) and BNF-treated (MRT) male rats. See Figure 
6-6 for metabolite identifications.
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Figure 6-16 Hepatic microsomal production o f total benzo[a]pyrene
metabolites in control and BNF-treated avian species and male rats. 
Total metabolite production refers to  the production o f  3-OH, 
9-OH, 7,8-diol, and 9,10-diol metabolites. See Figure 6-1 for 
species identifications.
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observed following treatment with /3NF. The constitutive capacity for ethoxyresorufin 
O-deethylation and the induction of this activity associated with /3NF administration 
were similar for the avian species examined. In contrast, interspecies differences 
were noted in the capacity of the avian hepatic microsomal system to hydroxylate 
B[a]P and in the effect of /3NF treatment upon total metabolite formation. Differences 
in metabolic profiles were also noted between the orders.
Constitutive EROD activity was comparable among all the species studied. When 
evaluated by order, however, greater basal activity was noted for the Anseriformes 
compared to the Galliformes. As seen in the rat, it appears that ethoxyresorufin has 
a high specificity for the /3NF-induced hepatic microsomal cytochrome P-450 of the 
avian species. Following /3NF treatment, significant increases in hepatic microsomal 
EROD activity were observed for each of the avian species examined. Increases 
based on specific activity were more pronounced than when based on turnover 
number. Induced levels observed for the birds were similar except for the Japanese 
quail which exhibited a significantly lower activity than all the other species except 
for the goose. Among the avian species, the induction response, based on EROD 
activity, was greatest for the chicken, intermediate for the Japanese quail, turkey, 
goose, Pekin duck, and Khaki Campbell duck and lowest for the Muscovy duck. 
Evaluated on the basis of order, the Galliformes demonstrated an induction of activity 
following /3NF that was twice that seen for the Anseriformes order. In comparison 
of the major and minor species, the most notable finding was a significant difference
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in the EROD activity between the treatment groups of the chicken and Japanese quail 
and the turkey and Japanese quail. Other significant differences noted were between 
the minor avian species.
Constitutive benzo[a]pyrene hydroxylase activity (based on the in vitro production of 
3-OH B[a]P, 9-OH B[rz]P, B[a]P 7,8-diol, and B[<a]P 9,10-diol) was comparable for 
the Galliformes and Anseriformes orders. However, significant differences in basal 
activity were observed between the major species and between the major and minor 
species of these orders.
Quantitative as well as qualitative differences in B[a]P metabolism were observed 
following /3NF treatment. Induction of B[a]P metabolism was observed in some avian 
species while others experienced no change or an actual decrease in metabolite 
formation. These differences were noted between the major species as well as 
between the major and minor species. In addition, greater AHH activity was observed 
in the Galliformes compared to the Anseriformes following /3NF.
In general, the metabolic profiles produced by the Galliformes species were similar. 
However, the characteristics o f B[a]P metabolism in the quail were more like those 
of the chicken than those of the turkey. Qualitative and quantitative differences in 
B[a]P metabolism were noted between the Anseriformes species. In general, the 
patterns of B[a]P metabolism demonstrated for the duck species were similar. The
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goose however, demonstrated profiles of metabolite formation that were different from 
those observed for the ducks. In comparison of the Galliformes and Anseriformes, 
the patterns of B[a]P metabolism observed for the chicken, Japanese quail, and turkey 
were different from those observed for the Pekin duck, Khaki Campbell duck, 
Muscovy duck, and goose. However, 3-OH B[a]P was the primary metabolite 
produced by all the species studied. Interspecies and interorder differences in product 
distributions were for the 9-OH B[a]P, B[a]P 7,8-diol, and B[a]P 9,10-diol 
metabolites.
In comparison to the rat, the avian species exhibited comparable B[a]P hydroxylase 
activity except for the turkey and Khaki Campbell duck which exhibited greater 
activity (based on turnover number). Patterns of metabolite formation in the rat were 
qualitatively and quantitatively dissimilar to those of the avian species.
6.3 Summary and Conclusions
6.3.1 Approval of Minor Use Avian Drugs
This study has served to provide information on the cytochrome P-450-dependent 
metabolic capacity of seven major and minor food-producing avian species for the 
classical model substrate, benzo[a]pyrene, and to characterize the differences in 
metabolism of this compound between species. Characterization of this important 
biotransformation pathway has provided data for the estimation of the activity of the
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avian hepatic mixed function monooxygenase system and for the relative rate of 
oxidation of structurally similar compounds in represented avian species.
The components of the hepatic microsomal system were demonstrated to be present 
at comparable levels in the Galliformes and Anseriformes species examined. This is 
an important finding since interspecies differences in metabolic capacity have been 
shown to be correlated with differences in cytochrome P-450 content and cytochrome 
P-450 reductase activity. The findings of this study indicate that there are interspecies 
differences in the capacity o f the avian hepatic cytochrome P-450 system to 
hydroxylate B[a]P. Significant quantitative differences in constitutive activity were 
observed between the major species and between major and minor species. The most 
notable difference observed was the high level of constitutive B[a]P hydroxylase 
activity demonstrated by the turkey compared to the other avian species. This finding 
suggests that drugs subject to biotransformation pathways involving polynuclear 
hydroxylation may be metabolized at a comparatively faster rate in turkeys than in 
other avian species. Similar metabolic profiles were demonstrated by the major and 
minor species and, in general, by the minor duck species. Of the birds studied, the 
characteristics of B[a]P metabolism were most different for the goose. This finding 
suggests, that for drugs similar in structure to the model compound B[a]P, it may not 
be appropriate to base predictions of drug fate in the goose on biotransformation data 
obtained in the chicken and turkey (major species). Qualitative and quantitative 
differences in the microsomal hydroxylation of B[a]P were observed between the
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major species and between major and minor species following treatment with /3NF. 
Differences were also noted between the orders. This variation in response is 
noteworthy from the standpoint that food-producing avian species are routinely 
exposed to a variety of chemicals that may affect cytochrome P-450-dependent 
activities and thus the biotransformation of administered therapeutic agents.
The results of this study further demonstrate that there are marked differences in the 
characteristics and metabolic capacity of the avian and rat hepatic cytochrome P-450 
systems. Consequently, it should be re-emphasized that predictions concerning drug 
metabolism in avian species should not be based on biotransformation data generated 
in the rat or other mammalian species.
This work has provided an important contribution to the comparative study of 
xenobiotic metabolism in domestic avian species by characterizing the components of 
the hepatic cytochrome P-450 system in seven major and minor species and by 
examining the metabolic oxidative capacity of these species though the development 
of metabolite profiles for a model substrate. It is anticipated that the results of this 
study will serve to support the interpretation of data submitted to the FDA for the 
purpose of obtaining approval for drug use in economically minor food-producing 
species such as the Japanese quail, Pekin duck, Khaki Campbell duck, Muscovy duck 
and goose.
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6.3.2 Domestic Avian Species as Sentinels in Ecotoxicological Studies
The results of the present study clearly indicate that the avian hepatic microsomal 
cytochrome P-450 mixed function monooxygenase system of selected domestic species 
is inducible by /3-naphthoflavone, a classical inducer belonging to an environmentally 
relevant class of compounds, the PAHs. The most consistent response observed 
following exposure to this compound was for the O-deethylation of ethoxyresorufin. 
Significant increases in this cytochrome P-450-dependent activity were observed for 
all seven species studied. This finding indicates that the avian hepatic cytochrome P- 
450 system of domestic avian species may be inducible by PAHs present in the 
environment and that the induction of EROD activity in these species may be useful 
as a biomarker of exposure to this class of compounds.
In contrast, the observed effects of |3NF administration on the other microsomal 
parameters examined varied between the species. However, two species, the chicken 
and Pekin duck, demonstrated increases in microsomal protein, cytochrome P-450 
content, and B[a]P hydroxylase activity following 0N F treatment. Therefore, it is 
possible that the induction of these parameters, particularly AHH activity, may be 
used as biomarkers of environmental chemical exposure in biomonitoring programs 
involving these species. The most dramatic response to jSNF treatment was observed 
for the hepatic microsomes of the chicken. Not only were increases observed for all 
the parameters examined (excluding cytochrome c reductase), but the chicken 
demonstrated the greatest increases in EROD and AHH activity of all the avian
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species studied. This finding suggests, that for the species examined, the chicken may 
be the best species to use as a sentinel for the assessment of exposure to PAHs present 
in the environment.
In situ assessments, utilizing test organisms, may be used to evaluate the potential 
impact of environmental contamination on human health or the health of indigenous 
populations (Sandhu and Lower, 1989). In light of the findings of this study, it is 
reasonable to propose that domestic avian species have potential application as 
sentinels of environmental chemical exposure by the utilization of these species in in 
situ assessments. Domestic species are readily available, inexpensive and relatively 
easy to maintain thus making them suitable test organisms for most sites of 
environmental concern.
In addition, based on the significant increases in EROD activity seen for the turkey, 
quail, Khaki Campbell duck, Muscovy duck and goose following 0N F administration, 
it can be concluded that indigenous populations of turkeys, ducks, geese and quail 
may have potential use as sentinel species for the assessment of environmental 
contamination.
Futhermore, based on the demonstrated changes in B[a]P metabolite distributions 
associated with |3NF exposure in these species, it may be possible, with further 
research, to utilize induction of the MFO system as a nondestructive biomarker of
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chemical exposure. This concept is based on the administration a nontoxic model 
compound, via the use of bait, to indigenous avian populations and the subsequent 
analysis of excreted metabolites to determine if metabolic pathways have been altered 
due to induction of the hepatic cytochrome P-450 system.
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APPENDIX: SUPPORTING FIGURES FOR METHODS
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Figure A -l Standard curve for the analysis o f protein concentration 
using bovine serum albumin (BSA).
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Figure A-2 Effect o f  hepatic microsomal protein concentration on resorufin
production for the control Pekin duck.
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Figure A-3 Effect o f hepatic microsomal protein concentration on resorufin
production for the treated Pekin duck.
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Figure A-4 Effect o f  hepatic microsomal protein concentration on resorufin
production for the control male rat.
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Figure A-5 Effect o f hepatic microsomal protein concentration on resorufin 
production for the treated male rat.
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Figure A-6 Resorufin standard curve for the determination o f ethoxyresorufin 
O-deethylase activity.
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Figure A-7 Effect o f hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the control chicken.
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FigureA-8 Effect o f hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the BNF-treated chicken.
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Figure A-9 Effect o f  hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the control rat.
To
ta
l 
B[
a]
P 
M
et
ab
ol
ite
 
Pr
od
uc
tio
n 
(P
ea
k 
A
re
a)
255
2000
1500
1000
500
0
0 1 2  3
Microsomal Protein (mg)
Figure A -10 Effect o f hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the BNF-treated rat.
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Figure A -l 1 Effect o f incubation time on benzo[a]pyrene metabolite 
production for the BNF-treated chicken.
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Figure A-12 Effect o f incubation time on benzo[a]pyrene metabolite 
production for tne BNF-treated rat.
STANDARD CURVES FOR QUANTITATION OF 
BENZO[a]PYRENE AND METABOLITES
Quantitation of the metabolites was achieved through 
the use of external standard calculations. Standards 
were prepared from stock solutions of B[a]P and each 
of the metabolites. Peak areas were used to establish 
standard curves for each analyte by plotting the 
integration areas of the generated peaks.
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Figure A -13 Standard curve for 3-hydroxybenzo[a]pyrene.
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Figure A -14 Standard curve for 9-hydroxybenzo[n]pyrene.
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Figure A -15 Standard curve for benzo[a]pyrene-7,8-diol.
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Figure A -16 Standard curve for benzo[a]pyrene-9,10-dihydrodiol.
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Figure A -17 Standard curve for benzo[a]pyrene.
METHOD BLANK CHROMATOGRAMS
A method blank was prepared for each analyte 
to determine if there were any components in 
the reaction mixture which might interfere 
with the identification and quantitation of 
the compounds interest. The method blank 
consisted of the reaction mixture without the 
microsomes and was spiked with B[a]P or one 
of the metabolites.
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Figure A -18 Method blank chromatogram and UV spectrum for
3-hydroxybenzo[a]pyrene.
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Figure A -19 Method blank chromatogram and UV spectrum for
9-hydroxybenzo[a]pyrene.
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Figure A-20 Method blank chromatogram for benzo[o]pyrene 7,8-dihydrodiol.
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Figure A-21 Method blank chromatogram and UV spectrum for
benzo[a]pyrene 9,10-dihydrodiol.
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Figure A-22 Method blank chromatogram and UV spectrum for benzo[a]pyrene.
M ICROSO M AL BLANK CHROM ATOGRAM S
A microsomal blank was prepared for each species to 
determine if there were any microsomal components 
which may interfere with the identification and 
quantitation of the compounds of interest. The microsomal 
blank consisted of the reaction mixture without B[a]P.
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Figure A-23 Microsomal blank chromatogram for the chicken.
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Figure A-24 Microsomal blank chromatogram for the Japanese quail.
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Figure A-25 Microsomal blank chromatogram for the turkey.
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Figure A-26 Microsomal blank chromatogram for the goose.
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Figure A-27 Microsomal blank chromatogram for the Pekin duck.
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Figure A-28 Microsomal blank chromatogram for the Khaki Campbell duck.
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Figure A-29 Microsomal blank chromatogram for the Muscovy duck.
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Figure A-30 Microsomal blank chromatogram for the rat.
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CHROMATOGRAMS OF BENZO[a]PYRENE METABOLITE FORMATION
Representative chromatograms of hepatic microsomal 
B[n]P metabolite formation by control and /3NF-treated 
avian species and the rat.
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Figure A -31 Chromatograms of benzo[a]pyrene metabolite formation by chicken hepatic microsomes.
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Figure A-32 Chromatograms of benzo[a]pyrene metabolite formation by Japanese quail hepatic microsomes.
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Figure A-33 Chromatograms of benzo[a]pyrene metabolite formation by turkey hepatic microsomes.
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Figure A-34 Chromatograms of benzo[a]pyrene metabolite formation by goose hepatic microsomes.
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Figure A-35 Chromatograms of benzo[a]pyrene metabolite formation by Khaki Campbell duck hepatic microsomes. NJoo4^
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Figure A-36 Chromatograms of benzo[a]pyrene metabolite formation by Pekin duck hepatic microsomes. 00
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Figure A-37 Chromatograms of benzo[a]pyrene metabolite formation by Muscovy duck hepatic microsomes.
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Figure A-38 Chromatograms of benzo[a]pyrene etabolite formation by rat hepatic microsomes. N)oo
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